word
"4),"
20h
ice
(30
(5%
(23
(25
eb1
lbd
aps
"sa,"
bes
22c
tcp
6k.
(1m
"6),"
mg.
nir
2ml
(8%
ddt
(%)
10m
17c
(~5
"mg,"
"v),"
9mm
12h
(24
8k.
"11,"
ttr
wrn
iso
10k
4c.
(17
spg
rsl
via
16c
39b
its
(75
sat
hck
psi
ki.
(mw
ck2
5).
(22
old
six
"1k,"
[ph
"42,"
"40,"
"38,"
"36,"
w/w
gsh
"mn,"
mul
"oc,"
dpd
"1,3"
kna
37k
"25,"
"30,"
idh
cat
d2o
pbg
"3k,"
k).
rt:
"2,0"
8ul
cit
cys
ppg
"cl,"
c2b
min
"ki,"
"kf,"
u3s
"eg,"
(or
mg)
(mr
"2,4"
"ml,"
nmr
(at
"2m,"
1+1
any
um)
n2.
"s.,"
"r.,"
"v.,"
"a.,"
mpg
v/w
mkl
ph5
(13
tpl
(35
gly
/ml
"m),"
dme
#87
vp1
[25
kbr
li3
dpa
"um,"
"5,5"
"20,"
lpv
udp
tdm
up.
ii)
mag
sor
bar
5ml
iii
"hf,"
1nm
(+)
gps
mer
fed
i3c
ctp
ph8
"4%,"
pet
(32
ttp
pre
"(r,"
pnp
cmp
"6r,"
2og
"b1,"
a12
ped
dip
"15,"
"7%,"
kit
(7%
ip3
ph4
pep
(no
na3
#32
7).
"8%,"
"up,"
red
mmt
"ca,"
gtp
9).
8k;
0mm
tag
tev
apo
pcb
na2
"br,"
"m.,"
meq
(to
x/v
"zn,"
"3%,"
(45
c).
6k;
"in,"
h2o
ump
coa
4k.
d-l
vp4
(ie
kcn
pef
may
put
mib
pge
no3
nap
"9%,"
na-
al.
(up
"ii,"
ion
has
"
1"
"k.,"
(v/
20k
25k
22k
ul)
(59
set
ph7
"3
"
w/o
18k
"29,"
"rt,"
cap
cpa
"10,"
.1m
had
15k
"2%,"
"0,1"
bis
"
5"
con
24k
.2m
lot
16k
21k
you
end
can
13k
"na,"
"
8"
o.1
17k
kpi
"
m"
"1,4"
bog
fad
kcl
ph.
egg
6ul
mg/
"
,"
bme
10-
few
"
a"
nai
1ul
mtx
ppe
mdl
"8k,"
dmf
tri
(15
ph=
"
4"
4ul
nh4
"4.,"
mm;
fbp
8mm
4%)
naf
g/l
low
sol
hen
mm.
btp
kda
[10
"7),"
way
"mm,"
mix
(w/
(14
"7,5"
ca.
atm
big
oeg
gel
new
(2m
ml)
"1,6"
box
01m
02m
5ul
"34,"
p21
out
g6p
"ng,"
7mm
6mm
(6%
pms
air
15c
pbs
"ac,"
tea
0.l
"8.,"
"5%,"
"5.,"
rat
sam
pol
19k
fmn
(3%
pek
"mo,"
"8),"
nak
all
8ml
4ml
dt.
"c),"
am.
"5k,"
"ph,"
h20
add
(na
ph:
"1.,"
due
imp
"26,"
1ml
"ul,"
2ul
co.
kh2
po4
get
o.2
sea
18c
inh
21c
2+2
ph6
no.
"
+"
"me,"
hr.
gpb
bba
rt.
bck
(12
(ar
ppm
"1m,"
~20
"k),"
"
2"
(16
"1,2"
ib2
23k
dte
gas
"
3"
dna
"3m,"
(in
"
6"
(11
(9%
f11
lre
a11
gol
ado
bef
off
cut
3b4
btb
#29
co-
gtb
iss
c33
n2)
lgk
??m
8k)
#28
4k)
[50
ndm
tbg
"f3,"
mgl
"c2,"
cm2
utp
"b6,"
"h6,"
e10
b11
"2
"
22-
#20
h5:
??l
bta
"66,"
oc.
m11
ph-
adk
g7)
#15
e1:
pgh
o/n
bsm
"m
"
etc
ddm
sit
"fd,"
(i)
b10
e3:
mol
a10
phy
l-1
eg.
c4:
[20
b12
eng
(60
0-4
cdo
(2%
3na
paa
kmb
e8:
kmo
upf
g7:
8).
dho
1.m
g4:
mif
gpp
og)
ipn
#96
"1),"
is:
h2)
"nl,"
#65
4oc
~13
~14
dl-
2d6
"6,5"
scn
#81
#45
f4:
"b4,"
trx
m/v
"f7,"
a8:
g11
10*
pea
"68,"
c2:
"h7,"
bp2
4c:
stx
dye
7))
ahl
tew
#46
aaa
lmb
5'-
4b0
sbv
bsa
"ht,"
"8,5"
lys
myo
sbg
"
:"
aal
rod
c9:
sg1
~12
5k;
hsa
bxa
tce
(48
14c
hmw
kn2
sta
mw.
mal
tir
pkt
sf9
d2:
1%.
fsr
(#9
5gp
eg]
50)
wck
pka
pbt
bam
"14,"
cd2
omp
f6.
ppt
f7:
kan
~35
bcs
3&4
e11
a6:
3hr
h12
ipa
pvp
atc
ap1
[32
kac
(39
map
pho
act
g2:
dc;
h11
(33
smt
??c
18h
tdh
edo
cpd
dhp
eth
~24
eg:
#61
bsi
#31
efe
~39
(+4
opt
d7)
rpm
c3:
g9:
nms
(+1
20m
"c9,"
kpo
tdp
xiv
d11
"dc,"
h10
~1m
(nh
xvi
a4:
peh
ids
koh
c8:
b6:
"n2,"
aha
(as
e6:
"h4,"
c6:
(m)
g8:
g1:
ebs
h6:
d9:
"e6,"
"a4,"
g6.
ml;
mcl
"80,"
sec
(4%
g5:
f1:
a2.
"4m,"
19c
d4:
f10
sds
~10
"f9,"
(ht
d7:
ul-
"a8,"
pfg
tes
~30
aid
c1:
"on,"
ul.
"d6,"
e5:
e4:
h9:
g3:
li2
b1:
25c
d1:
bio
"0,2"
4k;
f8:
(26
"g6,"
(80
mse
dcs
"d2,"
hit
vs.
dih
c5:
e9:
"pe,"
"2,5"
d3:
"a5,"
"c8,"
pag
h3:
k15
"fo,"
"v8,"
top
"
("
pda
"og,"
xii
g10
"a2,"
16h
"c6,"
f9:
"b2,"
e2:
"h3,"
a2:
a1:
"a6,"
ln2
"h9,"
"9),"
"f1,"
fol
sh2
b3:
(85
25-
"d1,"
"d7,"
(mg
"d3,"
"a9,"
b5:
"e1,"
~ph
ten
dmo
"f6,"
a3:
nl-
mrc
hed
"b5,"
~25
f2:
f6p
c11
cko
oac
h2:
c10
~15
lcp
(27
uox
nl.
8c.
cdp
1h.
seh
sah
um.
72h
nl;
dry
1hr
(19
h2s
mg;
d12
"12,"
nps
na+
gmp
use
"h5,"
a4.
aab
pdg
(21
ph)
eg;
kdo
[11
c7:
uk)
asd
m/m
"a3,"
d5:
c6c
b7:
p.h
g6:
ans
vdx
b2:
h1:
e12
f12
sd2
ca)
it.
30'
"2a,"
b4:
wt%
b8:
f3:
ml.
"6%,"
#6:
db:
"1,5"
"g8,"
"e4,"
"g5,"
pee
10)
"a7,"
"b9,"
"d5,"
a9:
cpr
#92
e2.
"h1,"
a5:
10x
d6:
"g2,"
thp
mmw
chc
f8.
5um
p/v
ph9
nl)
abc
(47
ip6
a7:
24h
c12
hai
"c5,"
thf
d/l
d10
nsc
id:
h7:
b9:
#1:
qeg
ihs
(18
mpd
oil
mes
"6k,"
"9.,"
"as,"
hrs
"5),"
t=4
mm)
pga
(50
deg
ams
for
tfe
"4c,"
(10
dtt
"7.,"
his
"2k,"
mm3
mme
"ts,"
"6.,"
3ul
gdp
of:
1).
see
2mm
(ph
(20
v/v
in:
"4k,"
pdb
did
was
3mm
amm
not
day
4mm
5mm
let
the
peg
adp
and
one
but
atp
+/-
plp
(40
ada
20c
1mm
so4
per
"ar,"
"c.,"
"1%,"
w/v
hcl
amp
nad
(by
two
are
"nog,"
mili
etoh
inva
02.m
"4k.,"
sgpp
rate
h12:
5-8%
g10:
poly
"i3c,"
(3.8
"c12,"
(40%
2.6m
8.3)
"2.9,"
m2tm
co2+
"aha,"
best
1/70
conc
"ln2,"
"pgh,"
grk6
ahpd
(4.5
"6-8,"
200m
"edo,"
c12:
"e11,"
h10:
soln
#NAZWA?
4.8.
64mm
6.8.
"7.6,"
"oik,"
gssg
file
temp
ml):
so4.
3-4m
12um
sb12
mwco
"ddt,"
meso
7.5.
15ul
e12:
ches
"tpp,"
10ul
"250,"
h2o)
"w/w,"
"19%,"
"udp,"
kscn
1-3%
35um
8mul
100m
ml-1
1:1)
"asn,"
7-8%
14c.
(22%
"rt.,"
a.m.
1.0m
zpr.
27mm
"pbs,"
"5:1,"
ampc
"pp2,"
6.1.
(1.1
"p8k,"
6.3.
pegs
5-6%
mk-2
(as)
"8.1,"
parp
d12:
[3.5
pfpc
"mm
"
"5-9,"
7.1.
farm
al's
g12:
276k
"4.1,"
(1.3
mmcr
"15k,"
"tea,"
pmsf
"c11,"
"b-4,"
100k
(~20
"bes,"
"ion,"
"6.7,"
12mm
70mm
1.5l
6.2;
0.7m
"k15,"
289k
"naf,"
"gdp,"
%v/v
0-5%
1.9m
"3.9,"
[0.1
"bec,"
(not
abh.
b11:
"h11,"
b-4:
5.8;
[16%
"fdh,"
"g11,"
jnk3
"57%,"
(8.7
abdc
ung2
6.6.
5.7)
(spg
95um
adp;
licl
(1.5
7.8.
(5mm
meoh
naf.
8.6.
csht
pdtp
"eq),"
nadp
8.2.
apcf
"fmn,"
"b10,"
7.0)
"g12,"
[0.2
79mm
"
7,"
a10:
"g10,"
).1m
7.2)
8.3.
ibmx
e11:
(3.5
"kdo,"
such
plp.
8.3;
8.2;
"8.3,"
"600,"
"thp,"
(mdl
"8-9,"
ph's
(24%
80mm
home
(0.2
"d12,"
"b11,"
"day,"
h11:
w/v%
"38%,"
6.8)
"h10,"
coa.
grb2
"
8%"
"cit,"
jcsg
upon
(32%
4.6.
11mm
(~12
20c.
9.5;
(14%
sol.
thin
"k,na"
"f12,"
"ph4,"
4.1;
"8.4,"
"3.5,"
7-9%
"16%,"
nabr
mix)
"mix,"
7.5)
275k
25%.
nacl
mol%
(8.8
6.7.
"cdp,"
7.6.
302k
310k
host
code
"low,"
7.8;
"2og,"
lcp)
0.9m
na-k
d2o.
30um
"335,"
"3.2,"
cmp.
0.21
"5mm,"
mg/l
5.4)
nai.
6.3)
"18c,"
9.0]
(ttp
"4.7,"
"10k,"
5.6)
adp.
"msh,"
"5.1,"
nag.
gas.
1.4m
(art
(0.1
na2s
dudp
3.0m
303k
test
na/k
5.7.
nh4f
"di-,"
mek1
4.2;
mihs
trka
0-25
(1:5
8.9)
dump
"ice,"
dutp
"hrs,"
"8.6,"
bef3
8.8)
(68%
jeff
imp.
"pap,"
bdm.
"7-9,"
"ate,"
(6.5
hpca
pcpt
"
2%"
"4.2,"
hrs)
282k
"15%,"
ssei
4.6)
(2.2
took
(6.0
peak
"350,"
(lb)
1aw5
15um
"atp,"
"leu,"
mg2+
"ph),"
mmp9
f11:
room
ln2.
"e10,"
4-oh
"9.8,"
"uma,"
cold
"gpp,"
"
15"
"4.3,"
"
4%"
40mm
"ppi,"
"vo4,"
ns5b
f67d
d10.
"22%,"
"30%,"
neat
cyro
dtt.
"
25"
0.1m
fad.
puck
"
na"
0.1<
four
3.0)
"vii,"
"
16"
42mm
k/na
"0,7m"
"9.1,"
3.8.
"
12"
~3-4
nad+
diol
550;
text
goes
"6,5,"
"h12,"
"5,5,"
"min,"
"9.4,"
f10:
this
248)
0-2%
"
27"
36mm
305k
(5.0
"832,"
drug
ni2+
(mmt
"ump,"
7.2;
dtt;
287k
b12:
5.1.
nad;
e10:
(2.4
0.3m
min.
zinc
"
30"
"pep,"
291k
a12:
"tis,"
oil)
sp-a
d10:
f12:
o.2m
44mm
b10:
sat.
g11:
"20),"
core
"1ul,"
h2o2
b-tr
mme.
(3.6
"ans,"
(2.6
chap
"g6p,"
"20c,"
boxa
q83s
rmla
naci
each
(1.4
tirs
a88m
"v/v,"
"1:5,"
mura
azm.
7.3-
(26%
5.8.
case
prpp
"
24"
"
22"
d11:
c10:
"imp,"
"mtt,"
peg3
(2-3
jrnl
taps
"400,"
fhit
mag)
"5.3,"
(2.5
284k
ros1
73mm
"270,"
301k
3.3m
4.2m
4.5m
4.4m
xtal
550)
"ipm,"
61mm
274k
"f11,"
65mm
4.0;
10um
"oac,"
"c10,"
"pdf,"
"hai,"
"14%,"
"d10,"
"gol,"
"d11,"
5-9%
1.8m
ul):
"22k,"
3.5)
tool
"8,5,"
aha.
"4.6,"
~0.1
glpf
(0.4
35mm
"g1p,"
"tmp,"
"abh,"
"1,4-"
data
"mm.,"
days
"8,5;"
gdp;
citr
"7,5,"
"pga,"
5.5)
0.8m
"asp,"
"mmt,"
"290,"
i.e.
(7.2
hcl.
o.1m
m.s.
4deg
mono
(5/4
"31%,"
"
1%"
50ul
8.4.
10k;
3.1m
",0.1"
"4-5,"
1-2m
2-5%
mthf
when
(ref
half
"anp,"
30%.
5.9.
8.0;
4.1m
tmao
(150
t=22
t=20
5.6;
4.7;
"ph9,"
egta
kept
pegl
"npi,"
6.7;
6-7%
they
"50%,"
3-5%
[35%
mix.
50nl
(20%
39e.
"sam,"
f-68
"d60,"
"1,6m"
[100
"21%,"
sulf
5.2;
4-7%
33mm
17mm
pa1l
mn2+
c8e4
ph4.
4.0)
"298,"
"aps,"
2-me
"pcb,"
38mm
mag.
wind
move
7-8.
dhap
gave
(1m)
"24%,"
imid
"0,2m"
"ppg,"
form
(60%
"6.3,"
"dfp,"
(1.9
1-8%
20mg
2mul
"0.0,"
13mm
392k
"nai,"
much
"238,"
312k
amm.
"18k,"
hcl;
"24h,"
"256,"
ndsb
mes;
"bmp,"
"23%,"
prot
mme)
313k
"70%,"
"mdp,"
"btp,"
20%v
step
(12%
8-9%
7.9.
"
90"
"nl),"
(300
"
6%"
"118,"
soc.
"no3,"
292k
"4oc,"
"idh,"
roy.
(3:1
(15%
"60%,"
"pbg,"
16c.
agao
"195,"
"9.3,"
20k)
6.5]
6.6)
"
75"
dhfr
"ddm,"
4.1)
k-na
(1.0
mm3)
fold
"2.5,"
1-4%
ph5;
"ipa,"
(ww)
some
than
unit
spin
"18%,"
dmso
rbcl
box.
(7.5
1mm.
(25%
2-3%
cacl
(ph:
was:
4.0.
"koh,"
(21%
"1mm,"
(291
60mm
30mm
ldao
12ul
tera
"9.7,"
5.0)
400)
15mm
more
mgac
v/v.
mpd)
atom
"900,"
"mrd,"
7.4;
"mgs,"
4.8)
ipns
76mm
both
w/v)
p400
ph6.
5.3.
"ipp,"
5.2.
6.9.
peg.
acna
(pdb
4.2.
aces
emts
cdcl
"100,"
"d2o,"
"201,"
"3mm,"
5.6.
271k
7.0.
part
308k
oppa
"ul),"
20um
uric
d(+)
"293,"
~2.0
"kbr,"
95mm
"13%,"
1-5%
18mm
(17%
"+1.,"
feii
crii
"c).,"
"2.2,"
"x29,"
fmn.
"5/4,"
v/v)
(23%
a54l
"000,"
peg4
5.9;
0-4%
v/v%
5.1;
(18%
14mm
6.2.
"pei,"
45mm
mole
last
(10%
"2.6,"
6.5;
"35k,"
(27%
"utp,"
nad.
.01m
6.5.
398k
468)
25mm
t-na
"gsh,"
mops
"797,"
"426,"
pure
7.1)
3h2o
(55%
g/ml
(0.3
bis-
ph8.
9.5.
ph7.
"tes,"
"3.4,"
plp)
v/v:
5mm.
most
"bh4,"
2-3m
tri-
mibs
tray
318k
ice)
"dme,"
"sah,"
(35%
"gar,"
amp.
cymr
hits
(7.9
kpo4
"chs,"
"cmp,"
"5.5,"
(0.6
bme;
7.3.
ntca
"0,05"
bind
"g/l,"
2.2m
"(4r,"
"3.6,"
(6.7
"1-1,"
k12.
hhed
(5.4
"spg,"
300;
kcl;
m600
"gly,"
"d58,"
393k
blue
dark
1.5k
"300,"
"fbp,"
"2,5%"
g/l)
4.2)
4.6;
t=23
"p21,"
4-8%
"0,1m"
(w/v
(v/v
6.4;
make
like
2-8%
4.5;
grid
k99a
"27),"
oil.
very
acsd
(298
zncl
pctp
(33%
five
(ii)
"ptn,"
gsh.
long
"35%,"
"nbg,"
"ptp,"
9.5)
",10%"
8.0)
"221,"
(2.0
hrs.
"dnc,"
(16%
1-6%
83mm
(2.1
67mm
"7.9,"
pact
3.7m
.02m
ions
zn2+
"air,"
fe2+
85mm
mass
"
2m"
bace
"f10,"
1-2%
5.5.
32mm
"4,6;"
"9.6,"
base
onto
"12%,"
"dte,"
"6-7,"
",and"
"3.7,"
4~6%
"2mm,"
"3.3,"
mes.
"7.4,"
(3/4
0.2n
"gas,"
"xmp,"
(1:2
(2:1
amps
kcl)
2:1)
(1:1
%w/v
"2k),"
6.9;
4.4)
mode
xprt
s1ra
"
1m"
"kcl,"
only
less
270k
urea
3.4)
"cl2,"
mol.
heps
4.0m
"arg,"
7.8)
4-6%
87mm
"paa,"
25mh
"629,"
(1.6
"obg,"
316k
hour
"26%,"
"ph5,"
"pps,"
back
held
4.3m
(so4
15mg
(3.2
sirp
3.5.
made
atp.
bank
plus
4-5%
1bpb
pgme
(2.8
"n/a,"
8.5.
ca2+
293k
"7,5%"
"2.8,"
"so4,"
"5.9,"
7.7.
7.7;
(4-6
"2.4,"
"s3p,"
grow
7.5]
"7-8,"
them
"p4k,"
mbco
bead
"40%,"
"500,"
pgis
h12)
(28%
rods
6.0.
63mm
"32%,"
4.5.
2.1m
5.0m
"w/v,"
24mm
(9.9
mncl
8.5;
"amf,"
2-7%
9.0.
ump.
dctp
w/v/
"etg,"
3.0.
2.0.
"lis,"
(29%
nai;
"11%,"
"b12,"
"3.1,"
91mm
5.0-
(~70
268k
(19%
rebc
323k
6.4)
mme;
2.4m
(65%
(50%
(the
situ
hplc
mm).
e65k
"nag,"
(250
"kdn,"
wt/v
siap
caco
5.2)
8.7)
0-6%
(3.9
"v/w,"
b-me
7.7)
286k
"kcn,"
4.3)
(500
%peg
3.4m
8.4)
(7.8
lead
"2:1,"
"h4b,"
395k
nrfb
7.2.
10mg
50um
camp
apha
have
cgmp
"mib,"
"the,"
23mm
pmme
3.8m
"ces,"
(9.5
"ip6,"
(0.8
orit
"ctp,"
"
40"
"
7%"
"gel,"
chey
5.5;
loop
0-50
"45%,"
"dna,"
good
8.1)
2.9m
coat
"an
"
used
opt:
3.9m
h60a
naoh
dhps
v/v;
give
(h1)
"550,"
degc
(ph=
"gtp,"
1.1m
embl
"p1k,"
"sm1,"
b4).
jscg
c9).
20k;
(0.9
8.2)
8.8.
"tdp,"
"lre,"
"fad,"
vcph
"k.
"
"6.6,"
kbr.
(160
pcmb
mpd;
6.0;
"196,"
"7.0,"
mgcl
5.4.
does
time
"dtd,"
(~10
285k
agar
plut
"ttp,"
(peg
gdp.
tpp;
c29s
apc4
"7,5;"
"4:6,"
6-8%
a.s.
10mm
tc2p
none
10k.
ck1d
a-86
tris
holo
(135
akt1
datp
ddao
281k
~0.2
"id
"
kno3
"um),"
"kpi,"
tent
uk).
"2k.,"
3-6%
well
"8mm,"
grew
(900
fegp
"agt,"
"
mm"
m.w.
gsad
5-7%
20%)
tert
3-9%
"5.8,"
"of
"
prfa
(mmw
[40%
500*
(100
gsmt
69mm
31mm
4.8m
18c.
"na,k"
br25
1.7m
week
"8,0,"
ph=8
[0.3
(3.7
0.4m
278k
~20%
"8,0)"
12c.
ap5a
50mm
"2.7,"
"f6p,"
(8.3
ampd
caps
pfn1
egfr
hung
mes/
came
"6.5,"
mpeg
"4.8,"
(lmw
pfo.
4.1.
0.5m
nh4i
dedn
"ph
"
"dtt,"
inos
8.1.
then
pj34
"har,"
dopc
5.0:
"h2),"
"
20"
(95%
"5.0,"
yihu
"10%,"
kits
4.4.
(mes
znac
"3.0,"
"4.9,"
open
0.5-
24-h
16%)
been
(30%
"oil,"
283k
40mg
zcd2
1:2)
"7.3,"
ptcp
hyg5
alfc
sqrr
0:1m
hdm2
uvsy
"2.0,"
bmp8
thdp
"oaa,"
(31%
16mm
suib
"8.9,"
"6.4,"
(for
9.0)
(1.8
bme)
6.5)
"1,54"
ttr-
6.9)
erk2
"6.1,"
pala
14c:
8.6)
"ph7,"
(2.7
2.0m
6.3;
type
wild
17c.
"peg,"
315k
"pvp,"
gold
"lm),"
(na+
"nh4,"
ire1
rtev
7.5;
3-8%
ice.
"mme,"
"75%,"
ht96
280k
amcl
prib
20oc
acta
"ada,"
many
8.5:
suit
1.2:
naac
acet
"
28"
"h2o,"
"po4,"
cp42
300k
[0.8
2(1)
"0,03"
2-pg
edta
277k
tecp
279k
(md)
(37%
~25%
"
to"
mth1
~0.4
(230
drop
4.0k
195)
55mm
2.3m
"0,25"
"ams,"
hcgc
sbtb
5.8)
sah.
"8.8,"
hcl)
tube
"na+,"
mme:
with
"and,"
etc.
~100
lare
were
(bsi
7.0;
sd-2
"ala,"
"lys,"
(541
ul).
(188
fill
coa:
4.7)
saro
5.5:
brr2
over
4.6:
napi
cdk2
psf4
note
6.5:
flat
"up
"
"25%,"
"plp,"
7.4)
ddm;
(see
down
"ph8,"
term
6.2)
life
nan3
"0.2,"
"0.1,"
nasa
2.8m
rctb
nad:
78mm
set:
prpb
/koh
"8.0,"
(200
0.6m
"
by"
7.4.
(140
null
into
mix:
nine
cm26
"deg,"
naf;
at15
6.0)
mega
"coa,"
"5,0,"
%mpd
5-ul
20k.
"5.6,"
"8
4"
coa;
1.2m
blga
"9.2,"
cbtp
ul44
0.lm
"mm),"
(0.5
gift
tcdh
frra
"2-
"
naga
8.0.
273k
(ppg
(1.2
adha
pfoa
"1/1,"
1/2)
"dmf,"
size
"750,"
min)
bme.
cryo
cscl
kcl.
2-4%
2-6%
295k
"e12,"
8-5%
msba
296k
larc
"20k,"
(2mm
"1,4m"
febs
day.
7.5:
tf85
"cl-,"
"8.7,"
5.6]
once
acid
~1.7
"hal,"
zn+2
nadh
"tln,"
mpd:
nai:
see:
(4.8
mpd.
"amp,"
"12,5"
"bme,"
"7.7,"
prop
slip
xiap
gmha
"6.2,"
"7.2,"
"
in"
13oc
"342,"
"246,"
gdp:
290k
mrc2
"al.,"
7.0:
"sbg,"
"pck,"
p218
foxe
3.6m
"20%,"
vol)
salt
5.0;
"9.5,"
hees
5.6:
4rse
"
3%"
"28%,"
soak
peg-
4.5)
hras
157c
done
48h.
(2.9
from
288k
min;
(128
that
caac
(atp
adp)
294k
"5-7,"
a59t
sida
"4.0,"
puta
"17%,"
40um
dtt=
"4.5,"
600)
0.2m
"red,"
"mpd,"
(9.0
"5.2,"
#36.
free
(9.7
"5.7,"
oryx
tog2
"kac,"
"psa,"
"5,15"
emob
5.0.
7.6)
just
"ph6,"
mes:
"
at"
"hcl,"
"7.5,"
tcep
75?l
"0,66"
3-4%
4.0]
[65%
next
7.6;
(8.0
3.2m
"
ph"
(bcs
leca
dead
seed
kpho
"5eu,"
6.1)
gtp)
"hts,"
cent
"dho,"
1.5m
"6.0,"
"1,6-"
cona
2.7m
phd2
110k
"072,"
600;
(80%
"4,6,"
"5.4,"
fine
csac
dmf)
eur.
tw12
"1/2,"
"
10"
cppu
vcid
"6.8,"
1/50
4.9.
(ph-
"box,"
dtnb
cd73
sddc
380k
"8.5,"
(4.0
ssue
~2.2
left
v/v/
"dap,"
c.a.
plp:
"
5%"
6.4.
"
32"
"nps,"
bpti
19c.
full
6h2o
"ip3,"
take
also
20%;
(3.0
"mes,"
"oga,"
"3.8,"
"poc,"
deg.
"9.0,"
cps1
"pkt,"
"0,10"
"1/3,"
hewl
[14%
adp:
298k
udr.
c148
dtt)
90mm
"
35"
jena
20mm
pde4
mgfp
1.6m
"
50"
p450
near
"1:2,"
299k
1.3m
[25%
"800,"
iron
mmol
"un9,"
th6h
3.5m
297k
mpro
pgqc
"6.9,"
ones
"
33"
(120
4.7.
1fua
"5
1"
(6.6
ycbb
phos
(11%
"pd2,"
mcsg
9.0;
mes)
site
same
"sds,"
mmes
a11:
"bog,"
"200,"
(600
"7.8,"
atp;
400;
8-6%
beta
ph=6
nnmt
peg;
"nad,"
hak3
cddp
75mm
01.m
daba
(eg)
kbr;
epps
(8.2
(45%
vivo
(9.8
"8.2,"
yjia
dtdp
2mkl
coli
"adp,"
o.n.
"lcp,"
"kit,"
(1-2
ppeg
~7.5
cucl
"gmp,"
slow
7.3)
(7.0
"cp7,"
sam.
"0,04"
2.5m
"1:1,"
galk
#21)
cylk
86um
6-9%
high
"7.1,"
8.5)
"
of"
"4.4,"
fphf
~2-5
cell
temed
"3.5),"
clean
"6.6),"
"(mpd,"
(ph4)
ph9.5
"pdtp,"
"8.9),"
7.50.
"9.75,"
"mes),"
round
"8.35,"
l-leu
teaoh
3.8mm
khpo4
"1.0m,"
6-12%
ph6.8
27-30
congo
6-6.5
2%-8%
0-250
"ph=6,"
egta.
tris.
naact
10.5.
mvapp
"0.8m,"
w/v-%
cover
=8.0)
4degc
46-67
grp78
srcl2
16deg
2:2ul
193k.
0.5ul
with:
6.32)
mopso
drop)
"(c1),"
6000;
(1.04
"dmso,"
tetra
"2001,"
caac.
"6.64,"
(8-10
(2.5m
xenon
neoca
(v:v)
etgly
4-4.5
mesph
"0.6m,"
5%mpd
"
fdh"
"8.2),"
mticl
p218:
"193k,"
0.28m
binds
1.28m
"5.57,"
r5645
"
22%"
"inha,"
"5.8),"
sadta
"
1.0"
"ph=9,"
0.23m
"tris,"
size)
2.5-3
100nl
tbcl3
tcep;
from:
(0.04
"pbp3,"
"dte),"
"d6:
"
phase
"5.05,"
2-dos
eg009
2+1ul
(tcep
"nbd1,"
16-18
6000)
adc-7
"6-7),"
"acet,"
"400.,"
"282k,"
17-23
1.5:1
420um
(1.7m
glnk1
22-30
3.15m
gamma
"7.7),"
"tdp.,"
lta4h
nh4br
date:
"wee1,"
"ftsz,"
7-10%
hemin
3350]
"thin,"
"4.0),"
ml-1.
6-14%
salts
0.36m
final
(0.2m
"6.54,"
trays
bcs-1
"(a7),"
robot
atad2
"myt1,"
0.34m
"2.5%,"
"heme,"
amso4
(0.03
"brdt,"
"3-cb,"
250nl
(less
280mm
"15/4,"
ph7.1
"cacl,"
k252c
"paps,"
(cat.
"3,000"
0.90m
d674a
10.4)
d564n
metoh
1.5ul
"6.1],"
0.2ul
26-32
"350),"
znac2
15-34
chaps
"
17%"
0.07m
(lll)
8.50:
2.20m
6-15%
0.64m
0.3mm
2000)
brief
0.5-1
cymal
"2,000"
kpc-2
"20c.,"
"7.33,"
2.35m
2.88m
ph7.2
"
33%"
14-18
"(b5),"
9.1mm
(m/w)
(1:20
(9.34
nonyl
(1:1)
0.95m
"6.86,"
c671a
0.21m
298kk
"gspp,"
"4.43,"
twice
dmapp
mme).
2.0mm
18-22
"
1.5"
3--5%
18-24
(dho)
5.0mm
1.8mm
coash
(tea)
4000)
1.32m
"4500,"
(m/v)
"3.75,"
"p400,"
0.02m
"6.4),"
semet
(h2o)
(11.3
"9.6),"
c671s
virus
"4.69,"
(0.5%
"dtt),"
3.85m
"ap6a,"
"dadp,"
"hewl,"
"9.4),"
motic
"edta,"
2.45m
14-26
20-27
green
"310k,"
7.6-8
naa50
index
"4.89,"
"5.89,"
napo4
0.13m
"jona,"
order
(14.3
(13.0
"4.4),"
1.00m
l-asn
(1.2m
"-7.0,"
"3-14,"
3.86m
ybcl3
"4.1),"
0.54m
"48.5,"
420mm
240mm
(1+1)
"form,"
store
(0.1m
"7.0.,"
"2,2,2"
c202a
2.27m
15sec
"3550,"
"6.2),"
"1.2m,"
"5.4),"
800mm
3/75%
"fggs,"
"6.7),"
"4.30,"
"273k,"
2.28m
mgoac
10sec
"
kcl"
"
1-5"
0.05m
"
1.6"
mouse
mgatp
"v/v),"
paics
slip.
"5.51,"
namal
apply
sodio
f16p2
"7.4),"
"4.2),"
"tmao,"
"7.2.,"
"pddf,"
"276k,"
0.85m
"cdcl,"
"zncl,"
"citr,"
"tmpa,"
(3-30
17-21
l-orn
ultra
0.11m
"5100,"
0.63m
0.65m
(each
desa2
3.35k
"znac,"
vapor
w1807
heavy
(18.0
salt)
(12.0
1.5mm
"ph6,5"
"day.,"
"7.5,,"
becl2
"8.15,"
v/v).
1.60m
150nl
(mmw)
"9.0),"
(sam)
e184k
peg6k
1.5ml
oxide
"adpr,"
hdac6
(15/4
"7.3),"
(0.45
200nl
5-20%
5.9);
appro
ph7.5
mops)
"mme,1"
mg2cl
night
1:10)
"kcns,"
"kcl2,"
1.2mm
15-30
7.0);
"temp,"
quick
27-31
5.0).
p6000
(pegs
1.25m
"ndsb,"
(bme)
35-40
2.15m
"naf.,"
ph8.3
1.64m
8-16%
"5.2%,"
l-asp
"cd2+,"
1.45m
0.92m
sirhp
"8.65,"
"dark,"
15-24
ph6.9
3-10%
0.9-1
hour.
4-10%
"6.3),"
7-13%
nan3]
"7.39,"
400nl
"co2+,"
100ul
cryo.
125mm
"8.5.,"
"3100,"
drop:
sodc1
glyco
4-14%
m-2.0
3350;
(from
25-28
l-arg
equal
"5.35,"
"7.85,"
neaca
"
0.8"
"(4%),"
"acna,"
"fspp,"
5-25%
acnir
"8.0.,"
30-80
4000]
"5.79,"
0.8-1
"6.33,"
mb002
"
13%"
"5.85,"
field
(0.5m
(13.5
(10.0
220mm
"15mm,"
"seed,"
amac.
291kk
sattr
"size,"
"5.0.,"
"
24%"
6.5:1
"cgmp,"
26-30
iu/ml
mucin
"4.15,"
"
3.5"
"mme),"
total
"11.5,"
b-me.
115mm
36-44
15-18
ac2cu
16-22
(kind
"h2o2,"
fatty
"6.76,"
"(
28"
4deg.
"12mm,"
serum
0.46m
"po4-,"
(30.0
"4
25"
"soak,"
tube.
200um
klpdc
tcep.
color
2.00.
"7.0],"
urate
kdo1:
1.3:1
170mm
macl2
w191g
ph3.5
myd88
(size
0.14m
"4.6.,"
0.19m
126mm
k112a
atpgs
15-17
"
28%"
"nnmt,"
week.
"287k,"
"(2/1,"
0.1ml
sizes
21oc.
0.1ul
k112r
liter
24-48
45-50
"2h2o,"
2.6mm
"rbcl,"
lino3
also:
na/ka
"3.8),"
free)
bacl2
(alfa
"1.4m,"
9-17%
"
mes"
8-8.5
4-28%
25-35
"5.64,"
"imid,"
0.01m
"cp42,"
"was
"
yop51
4:2ul
tylm1
"3.5m,"
mg/ml
"=7.5,"
caps/
"p450,"
"prop,"
7.2).
m-0.5
1-11%
2.52m
"6.5),"
dhp-b
1.52m
3.6-4
thn27
"hour,"
5.76m
40-50
lbadh
"21%
"
tbxo4
3.3mm
1.1mm
10-mm
"6.6.,"
(21.4
(v/w)
(p:r)
hex-1
"296k,"
(1ul)
"
1ul"
0-100
dtpaa
"2.2m,"
"300k,"
500nl
10mm.
1.35m
malic
h2so4
n2/h2
"7.4],"
"tecp,"
zn+2.
500ul
hmdii
mpd).
"sol.,"
(same
sodim
34-37
28%).
1.87m
(jena
well.
50-75
7-16%
15-45
irak4
focus
7.3).
peg3k
"6.57,"
1-1.4
110mm
ph4.7
50/50
soak:
well:
600um
340mm
degc.
"10.4,"
soaks
"6,000"
"dhpc,"
data.
"both,"
"d2o),"
0.7-1
yield
"vivo,"
10mmm
"8.1),"
"mag),"
smcl3
ams04
mgcl2
(cryo
6.75.
cryo;
0.60m
"(f9),"
0-0.1
"(d7),"
ph9.0
"cdk2,"
[peg]
"
16%"
2kmme
165mm
hcaii
"dthd,"
24-26
/w/v)
"eq.),"
"mg/m,"
w179f
gsk-3
2%v/v
midas
po/oh
1.9-2
6-16%
"4.54,"
(pst)
"(h7),"
pegme
media
"2hrs,"
cry3a
"(h3),"
"(d4),"
2.2mm
6.0);
ph5.2
light
5-ip7
5.5).
"198k,"
"liac,"
(g9):
"mst3,"
data:
clear
prior
"(g7),"
"(d1),"
6%-8%
277k.
"cell,"
"7.83,"
"gucl,"
0-20%
"3350,"
"(a2),"
"(d8),"
3000;
(6.25
x-man
"2.4m,"
"chey,"
"2.5m,"
"5.43,"
ph6.4
"unag,"
8-18%
base/
bolus
"mura,"
hair.
hepes
8.3).
5.5mm
30min
22-24
"5,100"
again
1.34m
nano2
(22.5
(20.5
(24.5
acid]
acid;
"7.65,"
"naco,"
6.7mm
ph6.6
"4.19,"
caoac
"4.33,"
"bath,"
"5.86,"
(22.7
0.67m
[v/v]
tray:
"
naf"
loops
dmso;
(0.07
9-12%
"30%),"
20-29
c327s
13-20
50-90
[0.2m
23-27
8%mpd
"6.04,"
kctd1
mmp12
"
400"
"
1.1"
wells
used:
"4000,"
ampso
ttrwt
kscn;
k2so4
agno3
"(e7),"
screw
anl-2
10.5)
8-12%
niso4
"5.5.,"
soak;
"7.55,"
"6.28,"
seal.
292kk
"(b6),"
(60.0
ph=7)
0.80m
28-34
top96
2.00m
conc.
ph7.6
(b4):
calg1
"(d3),"
"6.5,,"
"macl,"
"22,5%"
msgpp
8.5);
"9.25,"
500mm
(29.0
"v/v.,"
(mcsg
(39.6
10min
"cscl,"
1.16m
sceen
ions.
hours
mg.ml
each:
"4.71,"
20%eg
mops/
"7.4,2"
"200k,"
tray;
"
mpd"
k2po4
(lcp)
"licl,"
18-23
ches/
"(pc),"
nacl:
"(h1),"
loop.
"4.14,"
1.88m
46-52
parts
tris:
2.6mg
(+/-)
"(d2),"
"(f8),"
cryo-
(13.8
"rg13,"
"gsh),"
3350)
gsh);
mcsg1
"#89),"
(2000
400);
"(h8),"
eif4e
"mode,"
1.8-2
acid/
pmsf;
"(1h),"
6.5);
least
"6.1),"
"udao,"
bicin
"1.7m,"
na2s.
"kras,"
320mm
(plus
over:
code:
"only,"
"2100,"
"4.53,"
"
7.5"
"6.0),"
btac]
"eizs,"
dmso]
"4450,"
"1150,"
310mm
"(c6),"
were:
cross
jscg+
ph5.3
"
.1m"
pj34.
"atas,"
1.48m
fdump
1.50m
(1.26
16-23
27-33
"4cw2,"
"kda),"
ldao)
ca-ii
"meso,"
(type
"3.4),"
mcsg4
made.
trap1
20-36
f171d
25-30
taken
"(12%,"
cacl2
(1:10
"(as),"
mmp9h
e402q
"(a3),"
v391q
"(g4),"
(0.02
ph6.2
embio
nadp+
pipes
"phzf,"
7.3)]
"4.73,"
6-20%
(ls).
3.25k
14-20
"zinc,"
mcsg3
apcpp
comes
dtt);
(0.17
1.3mm
"pctp,"
"600.,"
"pq50,"
2000;
"agpa,"
24hrs
nadp.
7.6).
"
26%"
"(naf,"
"nai),"
urea;
"pcpt,"
named
ph3.6
aziru
ph4.8
fecl3
acid:
(11.4
cubmb
tray.
"tray,"
nanol
[w/w]
ssfs6
(dtt)
1000;
3000)
"(d6),"
"hcl),"
"5,000"
ph4.0
(3.25
"(c9),"
(35.6
(app.
1.2mg
"chap,"
(slow
qubic
105mm
"5.1),"
"(b9),"
"mbcd,"
"7.52,"
"dapd,"
"b-me,"
(mmt)
cr_24
smear
(11.6
0.94m
would
(jcsg
nadh;
"8000,"
(68.0
32-35
"0.4
"
fully
(34.6
mcsg2
200mm
"6.77,"
(42.4
2.40m
"5.97,"
month
mix):
pause
mgsc1
0.17m
"(a5),"
(67.0
mpd);
7.1).
"(c2),"
ypde1
(w:v)
chipx
(100%
(1.6m
1.56m
23-25
24-30
(0.09
"7.5],"
300).
0.3ul
prcl3
"peg4,"
0.8ul
"6.5],"
"nacl,"
4.6)]
2%peg
"(b7),"
8.0);
"mg2+,"
28-33
1.0ul
(ada)
amcpp
150mm
(0.18
slide
l-glu
doped
"
45%"
apad+
13-25
(29.4
peg1k
2-2.5
"1,000"
1-3.5
"efts,"
(11.7
(drop
(34.4
l-trp
"brd4,"
delta
(5-60
"atp,5"
"8.5],"
"(f6),"
20-26
"(c3),"
1.4mg
(w:w)
"5.66,"
(0.15
nacit
"dtt,3"
"6000,"
(32.6
poly-
appcp
1.42m
"(30%,"
nacad
1.4mm
mth1.
h307a
0.91m
0.49m
2%-4%
2-2.2
38-43
"6.9),"
biol.
0.33m
"grew,"
(ph7)
"geel,"
293kk
ches:
"6.72,"
10.5;
"8.8),"
325mm
hpgis
15-35
those
1.53m
0.84m
"8.05,"
"7.9),"
13-16
soak.
1w77)
since
1000)
"dutp,"
28-32
"hcgc,"
"degc,"
"2ylr,"
linak
"8.0
"
"(1:1,"
100mm
0.04n
"5.40,"
113mm
"8.3),"
2.5ml
3.0mm
capso
0.27m
"(md),"
0.68m
"ibmx,"
"nicl,"
k-po4
1.14m
(17/8
350mm
"(og),"
"4.35,"
glu-c
model
1500)
760mm
"11.0,"
"ggpp,"
1.27m
mmpeg
wtttr
"3-12,"
"3.0),"
"8.57,"
"3.7),"
"5-7%,"
minus
"6.17,"
"7.47,"
cucl2
"
18%"
rapid
293k;
"
35%"
tris)
"7.71,"
after
nabr;
madex
"dudp,"
1.6mm
"7)
5"
(hcl)
0-400
"2250,"
"dtmp,"
"5.95,"
"
11%"
100um
1.86m
"10.8,"
carsr
277k;
30-33
"8.67,"
"8.17,"
45-75
"lcts,"
"5.45,"
7.5))
7.4).
"2.0m,"
small
0.96m
ycl3.
drops
(that
30-60
1.5k;
1.1mg
"8.7),"
ph6.0
5.5);
4.43:
days;
6.0).
m7gtp
p3350
750mm
"(c5),"
temp:
315mm
3-3.5
refer
30sec
sweep
(both
ice).
(mpd)
(0.01
nadp:
"(g5),"
(puck
sugar
"popg,"
"pope,"
nacac
"otma,"
0.29m
fdh-h
"6.07,"
1.90.
2.50.
3.25.
where
"amac,"
0-15%
"pled,"
4-hrs
"7.6.,"
"0.3m,"
"1.1m,"
"ml-1,"
kclo4
230mm
l-ser
8-24%
weeks
"3,350"
20eg:
ph8.4
5.75)
281k.
caged
":
10"
":
15"
3%mpd
degr.
adh-a
"(c4),"
"(w/v,"
ph7.9
(2.0%
phaz7
"2x6a,"
16hrs
using
"udpg,"
"na/k,"
"tetr,"
added
"-hcl,"
1.5k.
0.93m
"1.5%,"
17-19
"550),"
1.8ul
(with
28-30
"nad),"
"naf),"
20-24
"ph7,5"
30-36
ampo4
2.63m
0.37m
"5,14%"
19-21
28-29
294k.
25-27
"5.55,"
"hemi,"
c-met
(0.05
"5.7),"
"alk5,"
298k.
"cryo,"
1-10%
"6.8.,"
2.55m
r9978
25w/v
aliso
"8.4),"
"alcc,"
(1.4m
1.6-2
naaco
20eg;
"w/v.,"
5-5.4
"drop,"
cat's
"3,5%,"
gdcl3
"6.43,"
"wbbb,"
magic
e100q
1/10.
di-na
"prfa,"
"card,"
1.84m
"(e2),"
ptp1b
"#14),"
50-60
calg4
"each,"
puck:
"2.6m,"
tcep)
"4600,"
0.5ml
nadp;
hour;
(peg)
"7.64,"
%v/v)
tecan
fiber
%w/v)
360mm
(20.0
14-24
1.18m
"3.9),"
"high,"
350ul
2.5ul
3.2m.
4.45m
2%-5%
horse
heart
5.5ph
15w/v
267mm
"grid,"
base)
(pact
7.0).
"0,05m"
(mme)
"6.85,"
"
3.0"
(31.3
large
1.39m
bace1
(1.7%
(1.0m
peg's
kdm4a
glove
soln.
3-12%
l-met
"dhfr,"
21-22
based
(nog)
#NAZWA?
k241a
"bis
"
"etoh,"
1.82m
momt5
"mops,"
107mm
(v/v)
"pnpp,"
1%w/v
4-8mm
"7.1),"
"
19%"
5%v/v
acids
2-20%
below
8.3);
"6h2o,"
salt.
cryos
suite
ph5.9
22-31
130mm
ratio
"6.29,"
"and
"
10.1)
"(f3),"
jm600
"mme.,"
"
21%"
(well
7-20%
ap5a.
cells
7.8].
20sec
"(2%),"
"(mes,"
molar
basic
smyd3
1.3ul
"
14%"
"w/v
"
nacl]
"7.3.,"
"none,"
fresh
"
2.2"
3.08m
15%eg
(2.7m
drop.
solid
21-24
"10.9,"
later
500ml
"7.0,,"
(11.0
"
32%"
"6.47,"
"peg
"
"10.2,"
azide
(evf)
"adp.,"
0.7mm
which
atg38
"8.86,"
"6.83,"
(0.12
"8.36,"
"2,0m,"
"
23%"
"15:1,"
grown
jcsg+
292k.
"mps1,"
(1.8%
(1.4%
"
1.3"
(0.24
8%peg
(0.3m
"9.1),"
"4.92,"
"days,"
etr1p
7.9).
temp.
"1,500"
ht-96
1.96m
under
9-10%
"5.67,"
(mib)
x-ray
"(g6),"
7.00;
na-ac
1.54m
5.25)
0.7ul
(d9):
"(g2),"
2000]
"5.75,"
"ions,"
"8.29,"
e219q
"4.65,"
mixed
accoa
nylon
(3.2m
"kp04,"
"5.93,"
1.40m
7.5);
"4.64,"
4.25)
(12.3
"(f4),"
seeds
30-50
3%v/v
"(3/4,"
0.4ul
2009)
277kk
"6.58,"
pegrx
"7.57,"
(5-10
[25mm
2-10%
(w/v)
y207s
"dtdp,"
"6.67,"
1500;
"2003,"
dried
7.4)]
"4.29,"
pmsf)
(d/l)
broad
0.2ml
0.4-1
addit
mimic
0-150
"20%
"
1.75m
"5.9),"
"ca2+,"
steps
dmso.
whose
(20mm
"
2.5"
"
1.8"
note:
175mm
285k.
soln:
"1bz4,"
"6.00,"
trace
"mpd),"
"8,000"
tubes
"taps,"
"6.25,"
"
500"
dapdc
units
ph6.3
4.5mm
"mm).,"
"5.14,"
"
12%"
mnso4
1.08m
"100k,"
"10mm,"
0.8mm
291k.
400mm
flash
toxin
"then,"
"nngh,"
8.5mm
250mm
"303k,"
0.75m
space
"1550,"
300mm
"7.50,"
"8.5),"
m-600
"a.s.,"
23-26
"
50%"
"
60%"
ethyl
mgadp
"1:10,"
"0.2m,"
5-10%
zncl2
"6.5.,"
"iptg,"
"1.3m,"
"10.6,"
293k.
"290k,"
"5.15,"
0.26m
alcl3
mol/l
"10.5,"
"15%
"
short
1.85m
"uvrb,"
peg5k
"1.8m,"
"5.12,"
"
34%"
"1450,"
"nabr,"
white
"the
"
"0.9m,"
amine
25-50
circa
"5.5),"
"
for"
(lms)
"dgtp,"
plate
"6.34,"
"4.80,"
2.16m
nh4cl
"thdp,"
tween
"
10%"
"
peg"
"5.20,"
prism
140mm
1.5-2
1.36m
stand
"279k,"
close
"7.40,"
edta)
study
"1,2,3"
"b-og,"
cdso4
m-peg
rnase
ph8.5
20-50
"5.80,"
group
"1aw5,"
used.
cdcl2
ph8.2
6.25.
0.16m
16-20
crane
"4.75,"
"week,"
"7.2),"
rods.
17-20
18-20
"well,"
edta.
"3450,"
[w/v]
"diol,"
"7.24,"
feso4
found
1.44m
alpha
"7.25,"
"ph=8,"
"epps,"
292.k
each)
"3-pg,"
(10mm
(1.92
(1.1m
"291k,"
4.7).
"acid,"
(agao
"pmsf,"
eight
beta-
"ctab,"
0.15m
licl;
8-14%
"8.0),"
"
550"
"
mme"
6.5).
"8.10,"
0.1mm
c12e9
"6.8),"
20.0k
"9.5),"
"3',5'"
sigma
bcm7.
[0.1m
"acov,"
"
dtt"
"
and"
"
hcl"
tris-
ether
7.5).
58-62
0-10%
"3400,"
"base,"
14-17
"297k,"
0.24m
proc.
"
was"
moved
"3000,"
1%-4%
8-20%
"murd,"
sodum
5.4).
"295k,"
uro-d
4.5).
batch
"durd,"
"7.2m,"
"3500,"
4-12%
"prpp,"
2.5mm
"salt,"
mncl2
"nan3,"
forms
nadph
three
mgso4
naoh.
drop;
"f-68,"
reach
"e-64,"
1.02m
"7.05,"
size.
"blue,"
"0.1m,"
value
"benc,"
acid.
30-40
"7.5),"
"hpo4,"
pbg-d
extra
2.3mm
c222.
"hand,"
imine
0.6mm
2-2.4
badly
40-80
ph6.5
"9.50,"
layer
"ph=5,"
0.10m
"50mm,"
"292k,"
"egta,"
190mm
"5000,"
6-10%
"4.60,"
0.32m
nad+.
liso4
"mpd.,"
295k.
"1500,"
hepps
"ddao,"
8.5).
angle
water
size:
"7.60,"
"5.25,"
0.18m
"400),"
"6.20,"
trial
deoxy
range
l-phe
(0.08
"damp,"
naoac
22.5k
ph4.2
at38h
"palo,"
while
1.65m
"5.60,"
"8.50,"
other
salt:
0.88m
"8.5
"
mepeg
"1:1.,"
0.30m
"
0.1"
"dgdg,"
9-13%
"kpo4,"
"7.20,"
licl.
"nh4f,"
"kscn,"
0.06m
"7.6),"
"8.00,"
title
"used,"
"4.50,"
180mm
(esa)
peg4k
375mm
"0.5m,"
"0.4m,"
litre
setup
7-15%
nano3
2-(n-
macro
"7.74,"
"mes.,"
3.5mm
"5.10,"
place
5-15%
5.6).
"nadp,"
0.12m
"fosa,"
prot:
"8.55,"
peg2k
ph7.8
"nadh,"
nicl2
8-13%
"hepe,"
"oil.,"
264mm
"nh4i,"
7-12%
"5.65,"
"7.80,"
(5mm)
"285k,"
(12.5
2.08m
"kno3,"
"tcep,"
ph5.5
(iii)
298.k
"1.5k,"
"f420,"
"napi,"
glass
"289k,"
"ches,"
agent
bring
"data,"
"5.30,"
"3300,"
"null,"
chess
"4.62,"
boric
"10.0,"
"aces,"
"10.3,"
"4.5),"
"6.80,"
"m600,"
"294k,"
"25mm,"
(50mm
"8.40,"
"3.83,"
"zn2+,"
"3.85,"
"293k,"
"5.2),"
"6.15,"
"asid,"
there
"6.45,"
"
1mm"
"277k,"
"30mm,"
ph7.4
"4.5.,"
"4.25,"
18.0k
"4.00,"
licl2
dark.
"8.20,"
cocl2
dahps
2.25m
5%w/v
(0.06
third
"camp,"
inner
ph7.0
"(7%),"
0.45m
ph4.5
metal
"4.8),"
cubic
lipid
above
4.6).
micro
"mn2+,"
"9.00,"
ddao.
"dttp,"
"acvg,"
225mm
9-11%
400).
point
given
1-1.5
(2001
"
0.5"
dimer
0.08m
appl.
0.04m
unit.
peg8k
13-15
cuso4
chain
"
40%"
p2(1)
2.4mm
"alf4,"
0.66m
nascn
1.0mm
"dtt.,"
nan3)
cell)
"5.0),"
31-kd
naso4
"2000,"
1990)
15-25
"
150"
p3(1)
2.10m
"c8e4,"
"7.10,"
1.05m
0.09m
znoac
0.20m
"c8e5,"
"dmpc,"
(ref.
0.2mm
na/k2
cscl.
6-11%
0.25m
"1540,"
10v/v
years
"with,"
times
"zn+2,"
"4.6),"
ph4.6
3.50.
every
babim
6.75)
naac.
20-30
dmso:
0.55m
160mm
700mm
nh4ac
0.35m
"6.23,"
"2so4,"
(nh4)
"5.6.,"
1.26m
1.95m
900mm
30-35
0.72m
bound
9.0).
"8.75,"
8.0).
"naoh,"
6.75;
0.4mm
c12e8
"
2.0"
(mpd;
8-11%
dmso)
cryo:
19-25
"20mm,"
ester
egta;
"heps,"
"dump,"
paper
0.22m
"5.50,"
"tirs,"
120mm
"5500,"
5000;
"caps,"
nan3.
293.k
22.0k
"
the"
"w/v),"
(mes)
7.5-8
"3.3k,"
"1985,"
entry
20-40
site.
8000;
7.5mm
trina
"urea,"
"6.32,"
"mgcl,"
"6.60,"
"281k,"
"6.50,"
"7.68,"
"ph=7,"
"
5mm"
"298k,"
"5.6),"
(2ul)
"
15%"
"5.00,"
"libr,"
ug/ml
"7.00,"
(tris
"288k,"
4.6mm
"1.5m,"
nh4oh
acid)
"2-me,"
"8.25,"
well-
"7.5.,"
zn2+)
"283k,"
aucl3
15-20
0.03m
ml-1)
4000;
8000)
450mm
"caac,"
2-me.
"(ii),"
these
"mncl,"
znso4
"6.35,"
kpo4)
about
1.55m
"6.70,"
hgcl2
5-12%
argon
their
tris;
nan3;
ph7.3
"ampa,"
co-mb
8-10%
"
25%"
nacl)
"emts,"
could
stock
"6.75,"
until
being
"1.6m,"
",0.1m"
295.k
octyl
t=28c
20-25
"7.15,"
"7.8),"
nacl.
"7.90,"
drop-
"315k,"
4-20%
"6.30,"
2.75m
=7.3.
days.
0.1-m
"ldao,"
"7.36,"
"meoh,"
ph5.6
"
100"
"10.1,"
human
mgac2
210mm
500um
"
2mm"
"ycl3,"
291.k
"
0.3"
names
"278k,"
time:
(w/w)
"nad+,"
"4.70,"
"7.75,"
known
state
0.5mm
1.15m
amino
"
0.2"
ph5.0
"1000,"
ph8.0
"mgac,"
"
200"
w/vol
x-100
"
20%"
first
"dhap,"
along
8-15%
"280k,"
prot.
"6.0.,"
"inos,"
"ampc,"
9-14%
"kmes,"
"naac,"
0.9mm
"acmc,"
"7.0),"
600mm
294.k
ph5.8
"6.10,"
6.9).
nacl;
"koac,"
"4,000"
550mm
"
30%"
"datp,"
1.12m
hilide
phenol
ph=4.4
18-21%
(10-16
55-70%
0.25ml
"(plp),"
24-27%
mgs04.
"nacl,1"
25-100
sml-2.
azide)
(wt/v)
(2og).
"(40%),"
"2.25m,"
"ph6.9,"
either
halide
(0.085
16-26%
murine
"weeks,"
34-36%
10-27%
20000;
excess
32-40%
"7.0,
"
nicl2;
na+/k+
k2hpo4
rinsed
"6000.,"
oxalic
slurry
0.20mm
(6.5).
0.10mm
"0.5mm,"
2-2.4m
550mme
cdcl2;
"(g11),"
mmol/l
"2,5-
"
"5-6.5,"
methyl
24-33%
13-17%
"(mpd),"
peg300
nitric
(0.03m
ph6.0.
"dtt,);"
22-25%
32-38%
ab3542
"l-pro,"
0.005m
0.5-1m
(2+2ul
gentle
"0.05m,"
(first
osmate
295.0k
n5-thf
279.0k
"hours,"
ligase
9.0-10
rounds
"0.1
m"
7.0));
mk3281
hcoona
(v/v))
6-7.5%
289.0k
steps;
"nascn,"
14-18%
ph4.25
sodiun
"zn_cl,"
"2000k,"
18-25%
"light,"
index)
amso4.
well).
"(dtt),"
"viejo,"
triton
18-23%
set-up
mgcl2;
ph7.5)
50-300
"ph4.2,"
"added,"
"x-100,"
"c12e8,"
luecke
291.0k
"msop),"
wt-cdo
ethers
ni(ii)
"azide,"
ribose
microm
"tubes,"
"amso4,"
:100um
ph4.5.
acid).
"140mm,"
"macl2,"
slight
vortex
atgpa1
11-12%
met741
"3,350;"
288.2k
bcdhps
lipid.
"10mm.,"
6000).
1.8-2m
"mops),"
3'-ump
formic
36-38%
8000).
carbon
31-35%
"0.25m,"
"days.,"
"gdcl3,"
(w/v)%
"
0.5%"
copper
ph8.5.
298.0k
"acid],"
"
0.3%"
18-24%
(11.71
0.5-1%
"ethyl,"
"l-tyr,"
(na/k)
"capso,"
"pek4k,"
"nano4,"
0.186m
anapoe
"slide,"
acetyl
acids:
xylose
(30mm)
mes.oh
wells.
293.0k
"acona,"
argon.
"p4000,"
14-19%
10%peg
"chess,"
"liso4,"
ph-7.5
entire
"50
mm"
steps:
tissue
amppnp
ph=8.5
cobalt
(1:1).
detail
"(ph5),"
2500mm
0.002m
21-24%
mgr/ml
volume
"
acid"
"mg/,ml"
24-29%
(final
"
7.5%"
0.214m
10-30%
"(f10),"
agent.
purple
"7.50),"
times.
3%etoh
"were
"
please
eluted
zncl2)
above.
"7.0).,"
mgml-1
12-20%
"8,000;"
ph6.2)
"from
"
orotic
33-35%
"ph8.4,"
pyl5-5
(v/v/)
ph7.5;
acetat
35-40%
75-150
column
"2000),"
steps.
and/or
15-16%
"nacl),"
"
then"
"ph4.0,"
(v/v).
anisic
"prot,5"
w/vpeg
(22.5%
0.014m
bottom
10000g
amonio
26-28%
pellet
"1.65m,"
streak
x-100)
"gdpcp,"
water)
bacl2.
ssumpk
"accpg,"
46-50%
25-26%
zn(ii)
4mg/ml
"6-6.5,"
ph7.2)
"1,000,"
"h2po4,"
approx
1-335;
"ph6.7,"
mg2so4
ph5.2.
mmtris
ph5.4.
nadp+;
"7-7.5,"
ph=8.6
12-22%
seeded
(iii).
"polyp,"
(hoac)
"btpop,"
"etgly,"
"10.0%,"
ph=7.2
"8.5
2"
"
0.17"
"k2co3,"
(40-60
cry6aa
mother
mothor
"cl2ca,"
m-2070
"9
2.3"
liquor
0.096m
14-21%
21-27%
li2s04
ddnapa
40%v/v
288.0k
"6,000,"
nh4so4
",100mm"
"nacl.,"
zncl2;
19-25%
0.1-20
across
"
were"
"phase,"
"in
40"
li2so4
0.19mm
ph=6.5
(0.02m
minute
"conc),"
(~48mm
pep629
mncl2;
0-0.5%
(malic
dione.
"1,500."
"7.5,
"
4.5-5%
34-38%
"(b10),"
(200mm
amount
tcglck
nudt15
1.67mm
almost
"9.0
8"
phenyl
18-19%
nascn;
"cocl2,"
"(6.0),"
nh4oac
80-85%
acetic
"0.13m,"
"0.12m,"
"0.08m,"
mili-m
15-25%
(18-20
9-11.5
(100mm
(jcsg+
6.25mm
(tcep)
ph=7.0
naseo4
"mgso4,"
"(0.1m,"
30-35%
45-55%
"ph3.6,"
cystin
"10.20,"
(cryo)
280.0k
0.112m
"nadph,"
"3.35k,"
(d12):
succoa
"acnh4,"
scales
thirty
20.5c.
source
8.75).
(1:2:2
pire1a
"0.1m
"
peg-me
"roper,"
"4000.,"
17-28%
"
with"
20-34%
10-240
18w/v%
"fecl3,"
36-45%
fusion
"jones,"
1:2:2)
4.5-7%
(11-15
29-32%
0-0.2m
(these
ph7.5.
valine
"fulop,"
(0.1m)
38-46%
weeks.
"znso4,"
0.25ul
glycol
wt-ttr
303.0k
"298k.,"
frozen
21-40%
nicl2.
20000]
0.264m
0.003m
"mgbr2,"
"index,"
"mg/ml,"
(1.2-2
"8,000."
"naso4,"
nakpo4
21-35%
"(50%),"
100.0k
(index
37-42%
k-phos
"sadta,"
42-44%
38-42%
"(32%),"
mgap5a
"
(100"
12-30%
closer
oxamic
"(v/v),"
silver
(space
prorp2
1mnacl
mikrol
gppnhp
ether.
manner
16-17%
casein
"used.,"
dthnl1
28-30%
18-35%
"kipo4,"
stock.
0.056m
1.344m
"37.5%,"
"sroac,"
placed
pegmme
30-45%
na2so4
"
0.14"
nacl).
became
"ph5.5,"
20000)
"ybcl3,"
ph7.4;
kinase
appear
cdso4.
delta.
lithum
siting
(h11):
nh4po4
"8000),"
14-22%
"mpd,
"
32-34%
60-100
shaker
plates
analog
heppso
millim
14~16%
13-16%
"1500.,"
2-fold
"6.0),1"
25%w/v
drops;
"peg8k,"
"t=20c,"
"kcl,20"
"
1.4m"
mgso4.
nb-216
24-28%
mega-8
"2008),"
mmp-13
nascn.
ratio:
murnac
63.6mm
36.4mm
"l-met,"
apo-xi
6-fold
except
"gdac3,"
eo/oh)
281.0k
2.5-8%
32-36%
water;
agents
"seeds,"
277.1k
cdcl2.
"acid),"
16-21%
49.5ul
12.5mm
citric
(mpeg)
naacet
saline
nadph;
serine
pde9a2
(amino
benzyl
10-17%
21-25%
"8000,,"
"
3.0m"
0.067m
44.4mm
18%peg
"
2.0m"
[100mm
"
8.5%"
0.072m
"(c10),"
"l-lys,"
"3-met,"
40-100
50-125
45-52%
(2:3:3
(2:1:2
papain
gmppnp
19-26%
80-200
lipdic
peg-4k
25-29%
"plate,"
(0.95m
(16%).
(2.5mm
"nadp+,"
11-13%
0.14mm
"(nad),"
"1:2:2,"
k2hgi4
sialic
"
dmso"
30-50%
"ph7.7,"
seeds.
phase)
sealed
me-peg
"anl-2,"
"(lcp),"
291.1k
295.5k
(nag);
1500mm
"ipns),"
(mops)
nano3;
2000mm
"(w/w),"
mg/ml;
mgs/ml
isomer
"nh4cl,"
kelvin
17-23%
prisms
"ph8.6,"
"coso4,"
"chaps,"
292.0k
"feso4,"
bcispf
pfispf
"
2.5%"
"napo2,"
drops:
"(fad),"
"mgoac,"
"(4.6),"
bruker
scaled
dishes
around
nano3.
usable
"media,"
devoid
edta);
acid);
"mopso,"
1-1.5m
"1000),"
"293k),"
mes(ph
"m2070,"
"jm600,"
(lipid
"3,350."
"smear,"
"i#14),"
mme550
12-24%
34-44%
"jcsg+,"
qiagen
peg400
25-38%
(fluka
"nacl2,"
gently
sample
31-36%
30-36%
"2kmme,"
(stock
smears
1ug/ml
peg20k
tetra-
access
"2.5:1,"
50-100
tubes.
ph4.6.
(dopc)
ph=5.6
spfcsa
spfcsi
bt3783
"nh4ac,"
"miros,"
"
1.6m"
0.035m
"3350k,"
nickel
30-32%
"fecl2,"
(w/v);
"ph4.6,"
change
citirc
hepes:
60hrs.
ensure
21-23%
"
2-4%"
"
data"
p5380)
l-glu.
"3,000,"
"3-14),"
length
peg600
40-50%
"base),"
ehrho1
14-24%
5%-10%
naoh).
"(1:1),"
"ph8.0,"
6.0(in
(naoh)
14-16%
(tris;
nahco3
amppcp
"cap5o,"
loaded
20-28%
27-35%
294.5k
"mg2cl,"
"ph6.3,"
0.010m
20%v/v
naoac.
24-32%
"(g12),"
direct
21-22%
na2wo4
80-100
"7.5-8,"
"120mm,"
0.75ul
32.5mm
0.200m
plate.
22-28%
6...16
0.100m
iii/iv
cacl2.
pegsii
(acid)
parent
target
"nano3,"
"ph6.5,"
"(c11),"
sites.
19-20%
served
t=277k
active
"
6.7]"
"(ph7),"
"grown,"
(under
trays.
"setup,"
"ph4.8,"
32-42%
18-30%
0-0.05
sponge
second
(1:100
stock:
(15-20
"5,000,"
28-34%
16%w/v
"renin,"
21-30%
"po/oh,"
"meoh),"
"3.25k,"
5-7.5%
former
"
40mm"
oxygen
"here.,"
1-3.5%
277.2k
"steps,"
pga-lm
(tween
15-24%
ph6.7.
setup)
"(8.0),"
"ph9.0,"
"ph5.0,"
"ph9.3,"
"crcl3,"
1000mm
287.0k
"3.350,"
setup.
"trays,"
"gapdh,"
"nacit,"
28-35%
itting
"rock1,"
bullet
cacl2)
1.25mm
"ph8.3,"
"293k.,"
28-33%
"
0.18"
ratios
"milk),"
ph5.6.
"c115d,"
0.25-1
ii-azm
"nappi,"
42-46%
apo-r2
2.8-3m
chapso
"(d11),"
"hgcl2,"
35-38%
293.5k
"k-po4,"
"3000),"
12-15%
higf-i
aurora
25-45%
"(na/k,"
18-33%
duplex
0.25m.
"2,000,"
"7.4,10"
"ph6.8,"
18-28%
(2ml):
1-10mm
mes-na
20~25%
setups
(2ul):
0.095m
20-27%
25-32%
"
1.8m"
"0.02m,"
rubber
0.150m
(grown
"
0.15"
"
25mm"
remove
"
1.5m"
24-35%
26-29%
amicon
trials
19-30%
(mixed
"peg2k,"
"hexan,"
cryst.
302.0k
ssgcid
walton
k+/na+
23-25%
maleic
"ph7.3,"
"1.25m,"
"nacal,"
17%w/v
30%v/v
milliq
facial
"(30%),"
15-22%
16%v/v
m7-gtp
293.1k
"10.0),"
"
drop"
"
well"
kainic
nu2058
30-40%
1.6-2m
17-24%
0.5mm.
"ph4.7,"
18-27%
nh4no3
80-160
0.15mm
"8.000,"
"batch,"
"[sugo,"
60-70%
"100mm,"
(nh4)3
glycin
"
cryo"
"final,"
fecl3.
"(5.0),"
"l-trp,"
1-step
"peg1k,"
"1:100,"
matrix
emodin
(midas
ed2001
"(a11),"
22%w/v
"naact,"
normal
"(6.5),"
wt/vol
nadp+.
13-19%
lysine
stock)
trizma
"m-600,"
1700mm
"ph5.9,"
litium
12-25%
ph7.0.
slides
mcsg-1
"becl2,"
21-26%
"nampt,"
"ph5.6,"
glicol
am2so4
290.9k
"0.2mm,"
"w/v)),"
"(b11),"
3500mm
"200mm,"
ratio.
16-20%
mgcho2
lanrfp
"ph9.2,"
"k2po4,"
26-33%
peg550
"
7.2,"
19-21%
"above,"
"drop.,"
0.167m
16%peg
"ampnp,"
(13-16
"atpys,"
(1-1.4
17-20%
"1,500,"
uinder
mgso4;
ratio;
0.004m
tri-na
10-40%
25-40%
"
sds,"
mcsg-i
0.171m
"(25%),"
betaog
%(m/v)
"(ph6),"
15-20%
"ph5.1,"
mg/ml.
(12.5%
11-16%
borate
"ph8,5,"
291.5k
"ph8.1,"
liso4)
(67.94
278.0k
ph=7.5
24~30%
rocker
"ph4.9,"
"4-10%,"
277.4k
9mg/ml
"nan3),"
hsv-tk
"cscl2,"
"(tris,"
12%w/v
"napo4,"
0.053m
10-20%
50-55%
(tris)
8%-13%
mutant
40-60%
"alasa,"
"dmso),"
3-4.5%
"ester,"
"ml302,"
cupric
(vol.)
"peg6k,"
bigger
0.086m
should
1925mm
"(h11),"
remark
41-46%
cb3717
25-33%
nadp+=
"ph8.5,"
fished
"(m/v),"
looped
15-40%
22-23%
cocl2.
m7gtp)
months
40-43%
20-30%
30-48%
peg350
"ph4.1,"
rigaku
15~20%
"znoac,"
60-64%
60-66%
ph5.0.
ferric
(10mm)
"20.0k,"
3000);
20-50%
"cells,"
11-21%
agent:
2.25mm
fucose
"20%eg,"
"~5min,"
30-34%
varied
peg4k;
"6.20),"
0.02mm
17-18%
"znac2,"
"mcsg1,"
mut46b
0.22mm
0.160m
cesium
"ph3.7,"
"
0.1m"
po/oh)
273.0k
294.0k
"ph4.3,"
"298.0,"
19-27%
"(f11),"
peg500
mops-k
"amine,"
"n-bog,"
"6.000,"
310.0k
"nh4oh,"
hepes;
"(gtn),"
"suite,"
"nicl2,"
robot.
19-23%
10-22%
"gw995,"
linear
25-42%
"large,"
-225mm
(dtt).
"(mes),"
"small,"
unique
"adpnp,"
26-34%
0.28mm
285.0k
"mgadp,"
0.061m
290.0k
vim-31
natrix
nacl);
mixed.
0.250m
"35000,"
18%w/v
1.600m
"mnso4,"
6000);
b-tris
3%-17%
4000);
17.5mm
mg.adp
"5.6ph,"
flavin
"(fmn),"
series
ph9.0)
mgcl);
bluish
"mgcl),"
30%peg
291.2k
1.2-2m
mmepeg
wizard
"33500,"
33-36%
"lino3,"
"0.4ul,"
"(g10),"
"(2:1),"
barium
1-1.25
ppg400
"cucl2,"
48-50%
22-26%
"water,"
10~15%
(mcsg2
(mcsg1
peg3k.
29-33%
screen
(drop:
ph6.5;
"ppgpp,"
idd594
"6.5)],"
25-31%
"0.15m,"
293.2k
21-16%
create
289.1k
format
283.0k
"
7.2%"
5000);
"5,100,"
"mes,2m"
pixsys
ed2003
hexane
60%v/v
24-34%
domain
"gpppg,"
22-27%
"f26bp,"
"(sam),"
mncl2]
trap96
cacl2;
(mcsg4
turned
green.
25%peg
"(pact,"
iodine
ph6.5.
(0.17m
"1.000,"
nadph.
55-65%
41-45%
"ether,"
sparse
"4,000."
"wtttr,"
adduct
5100);
"caac2,"
degree
0.085m
"caoac,"
(nh4)2
"(b12),"
before
number
35-45%
1000ul
"6.58),"
"cacl2,"
40-44%
hmmp12
"
0.16"
"tris),"
"
0.01"
uranyl
"6000),"
8000);
na3vo4
growth
"
tris"
28-31%
tk-666
3350);
(462.5
"(mme),"
200-nl
10-11%
16-23%
"4,000,"
"acids,"
5-10mm
co(ii)
socium
"
0.05"
"
0.02"
(mcsg3
"alcl3,"
35-60%
"cprpp,"
basic)
20-26%
20.8mm
"l-his,"
15-18%
"tvnir,"
cholic
"ph7.8,"
23-33%
"(0.2m,"
296.0k
(20-30
drops)
3mg/ml
27-31%
sanosl
"ph8.8,"
2mg/ml
26-31%
"cdso4,"
25-30%
6mg/ml
13-15%
caught
couple
(v/v)%
"
20mm"
"(50mm,"
"ph7.9,"
32-35%
23-26%
350mme
ada(ph
"gdpnp,"
20%peg
32%peg
26-36%
"300mm,"
adding
10-18%
higher
30-38%
10-100
ph=5.7
oryx-8
"(pvdf,"
"yc-17,"
"ph8.2,"
1k/peg
ficoll
showed
"(1.5m,"
19-22%
27-30%
10-15%
random
50-200
chayen
proten
"ph7.6,"
(0.12m
2-drop
18-22%
"
na/k"
(0.09m
75-125
"2000,2"
100%n2
200-mm
100-mm
"acid.,"
"agent,"
lambda
drop).
azide;
device
nh4oh.
ph=5.0
"ph4.4,"
(w/w).
0.17mm
"2,000."
"ampcp,"
ph=6.0
"lett.,"
ligand
grown.
strain
native
10-13%
"20,000"
(cryo:
62-64%
11-26%
latter
(batch
oxonic
"5,000;"
midtm;
ph7.0;
cacl2:
"0.10m,"
12-13%
(ches)
l-asn.
0.56mm
medium
avidin
2weeks
mixing
"ph6.4,"
52-58%
"beso4,"
11-14%
"salts,"
(v/w/)
mgcl2.
quartz
"peg5k,"
25-28%
double
"
3-5%"
mgcl2)
"ercl3,"
system
0.1mes
rotein
23-27%
50%v/v
pxp9-8
peg10k
ethane
shaped
"8.0
1"
"(7.9),"
liters
c18coa
"twice,"
kh2po3
solium
14-17%
ph=5.5
1100mm
298.5k
50-150
(500mm
(hepes
weight
triscl
zzu5-1
70-75%
plunge
washed
proleu
mm/150
10-16%
ph8.0.
jto-fl
azide.
22-34%
3350).
ph=4.6
"l-cys,"
11-15%
"hocl3,"
method
23-24%
stream
acid))
"nan3.,"
ul+2ul
"names,"
mnso4.
rabbit
23-30%
(kscn)
24%w/v
33-51%
tri-li
20-22%
26-32%
reduce
(mepeg
being:
"20000,"
27-33%
"lucl3,"
17-22%
ambwb'
mature
(added
"cm121,"
24-26%
"
50mm"
"6.5).,"
"(w/v),"
btprop
"paper,"
20~28%
(salt)
"
0.2m"
.1-.3m
"preq1,"
"preq0,"
citrat
"tcep.,"
13-18%
1600mm
fungal
"ph6.1,"
(apcf)
di-nh4
camkii
crysta
solved
agency
"ph5.7,"
37-41%
"3350),"
stored
(5x5).
sawyer
"(ada),"
soidum
"7.0
1"
adohcy
"(dho),"
gelled
15-19%
mes_na
1200mm
"19,150"
45-50%
"apcpp,"
"(12%),"
enzyme
"ph8.7,"
"(98%),"
ph=6.2
"(amp),"
ph5.5;
27-37%
14-15%
"0.01m,"
"10.5),"
tb-xo4
"acet.,"
"ratio,"
"
10mm"
0.135m
propan
3%dmso
"3350.,"
0.008m
(about
14-25%
"drops,"
"eg
10"
"(8.5),"
"4000),"
"mgac2,"
binary
51-63%
14-20%
"0.17m,"
sodium
pbp5fm
iodide
"ph9.5,"
bicine
%(v/v)
ph6.8.
200/50
"8000.,"
0.225m
needle
"niso4,"
22-24%
23-28%
"ph5.3,"
ph5.2;
"ph5.2,"
"p3350,"
0.015m
"chlor,"
0.007m
(25.5%
(pmid:
0.45mm
0.75mm
"edta.,"
capde2
20%eg:
hours.
19-24%
26-27%
40-42%
vx-787
agaist
junior
34-40%
"peg3k,"
"nano2,"
sosium
"mvapp,"
"srcl2,"
bovine
38-40%
36-40%
(h2o)6
(10-20
"(7.5),"
70-270
12-14%
0.05ml
17-19%
micron
0.7-1m
"7.75),"
ampcpp
slowly
oxa-48
values
insp6.
limbro
5-15mm
1mg/ml
esf921
"mncl2,"
(0.5-3
"12000,"
cooled
"(sah),"
0.066m
0.175m
thawed
"dapk1,"
60-190
0.033m
"10000,"
thdpp)
"
0.3m"
50-60%
"8k
8%"
mncl2.
zncl2.
factor
0.95mm
0.065m
crassa
(nunc)
nl+100
31-42%
12-16%
20-24%
"bacl2,"
v/v(%)
277.0k
feso4;
"citr.,"
18%v/v
"pegsm,"
27-32%
"ph6.2,"
w/v(%)
v/vpeg
300.0k
"ybcl2,"
0.052m
paspo2
final.
ratio)
bt1622
znso4.
"ph5.8,"
"
(for"
giving
(w/v).
(11-13
versus
"
8.0,"
biotin
colour
"ph=8,5"
15%peg
passed
"
7.0,"
25-50%
3.5-5%
"5.5).,"
15-17%
fsp006
1.5mkl
fsp007
"ph3.8,"
"7
17%"
20-40%
inside
insect
induce
e.coli
(helix
0.05mm
accoa)
"5kmme,"
"(atp),"
aic499
na-mes
0.185m
pre084
"ph7.5,"
[cryo:
soduim
10%w/v
11-18%
liso4.
meter.
"8,000,"
ph7.4.
3-fold
"days),"
lamour
drops.
5mg/ml
month.
"(udr),"
slide.
camera
ph7.2.
mounts
"
0.03"
15.7mm
295.4k
(mpd).
"drop),"
200/4%
np_peg
0.045m
0.055m
"fdump,"
0.016m
hepese
23-31%
0.75ml
bridge
"atpgs,"
plate;
0.075m
ph:4.5
26-30%
"licl2,"
compas
ph=4.5
8%-18%
293.4k
first)
kh2po4
hdac10
obtain
s-hg-s
poq5-9
70-170
17%peg
20-23%
0.020m
soaked
ph=7.8
znso4+
4degc.
"
0.10"
"nh4br,"
drop:1
"(10%),"
nh4cl;
10-12%
"nacac,"
(mpd);
"
75mm"
"1,2,6-"
"alcl2,"
"cdcl2,"
"k3po4,"
"zncl2,"
"oxide,"
13-20%
12-17%
fbpase
linbro
[hepes
lisium
"pipes,"
"v/v)],"
0.025m
12-28%
277.5k
aldose
na3cit
nachoo
"nh3cl,"
"ed600,"
"x-305,"
"mgno3,"
"4.5).,"
"ph6.0,"
"ph4.5,"
20-32%
peg4k.
msapah
"7.06),"
"5.79),"
(10-12
28-32%
"(bme),"
16-22%
"k2no3,"
1.5-2m
10-14%
adipic
(dmso)
40-45%
anoxic
nh4so2
(w/v))
16-24%
"(20%),"
hours:
peg-8k
"mgatp,"
znso4:
[malic
5k.mme
"f2
16"
0.001m
"1rno),"
"0.5:1,"
"ac2cu,"
"tris],"
"5%mpd,"
"1500),"
60-65%
thymol
7mg/ml
hours)
5-fold
"2.1
m"
39-41%
(base)
62%v/v
raised
"mgcl2,"
"
zinc"
dithio
0.65mm
"(d10),"
"babim,"
"7.5
4"
"(btp),"
"2%mpd,"
42.5mm
0.006m
(total
"4k
10"
"pfmap,"
"
0.1%"
mg/ml]
6.00);
water.
c-star
14%w/v
15%w/v
smputa
malate
larger
17-21%
15%v/v
"cuso4,"
putida
nadh4;
28-41%
30-60%
"hepps,"
16-18%
"ph6.6,"
kh2p04
"ph10),"
cyclic
25-27%
8mg/ml
yppbp2
erbium
likely
result
(0.180
"accoa,"
ph=9.0
nickle
20%w/v
"hepes,"
"6
0.1"
15-30%
%(w/v)
"l-asn,"
"l-asp,"
0.25mm
"mgcl.,"
"(7.0),"
ved0-8
18-20%
"naoac,"
"m
20%"
"

20"
"gppcp,"
"cd1
2"
"ph4,
"
pde5a1
hepes.
(0.50%
glcnac
35-42%
"iprop,"
"4%mpd,"
"g-6-p,"
0.125m
25-35%
bright
"sigma,"
yellow
22%peg
3-drop
17-25%
mk1775
"
30mm"
l-6876
"6.15),"
serial
added.
liquid
powder
liso4;
"k2so4,"
ether)
18-26%
ph=8.0
se-met
mcsg1:
single
296.4k
20-25%
hepes/
"p8000,"
"rs-1,2"
during
37-45%
"
12.5"
(large
16-19%
nextal
"3,350,"
22-30%
bi2536
pipes.
mg/ml)
3-3.5%
"plus
"
"
soak"
mgcl2:
"xp819,"
"
caps"
27-29%
20-21%
ration
izs6-6
filled
(pmme)
20-35%
"broad,"
36-52%
"ph3.5,"
peg200
fosakp
0.8-1m
29-31%
"dmso.,"
"100ml,"
30%w/v
amso4;
microl
above)
"
0.4%"
vapour
filter
"6,000."
seeds:
5(w/v)
"10,000"
"mixed,"
"stock,"
(10-15
mg/ml:
period
0.170m
"1.76m,"
formed
"ph5.4,"
"conc.,"
smiles
"(peg),"
equiv.
12-18%
"na-ac,"
"ph7.0,"
"9
2.5"
"ph7.1,"
dmso).
pooled
0.7-ul
cation
30-33%
stocks
lectin
buffer
(sigma
297.0k
16-34%
12.5?%
"week.,"
1or2).
na2po4
range.
13-14%
0.01mm
"mme2k,"
bmc014
7-fold
"ph8.9,"
(edta)
31-34%
"robot,"
saltrx
"peg4k,"
0.050m
4000).
setup:
"
3350"
40-30%
296.2k
24-30%
within
"ph7.4,"
"eo/oh,"
0.44mm
10-25%
cuso4:
4-fold
"
days"
"235mm,"
"ph7.2,"
250-450
"eo/oh),"
achieve
300-400
buffer:
"
tcep,"
6%(w/v)
proplex
"
2000,"
lactose
"7.0)].,"
1.4-2.0
average
ambient
291.15k
elution
"dioxan,"
5mg/ml.
"
ratio"
bicine;
0.0500m
nahepes
related
"cacl2),"
quinine
4.0-4.4
limited
apo-bfr
(soaked
mercury
ferulic
"to
the"
ranging
"adohcy,"
"ph=6.0,"
cymal-1
0.0200m
"7mg/ml,"
1.0-1.4
"50%mpd,"
"200000,"
"
12.5%"
gradual
2.5-6.5
forming
dmso-d6
(buffer
tris(ph
glucose
(ligand
1.1-1.3
(1965).
sokalan
glycol;
0.1600m
"nh4no3,"
303.15k
16%-20%
microl)
ananain
matured
4.5-4.8
his-tag
"ed2001,"
peg5000
"(tcep),"
ssodium
"200
50"
method:
15%~20%
200-350
dragged
glycols
"
0.17%"
"m
na/k"
"added.,"
greiner
thawing
changed
1.8-2.0
sodiium
"6.5
18"
20mg/ml
"phza/b,"
"(c8e6),"
20-80mm
volume.
celsius
0.085mm
"8.5
20"
7.0-7.3
"ratio.,"
3.0-3.5
"4k,0.2m"
milli-m
bes/tea
ps01368
(5mcl):
natrium
zn(ac)2
"20.000,"
microl;
"naaso2,"
prepare
started
sokolan
mes-hcl
"sulfat,"
"cymal5,"
treated
2.6-2.9
aldh3a1
emerald
"basic),"
propane
1.2-1.5
"iodide,"
"ph=7.8,"
ammoium
2.4000m
"pegmme,"
"
0.12m"
1.25-2m
"ni2so4,"
0.0400m
na2hpo4
"slides,"
"
100mm"
peg/ion
na(oac)
"4000,
"
native:
methoxy
growth.
binding
quality
removal
dodecyl
"ph'ed),"
"
32.5%"
"final
"
0.4/0.4
"5.0
25"
alcohol
liquor:
"thesit,"
"bicine,"
25mg/ml
"kinase,"
"valine,"
"30%v/v,"
sucrose
sodium/
"ph7.75,"
"ph=5.6,"
"[v/v]),"
kh2po4/
200+200
density
285.15k
6.0-6.5
ortho-2
tcep-cl
"nacl,4%"
b-octyl
"(tmao),"
ponceau
"
0.03m"
462.5ul
ps01581
300.15k
peg1000
mg/ml)+
"mm
peg"
"5mg/ml,"
"(1956),"
glyceol
"ph=7.2,"
celcius
amp-pcp
science
"0.4
ul"
udpnag)
volume:
(btac)]
studies
tartrat
"ph=7.0,"
tricine
"smears,"
277.00k
"
mnso4"
0.8-1.0
15mg/ml
"na3cit,"
"ph=5.5,"
ps01056
100-130
"varied,"
288.15k
1.0-1.3
in-situ
"nacaco,"
nominal
volumes
"4000,50"
"ratios,"
degress
uridine
(60-100
entries
"equal
"
"degree,"
peg400;
largest
(1.8305
25%-30%
"forms.,"
"10mg/
"
"mme550,"
0.25-30
295.15k
3%(w/v)
sulfite
(ph4.5)
"malate,"
pw33411
"li2s04,"
arf1dbd
0.0100m
277.15k
"nakpo4,"
10mg.ml
"5%
mes"
suramin
benzoyl
0.2-0.5
300-500
organic
0.010mm
1.5-1.8
7.5-8.0
"analog,"
"to
19%"
(27-30%
camphor
"6.0
20"
"ph6.25,"
(w/vol)
2000mme
2.3-4.0
cx-4945
14mg/ml
"6.5
20"
(stock:
micro-m
1.3-1.5
thiamin
"10,000,"
29%-31%
(2004).
ammonum
benzene
"akr1d1,"
sample.
salting
"nh4so4,"
"8k,0.1m"
azide).
1.4500m
replace
5.5-6.1
"ph=8.5,"
"ph10.0,"
"
mixed"
buffer3
(ph6.5)
mpd/peg
"mixed.,"
amounts
"peg300,"
"domain,"
peg-200
6.7-7.3
"mgs/ml,"
"
20-30"
echaler
60mg/ml
hepe-na
briefly
0.5%v/v
8.0-8.5
glycol:
"actate,"
281.16k
8.2-8.5
2.4-2.8
"ampcpp,"
"ph=5.0,"
2.1-2.6
another
"(drop),"
6.6-6.8
"(tera),"
6.1-6.2
li2so4;
dispase
296.15k
3.2000m
15-well
glycero
2.0000m
20-30mm
direct:
6.0-9.5
suggest
0.7-0.8
"
hepes"
defined
microl.
2.0-2.3
ph6.0).
0.2-0.3
"291.0k,"
"
25.5%"
"ph10.5,"
aqueous
0.8000m
1.2000m
brought
qiagens
authors
mbclass
2.0-2.2
"
stock"
mops(ph
removed
1.4-1.6
"
22.5%"
epoxide
buffers
5.5-6.5
"10%peg,"
ebselen
appears
memgold
"%
nacl"
0.2/0.4
"methyl,"
"set-up,"
"cobalt,"
"peg12k,"
8%(v/v)
0.9-1.1
(around
16%-18%
5.0-7.0
nfeg12a
1.6-2.3
"zncl2.,"
"li2so4,"
7.5-9.5
"ed2003,"
(24-34%
1.6-2.1
mgcl2);
0.5-0.6
gly-tyr
"nad(+),"
"10%,peg"
satured
3.2-3.8
7.0-7.5
(nh4)2h
hepesna
bincine
polymer
"100000,"
needles
1.5-2.5
"w1400.,"
hclasp1
vacuum.
"
16.65"
"6000,25"
(277k);
"amppcp,"
peg200.
0.1700m
rhenium
pyrrole
1.0000m
40mg/ml
acetate
"nh2oac,"
yttrium
0.2000m
exposed
1.6000m
syringe
ph=7.0.
5.5-6.0
"peg600,"
various
"5%
peg"
cluster
"mme
10"
200-275
without
robbins
phoenix
"
0.08m"
(hepes)
samples
"drops),"
9-10.5%
li2so4.
7%(w/v)
9%(v/v)
16.5-20
10-20mm
(newman
swissci
1.7-2.7
protien
4.5-5.0
0.7-1.5
0.0011m
2.75-3%
5.3-6.5
percent
parafin
tris/10
zhdac10
carried
"
(v/v)"
bufffer
weight)
protein
"uracil,"
12%-25%
formate
cyanate
ph=7.5.
slution
(volume
"na(ac),"
sebacic
suberic
"8k
.1m"
292.15k
"ml
0.1"
"(sat.),"
1.5-1.7
"ph=7.7,"
scdna-1
ndsb256
"excess,"
lipidic
caesium
"3350
5"
crystal
0.3000m
states.
(sodium
l124671
20%-26%
"(caps),"
nitrite
"nh4scn,"
acetete
quickly
lysines
7%(v/v)
"7.5
25"
passage
partial
surface
"3,350.,"
4%(v/v)
"mutant,"
"nh4oac,"
(0.05m)
0.2500m
liquor.
"8.5,0.2"
"nahcoo,"
0.7-1.0
"35%mpd,"
"weight,"
24-well
"(10mm),"
plastic
100-200
(mutant
"peg800,"
enzyme:
0.9-1.5
120-160
150-200
alanine
"tartr.,"
"naco2h,"
proline
7.1-7.7
"growth,"
p212121
"25-40%,"
1.8-2.3
buffer)
"amppnp,"
"ph=6.3,"
(ph5.5)
equally
1.5-2.2
reverse
0.1860m
"7.0
10"
7.5-25%
ph=6.5;
hampton
"
0.02%"
hydrate
glycol)
"peg550,"
"7.5),40"
"pctp-4,"
"months,"
"acetat,"
malonic
h-chain
0.4:0.4
nh4no3;
1.6-2.4
5.1-5.3
7.0-7.1
1%(v/v)
0.4-1.5
7.9-8.2
initial
0.3-0.9
"ketone,"
alkalis
1.5-1.6
mes/koh
(either
refined
293.15k
"
ether"
growth:
hega-10
whisker
20k/mme
"
0.05m"
100/100
10%-15%
peg8000
1.1-1.7
subunit
puckid:
peg3550
"donors,"
6.4-7.9
"hega-9,"
23mg/ml
butanol
0.1000m
volume)
2ul:2ul
gycerol
parabar
"ph8.25,"
292.16k
galnac.
nh4cooh
l304507
(0.0125
natural
"1:2:2),"
"nh4so2,"
finally
primary
tartate
kelvin.
liquor)
"hepes),"
"ph:7.5,"
"hdac10,"
ethylen
tri-hcl
"mw4000,"
2-deoxy
product
di-hcl.
"
p2(1)"
6%(v/v)
294.15k
sulfate
na2so4;
8mg/ml;
0.6-0.8
"mes-na,"
"cl
0.1"
"pga-lm,"
monomer
7.5-10%
150-350
"gdp,1.8"
1.8-2.2
"mgso4,2"
allowed
1.2-1.4
milii-m
"lysine,"
similar
peg20k)
peg10k)
"peg-4k,"
improve
"10000),"
between
160-400
"
nacl,"
(base);
"8mg/ml,"
gravity
"thymol,"
"medium,"
applied
1.5-2.1
"550mme,"
0.1-0.3
mmonium
sealing
6.5-8.5
0.5-0.7
0.6-1.2
"m
dmso"
unknown
1.0-1.2
kh2po4.
"19-22%,"
"(100mm,"
rapidly
timolol
sodiumu
80mg/ml
"(ldao),"
usually
diluted
100-300
"ph=4.8,"
2.1-2.4
2.5-15%
direct)
screen.
drops).
however
fragile
beta-og
137-322
0.6-1.1
"single,"
(k2hpo4
4.1-4.2
"dmso,25"
1.1-1.2
0.001ml
"
nadph"
"h2so4),"
lattice
"adomet,"
"caoac2,"
optimum
(100%);
n-hexyl
"3,350)."
"hega-8,"
400-500
"minotc,"
"2,4-mpd"
located
"mpd
10"
a861146
na/kpo4
"ribose,"
6.3-7.1
cyanide
"3350,ph"
19mg/ml
dextran
0.4-0.6
"

150"
"6k
peg"
&#956;l
9%(w/v)
screens
colored
process
"nme4cl,"
dicamba
"
stand"
"hours.,"
32ug/ml
"ph=6.2,"
"peg500,"
"3350
1"
1.8-2.1
glyerol
"dtt,18%"
"mega-8,"
microm.
5.6-5.9
thirdly
malate.
2.3-2.5
287.15k
pde10a2
bicine)
maximum
5.2-5.6
(12-19%
methods
acteate
cations
"8.0
3%"
"277.0k,"
reached
"abi-pp,"
"
0.4mm"
buffer.
"
grown"
culture
kpi/22%
jcsg_a8
25%-32%
"4.0
25"
200-300
"3350
3"
"6.5
2%"
"sample,"
acid(ph
t-butyl
"6.0
14"
papain.
11mg/ml
"ph6.00,"
(2mcl):
"weeks.,"
carbon.
2.5000m
"t-buoh,"
"294.0k,"
1.6-2.0
"ph=4.6,"
"(mgcl2,"
merging
"propan,"
"mcsg-1,"
intense
"
0.10m"
"mg/ml),"
"5.0
20"
peg1500
"i-proh,"
4.3-4.7
1.2600m
0.5000m
18mg/ml
crushed
"6.5,25%"
"(v/v),1"
0.5-1.0
"8.15,
"
"trials,"
0.1-0.5
13%-17%
rystals
ferrous
celsium
"t-booh,"
14%-16%
"screen,"
"trisac,"
bph-651
"seeds.,"
seeding
"liquid,"
"%(v/v),"
above).
0.3-0.5
"ph7.4),"
suflate
ps00257
decanol
2.0-2.4
nitrate
"iodine,"
"plates,"
"alkyne,"
"
order"
serovar
0-200mm
2.8-3.3
"hcoona,"
labeled
ps01186
sr48692
"above.,"
amso4);
"ph9.0),"
mitegen
peg-500
"4mg/ml,"
pw30213
"mg2so4,"
(dmso).
2.4-2.6
(mepeg)
"saline,"
ratios.
1.9-2.4
297.15k
terbium
ethanol
counter
loading
rppep-1
"btprop,"
ammonia
"1/2/2),"
5000mme
gryphon
"naacet,"
device.
1.6~3.2
"4k
0.2"
"serine,"
"1500
5"
hosting
"dz-305,"
serine.
ps01459
10mg/ml
ps01383
"mpeg2k,"
"acid,1%"
"ph=6.5,"
0.7-0.9
tenfold
sufonic
1.6/1.8
(50-200
varying
"
well:"
"ph=6.4,"
"gmppnp,"
"ethgly,"
0.3-0.7
"aesar),"
udp-gal
microl/
calcuim
"9mg/ml,"
"1990)
"
(15-20%
0.050ml
5-7.5);
"20,000,"
premier
"doxytc,"
100-400
"12%peg,"
"mgcl2.,"
mutants
acrylic
0.1-0.4
n-octyl
"(acid),"
1.9-2.1
1.8-1.9
283.15k
ps00632
3.5-4.0
"mgcl2,1"
"nahco3,"
"6.2
10"
nh42so4
1.7-2.1
100-160
format.
setting
"fe(ii),"
"c11dao,"
4%(w/v)
"ca.atp,"
"gppnhp,"
0.005mm
"na2hpo,"
n-nonyl
ph=5.0.
enhance
peg-800
ps38292
mg.ml-1
24-mer)
stocks)
"
20.9%"
calibre
"(2-8%),"
cymal-5
set-up.
mg/ml):
direct;
6.8-8.2
nacl.ph
"7.5
20"
"na3vo4,"
"mg/ml.,"
0-0.275
5.6-5.8
"298.0k,"
18%-20%
"
mg/ml"
"ph8.0),"
5-insp7
bi-tris
"ph7.0),"
optimal
peg400)
gol_p4k
cymal-6
5%(v/v)
"261062,"
pw28486
(16-18%
20%-30%
"300,0.1"
10.00mm
ps00688
26mg/ml
5.1-5.9
ammonim
acatate
0.4-1.0
5.0-5.5
amppnp;
4.0-7.0
"7.0
8%"
"xylose,"
29%-33%
sodiaum
"peg20k,"
"400
15"
1.5-2.0
"sp1066,"
(35-39%
10%dmso
0.2-0.4
(2002).
(18-20%
(pegmme
t-state
oxygen)
"cooper,"
smears)
covered
"hepes
"
"ph=6.8,"
281.15k
"system,"
1.0-1.1
(ph6.0)
bromide
ph=8.5)
chamber
7.5-8.5
mavdhfr
"slowly,"
"7.4
50"
7.5-8.8
20.00mm
0.8-1.4
"20000),"
6.0-7.5
"ligand,"
(nano3;
"nacl
1"
(base):
"ph=3.5,"
0.0.06m
"ph=4.5,"
hanging
3.4-3.7
30%-35%
final).
reacted
peg-400
"7.0
20"
peg2200
filters
"hepes5,"
"tris-8,"
22mg/ml
others.
"
using"
0.0025m
"(50mm),"
phasing
150-300
2.3-3.0
"am2so4,"
visible
"pef(s),"
250-600
6.2-6.8
ligands
instead
"
vapor"
minutes
0.8-1.2
bistris
"adp-mg,"
"na2so4,"
mg/ml);
maximal
milli-q
"25-50%,"
na2s2o4
1microl
"klhxk1,"
"6.5
25"
"mgcl2),"
"dddmab,"
"(0.2m),"
200-220
respect
peg-600
(0.005m
"neu5ac,"
"(dmso),"
"(2.4m),"
0.002ml
"10,000)"
system)
0.7-1.2
fomblin
po/oh);
"di-hcl,"
micro-l
iodide.
iodide:
"peg35k,"
1.8-2.5
0.3-0.4
"volume,"
2.1-2.3
placed.
"4.9
20"
"ipa
25"
"(acros,"
crsytal
290.15k
bicine/
2(v/v)%
4.8-5.2
ligand.
"ph=7.5,"
ph=5.5)
mme2000
peg300.
inlb321
peg400.
250-350
2.2-2.4
"
10.0%"
vol/vol
methane
minimum
0.2-1.6
phytate
0.4-1.4
msodium
"7.5
2m"
0.4-0.7
iodide;
labtech
"(3350),"
"

0.1"
210-250
peg-300
develop
"4.7
20"
ed-2003
2.0-3.0
(1-571)
"
200mm"
nuc-pro
cleaved
aldh7a1
"24-27%,"
(hepps)
"kh2po4,"
mes-koh
45-60mm
"calcl2,"
"mehgac,"
"ph=8.0,"
cellulo
5%(w/v)
"copper,"
produce
harvest
"
0.1mm"
"ph-4.6,"
"wright,"
"8000,5%"
nh4hpo4
279.15k
xylitol
"na/kpi,"
1.7-1.9
"750mme,"
(screen
hepes).
ute6-14
soluble
nh4sso4
1.2-1.6
chicken
0.9-1.2
130-200
"muscle,"
"ph=9.0,"
30mg/ml
further
"3.5mm
"
stirred
"drops.,"
"cryo;
"
l3mbtl1
(ph4.8)
racemic
15%-30%
peg3000
"method,"
112.5mm
glycol.
gelling
acetone
"42%mpd,"
tris-hc
0.6-0.7
"pep426,"
0.003m.
"citrat,"
"0.001m,"
250-325
mg/ml).
1.6-1.8
0.001mm
7.2-7.8
1.7-2.0
ps00647
"sufate,"
6mg/ml.
typical
7.0-8.5
"peg10k,"
"biotin,"
trypsin
cloride
ala-phe
"buffer,"
"batch
"
~5-10mm
layered
microm)
0.3-1.0
0.4+0.4
pw37974
excess.
amp-pnp
"of
the"
"ph=7.4,"
oxonate
na2s2o3
(10-15%
"
500um"
peg2000
domains
50mg/ml
2microl
(0.025%
"edta,
"
"mes,0.2"
calsium
mission
dibasic
15-20mm
peptide
changes
extract
"500mme,"
30%-32%
3.8-4.8
"nh4po4,"
28%-30%
degrees
calcium
"
0.005"
12mg/ml
(20-25%
classic
cryosol
"su9516,"
"glcnac,"
"ammso4,"
"jws648,"
1.9-3.0
(4mg/ml
"camkii,"
"na-mes,"
"
tris,"
trials.
10-15mm
"
weeks"
onboard
"anoxic,"
(acid))
adducts
"(<10%),"
cadmium
agarose
(acid);
details
"
0.050"
buffer;
content
highest
"
cryo:"
sitting
"zn(ii),"
"k2hpo4,"
"number,"
"ph-6.2,"
"peg400,"
"(ches),"
cymal-2
0.6-3.0
"nacooh,"
microl:
(base)/
pre-mix
"ph-6.0,"
"6.0
10"
(ph5.0)
"zeatin,"
"8.0
20"
seconds
0.3-0.6
mtbfpgs
"nh2so4,"
(0.29m)
277.16k
cictric
reduced
"peg200,"
chromic
"liquor,"
mineral
hr2-122
2.0-2.5
deposit
peg200;
0.0475m
diethyl
peg600.
direcly
"ph=2.9,"
tris-cl
5.5-7.0
"glycol,"
4degree
(0.44m)
"papain,"
mg/ml-1
"(0.5:1,"
0.1-0.2
4.0-4.5
"ph=4.0,"
"nacl
5"
3.2-3.4
"6,000)."
5.4-6.1
(ph8.4)
137-208
mtglnk2
(ph7.4)
(1978).
section
"(1978),"
1.2-2.2
30-40mm
10%-20%
"x-link,"
mol.l-1
peg2250
"
heavy"
"(ddao),"
tris-ph
~6mg/ml
lipids:
n-oxide
"ul
set"
oxamate
tris-ac
k2hpo4.
silicon
dipping
against
"m
nacl"
50-60mm
35mg/ml
cacl2).
(53-60%
"295.0k,"
"ph=6.6,"
ph=4.0;
tcep(no
8.5-9.0
lmtyrrs
(tcep).
16mg/ml
7.5~8.5
method;
96-well
analog.
ph=6.50
7.7-7.8
2.0-1.8
mme-peg
mixture
mutant.
nahco3.
1.3-1.6
21%-27%
hours).
"na2po4,"
(20%w/v
citrate
6.5-7.0
140-200
synergy
27mg/ml
100~200
"(0.1m),"
5-molar
"phenol,"
trishcl
ph=8.5.
"5.6
30"
"glicol,"
(ratios
"10-15%,"
caffeic
"galnac,"
freshly
"
after"
remark:
1/2/2).
7.2/0.6
25%-35%
basilea
"
0.01m"
(final)
droplet
1.4-1.8
hours.)
mes/0.1
"tymine,"
"ch2thf,"
(27-33%
298.15k
"minute,"
(ph8.7)
liqueur
17%-19%
"vapor
"
"days
,"
ph=5.0;
pik-iii
filter.
0.0003m
220-250
"slfate,"
"ph4.50,"
fumaric
cg10062
plates.
through
ph=6.5.
mannose
"
mgcl2"
gly-gly
ph=7.5;
6.5-7.5
"nach02,"
2.6-3.0
17mg/ml
"(base),"
1.7-2.2
ph=5.75
d-malic
"40%mpd,"
mes/hcl
ps00621
"3350
2"
washing
"
0.002"
"10,000g"
3%(v/v)
ki/50mm
"
drop:"
(5.65).
3.7-4.3
ed-2001
pentane
combine
"(tris),"
0.0005m
"27-32%,"
(20-18%
dioxane
2%(v/v)
200-400
microns
"
about"
"
0.001"
"400
5%"
"4000
5"
ratio);
trapped
"formed,"
"7.4
60"
"(kscn),"
kcl/22%
annexin
working
"
h2fdh"
"li2o4s,"
paepec2
2.2-2.8
4.5-5.5
"20,000."
"ethane,"
"
m-bdh"
(23-25%
"(+)-1,3"
"direct,"
0.0075m
glycine
present
ph=7.0;
"ether),"
ratio).
"65%mpd,"
complex
several
maltose
(ph8.5)
"coa-sh,"
"kscn
3"
13.5-15
1.6-2.2
met-mb.
"m
tris"
2.2-2.5
(ph7.0)
"8.5
50"
1.7-1.8
frozen.
"m-600.,"
mcsg-ii
oxalate
"ph=5.7,"
"sulph.,"
0.9-1.0
stopped
soaking
cryooil
"%
cacl"
diamine
degree.
bullets
(1.8mm)
lithium
"6mg/ml,"
7.5-9.0
nacacod
approx.
"

for"
"ppg400,"
induced
"8.0
21"
"
0.06m"
"fucose,"
(methyl
"in
100"
"ester),"
"350mme,"
7.0-8.0
na2so4.
150-250
screen:
peg-ion
purpose
tris.cl
"
human"
sample:
maleate
"zn2so4,"
(0.6mm)
amonium
sulfato
"walton,"
"meshcl,"
"mme5k),"
folinic
"200mm
"
"mops,ph"
"
bacl2"
"mes_na,"
"8.5
9%"
1.8-2.4
"
mncl2"
nh4so4.
"
becl2"
"aceate,"
tetr(a)
15%-20%
"peg-8k,"
blg-ret
1.9-2.2
absence
"ph
8.5"
"hepes.,"
spotted
choline
benzoic
"ph5.50,"
peg3350
(sigma)
mpd_peg
taurine
"ph=4.2,"
oxidase
"
(w/v)"
"format,"
13mg/ml
"sodium,"
"kelvin,"
screen)
otce15a
variant
15%-25%
peg3500
"293.0k,"
months.
adenine
cryomix
1.9-2.0
400-800
462.5?l
bicine:
reserve
k2ptbr6
"etghly,"
300-350
0.0175m
corning
28mg/ml
"mg(ii),"
"4.6,30%"
mounted
(8.60).
"
cacl2"
"mg(2+),"
8%(w/v)
"10,000."
rations
"10-20%,"
tris/cl
ped3350
(6.36).
"12-20%,"
cooling
"edta
5"
5microl
"6.5
12"
melting
"
0.25%"
"2-8
mm"
"20,000;"
(~30%).
storage
excess)
ternary
peg4000
"pep629,"
na2so3.
reagent
"cb3717,"
6.8-7.2
1.6-1.7
weight~
"10.000,"
200-250
0.6-0.9
"ph=8.6,"
0.8-1.1
miralax
segment
"5.5
25"
ab16-21
iodide)
"drop,
"
10ug/ml
plunged
albumin
2%(w/v)
udpglca
"6.5
5%"
"po/oh),"
100-250
/malate
10-fold
glycole
manzoni
200-500
"7.5
1%"
"mgr/ml,"
method.
1%(w/v)
305-324
peg-550
"soaked,"
heparin
ligand:
"500dme,"
(2016).
21%~27%
aerobic
peg6000
growing
0.4-0.5
"pef400,"
betaine
nah2po4
3.4-3.8
seeded.
1.4-1.7
(10-20%
"citric,"
cymal-7
(chaps)
21mg/ml
k/na-pi
"(nano3,"
"tvnirb,"
prevent
"cooled,"
20-70mm
"triscl,"
(18-24%
1.6-1.9
l-malic
"
equal"
floride
contact
"mg-atp,"
(ph7.5)
dimeric
yielded
2.5-2.8
"60%mpd,"
20%-25%
9.5-15%
vanadyl
"mixing,"
"chapso,"
"appnhp,"
1.4000m
"
0.25m"
"peg350,"
"na3po4,"
"ph-8.5,"
1.5-1.9
(12.1m)
direct.
(m101a)
(8.99).
edo_p8k
289.15k
coupled
"ratio),"
etylene
"ph6.75,"
(qiagen
"2mmdtt,"
"borate,"
"nacl,
"
"na2so3,"
feiiso4
1.3-1.4
bicelle
(citric
growth)
"
150mm"
contain
100-150
udp-glc
peg-mme
created
"12-15%,"
0.4-0.8
choride
(wizard
tatrate
reagens
li2so4)
0.7-12%
"enzyme,"
"nacl,0.1"
(0.5/9.5
"6.0-6.5,"
berkeley
imidazol
"(1.5ul),"
acetone.
droplets
26%(v/v)
"citrate,"
"peg-550,"
"7.0
0.2"
untagged
cacl2and
coumaric
"
15-30%"
"hydrate,"
"peg6,000"
"5.6
14%"
34%(w/v)
"(sigma),"
0.5-0.65
"psl0413,"
"acetone,"
applying
14%(v/v)
"trypsin,"
3.4mg/ml
paynteri
"paa5100,"
0.3-1.3m
60mg/ml.
(qiagen)
butanol.
25%(w/v)
"7.5
15%"
amminium
rotation
ethlyene
methanol
directly
"maleate,"
"14mg/ml,"
[pin_id:
"8.0
0.1"
"5.5
28%"
"5.6-6.2,"
0.2-0.25
2.75-3.3
"na2s2o3,"
18mg/ml.
28%(w/v)
chloride
"oxonate,"
10%(v/v)
"glycole,"
guaiacol
6.3mg/ml
secondly
19%(v/v)
bromide:
"4k
0.2m"
16-16.5%
"5.2-6.0,"
protein.
"removed,"
32.0%w/v
"
mother"
ed-2001.
"ndsb256,"
ammonium
dho-like
"
23-30%"
"peg3500,"
"sulfate,"
"salicin,"
(8%(w/v)
before).
2.9-3.3m
targetdb
(ph=6.5)
0.1-0.16
"mpd
0.1"
"18mg/ml,"
"cooling,"
"mrs4598,"
"6.5-6.9,"
compound
nitrate.
ammonuim
fructose
(200-400
samarium
(micro)l
"5.5-6.2,"
6.5-6.8.
6000/13%
"9.3
25%"
"7.0
10%"
"tatrate,"
alcohols
3.0-3.2m
"pgsmear,"
"6.75
5%"
(2-well)
"4.8-5.1,"
"5.5
13%"
viologen
"na2hpo4,"
naacetat
"5.5
19%"
"4.5
0.6"
(lipidic
"7.0
12%"
"8.5-9.0,"
ck2alpha
"
soaked"
ammoinum
"bicine),"
channels
"6.2-8.2,"
"2k,
20%"
"8.5
18%"
2000-mme
"
buffer"
celsius.
"10k)
75"
"dtt
3.5"
mixture.
"6.5
16%"
"high
70"
"5.6
20%"
"7.0
20%"
#NAZWA?
6.0mg/ml
glycogen
tcrpdec1
0.402ml.
"7.4-7.8,"
"7.5
60%"
5-insp7.
"2000mme,"
pourcent
(hanging
(aai101)
vaseline
"6.5
15%"
(hcoona)
"5.5-5.8,"
0.2-0.4m
"8.5,
30"
"9.5
200"
"6.0-6.8,"
(w:v)peg
two-drop
1.9-2.0m
xanthine
solution
nah2po4;
"
13.52%"
hydrogen
"gly-gly,"
"maltose,"
dispense
"6.5
0.2"
(20mg/ml
isolated
flushing
"kainate,"
2.5-2.7m
mosquito
produced
citrate:
0.2-0.1m
"mrs4602,"
method).
(3.7-4.1
"ligands,"
25-mg/ml
0.9-1.5m
"
sodium"
degrees)
3.7-3.9m
"labtech,"
peg3.35k
resealed
"na-ches,"
"6.5
28%"
3.0-6.0%
succinyl
"4.6
1.7"
"21mg/ml,"
"7.5,
45"
"5.5
peg"
"(tmano),"
"6.8-8.2,"
tris:hcl
8.1mg/ml
"

drop"
"5.6-5.8,"
"iodide),"
"(fluka),"
observed
qiagen).
33%(w/v)
"4.0
0.6"
"spg
25%"
55%(v/v)
"6.2
100"
"(ph7.9),"
"maliate,"
phoenito
trypton;
cryofull
"nh4cooh,"
syringol
"6.5
160"
"
remove"
syringes
"7.5-8.5,"
oxidized
2.2-2.4m
(8mg/ml)
terasaki
"%
mgcl2"
25mg/ml:
"7.5
20%"
"ph
5.0."
18mg/ml:
~10mg/ml
1.5-2.5%
pipes-na
defatted
"nahepes,"
propane;
0.9-1.15
nitrate:
"mpeg-5k,"
(0.1~0.2
"(25~29%,"
phoshate
0.85-1.2
2.1-2.4m
yielding
"m
nacl,"
glycerin
"7.6
0.1"
mg(oac)2
"
19-23%"
"4k
0.01"
6.1-6.5)
luteolin
consists
v30m-ttr
"acetate,"
"7.0
0.1"
"peg5000,"
5.7mg/ml
"
tb-xo4"
glucose)
ndsb-201
mercuric
135468a)
(quiagen
peg8000)
50microm
"6000
2%"
acetate:
"nad+
20"
"7.5
14%"
"protein,"
"zncl2
1"
"7.5
10%"
"5.0-5.3,"
"gylcine,"
ada/naoh
achieved
electron
density;
"
liquor"
"5.2
4.1"
ancestor
protein;
brd4-bd1
reaching
"6.5,
2m"
"6.5
0.6"
buffers:
oxamate)
l-rv1738
peg6000)
8.6-9.2)
mpeg5000
ndsb-211
"buffers,"
details.
8.5/0.1m
"beta-og,"
reagent:
starting
(3.2-3.5
"6.5
30%"
nitrate;
(v/v)peg
(nh)2so4
propane:
clhoride
"7.0
16%"
3.5mg/ml
follows:
"dioxane,"
delta114
pegmme2k
freezing
fraction
"ph(8.3),"
5.5-6.5.
bentaine
base/hcl
manually
"4.4
0.6"
cryomix:
(buffer)
"octanol,"
1.7-2.1m
"lactose,"
diffract
aps21idf
"acid
10"
"400
100"
allergic
og-bound
position
"cloride,"
inverted
"cymal-5,"
kau(cn)2
gsh/gssg
cryo:add
protocol
"xylitol,"
tris.hcl
against:
geometry
20+/-0.1
"5.0
25%"
1.6-2.3m
"paraton,"
0.8-1.8m
"mm
tris"
"7.0-7.6,"
glovebox
"5.5
17%"
"nitrite,"
"7.5
100"
"cyanide,"
ctx-m-14
paraffin
"5000
10"
d-rv1738
membrane
"400
0.1"
"6000
ph"
"mes
36%"
"7.5
25%"
"4000
10"
"1,5-ip8,"
"m
hepes"
peg20000
12-15.5%
34.0%w/v
"3350
10"
"7.1-7.6,"
3.0-3.5m
"amso4,3%"
glycine;
0.1~0.2m
"8.5
20%"
"gol_p4k,"
rebuffer
"6.5
200"
nucleate
trisbase
/nah2po4
desalted
"hmg-coa,"
additive
reducing
"number
"
(average
33.0%w/v
glyc?rol
labelled
set-ups.
"hepes,
"
"calcium,"
peg6000=
mellitic
"400
25%"
"(0.15m),"
filtered
"6.5
26%"
jeffmine
dialyzed
"ul
drop"
"c
plate"
na-hepes
soaking)
"7.7.
3%"
mes/naoh
(soaked)
dimethyl
(complex
"8.5
30%"
"96-well,"
"propone,"
"7.0
22%"
"8.5
2.0"
(3mg/ml)
(30mg/ml
"ph
6.0,"
peg33500
reagent.
1.1-1.4m
labtech)
"6.5
18%"
"5.0
20%"
crystal:
"nacl
50"
"trishcl,"
hydrogel
"
2.44mm"
"mgcl2,
"
potasium
mes/tris
0.1mgcl2
authors.
na2hpo4/
"(ph4.2),"
"

cryo"
"6.2-7.0,"
mg(no3)2
referred
"mgcl,0.1"
droplet:
"7.5
30%"
"(acid)],"
1.75-2.0
dibasic.
propane.
supplied
external
"s3-k301,"
"8.5
12%"
"7.0,
5%"
cryo:15%
lysozyme
glcyerol
20mg/ml:
"(12.5%),"
5.1-5.3.
"8.5
0.5"
ethanol;
spacelab
"peg4600,"
"7.5
0.2"
0.4-0.45
clusters
"5.1-5.4,"
"sodium
"
"nacl
20"
"7.4-7.7,"
"therein,"
facility
(mixture
"400
0.2"
"malnate,"
"ph
7.5,"
"ph=n/a),"
"(340um),"
contents
254099c3
"degree.,"
"(350um),"
provided
european
"5.5-6.8,"
0.05-0.2
nitrite.
(na2hpo4
volumes.
"mme
200"
advanced
appeared
"7.8
200"
8.0-8.5)
2.5-3.0m
2000mme;
1.8-2.0m
sulfate;
"tris-cl,"
0.04375m
"alkalis,"
fumarate
yittrium
"smears),"
"peg6000,"
"7.2-7.5,"
peg6000.
micelles
bromide;
nach3coo
12/mg/ml
"peg3,350"
"6.0
200"
di-basic
11mg/ml.
"guanine,"
0.05%w/v
"ul
well"
"(ph5.0),"
1.8-2.1m
22.5-30%
pipetted
hamilton
"complex,"
36%(w/v)
notrogen
"mes-koh,"
"7.5
peg"
"peg3350,"
"dgtpase,"
"mpd
20%"
7mgs/ml.
"6.1-6.4,"
"mepeg5k,"
neomycin
"neamine,"
"etcdpk1,"
"6000
5%"
material
"acid
50"
6.0-7.0)
(w/v)peg
"ed-2003,"
ammoniun
"5.0
200"
"peg8,000"
catechol
53h7145)
"aldh1a2,"
succinic
"set-up.,"
"nitrate,"
"system),"
aluminum
"8.6-8.8,"
7.6-8.5.
bis-tris
1-2-1.4m
"glucose,"
potassim
"400
200"
"400
150"
"orotate,"
crystals
"briefly,"
chambers
serially
"letters,"
"amp-pnp,"
formate:
"degrees,"
tris-hci
"adenine,"
"8.5
24%"
"8.5
15%"
500-mme:
7.5-7.7)
"4.4-4.6,"
naproxen
ndsb-221
peg3350:
"a771726,"
"kbr
200"
"trypton,"
"propane,"
"na2moo4,"
"5.5
0.2"
"hepesna,"
(hampton
8.5mg/ml
10mg/ml.
"8.5
0.1"
0.0005ml
d-xylose
"8.5
0.2"
ed-2003.
"cystine,"
"4.2
25%"
"6.0
20%"
elastase
peg-8000
"7.5
200"
"na-mops,"
"4.8-5.0,"
0.7-1.0m
hampoton
"10000
8"
linoleic
plasmid.
bacillus
"bi-tris,"
50-250mm
injected
"20mg/ml,"
12.5-25%
6.4mg/ml
"8.5-9.5,"
molecule
500-fold
"arg-hcl,"
"13mg/ml,"
"peg-400,"
"ph:5.00,"
"ph:6.50,"
"5.5-6.0,"
"6.5
20%"
dialysis
density.
arsenate
"(ph7.2),"
obtained
multiple
lattices
"qiagen),"
7.3-8.3)
halogens
carrying
"10k
0.3"
(without
"peg2250,"
peg400);
divalent
"peg1000,"
"5.0-6.5,"
"naazide,"
"5.0-7.0,"
octanoic
"alcohol,"
"8.9,0.2m"
hexylene
"7.0
200"
"4.8-6.0,"
"5.5
25%"
immersed
"(acid)),"
"6.3-6.5,"
"5.0-5.7,"
"ndsb221,"
"10
0.7m"
5.2-5.4;
"cineole,"
ethanol)
glyceryl
"modeled,"
"5.0)
5%"
tartrate
"7.0
15%"
"30mg/ml,"
"8.0
0.2"
attached
screened
"8.0
25%"
"zn(ac)2,"
mes:naoh
18mg/ml;
polymer.
"(mangel,"
"suffolk,"
ephrinb2
occupied
palmitic
ammunium
disodium
"4.4-4.7,"
citrate;
7.0-8.0.
clonixin
"6.0/6.5,"
7.9-8.0)
6.3-6.7)
plunging
enhanced
glycerol
dioleoyl
"mgcl(2),"
peg1000h
"
hepes,"
8.3mg/ml
pancreas
"(qiagen,"
mes-naoh
follows.
glucose;
"6.5
10%"
7.7mg/ml
"7.4,25mm"
"tris/cl,"
"4.6
20%"
34%(v/v)
"8000,0.2"
propane)
"pctp-10,"
(ph=8.0)
27.5-35%
(s)-mpd.
"
(large"
"l-l-asp,"
fuconate
barcode:
"tris
ph"
glycol)]
thrombin
na2hpo4;
"mes
0.1"
dibasic)
"6.5
12%"
"8.2
28%"
acetate/
"6.9-7.1,"
sulfonic
"8000
2."
"5.5
20%"
271854a7
"6.8-7.8,"
research
"5.0:
15"
"dtt
0.1"
"5.0
0.2"
overlaid
100mg/ml
"7.5
1.6"
normally
together
s-malate
"mg(ac)2,"
(product
peg-1450
"8.5
200"
itaconic
"zhdac10,"
(2.5-2.8
h3b-4193
23mg/ml:
"mgcl2
5"
"edo_p8k,"
5.3-6.5.
"5.6-6.5,"
1264062)
"3350,0.2"
"6.5
25%"
(10-22)%
5.0mg/ml
0.1(w/v)
"
3,350."
tris-mes
citation
"ethonal,"
peg4000)
"7.2-8.0,"
standard
centered
"[carter,"
"sparse
"
"4000,0.1"
439-446]
"6.0
25%"
composed
"k2hpo4),"
gradient
0.6-3.0%
27%(v/v)
nh4hpo4.
"peg400.,"
synthase
(kh2po4)
fluoride
"acid-d4,"
"treated,"
"k2hpo4.,"
"w/v
peg"
sorbitol
29%(v/v)
"buffer.,"
citrate.
"0.1mmes,"
50-100mm
(bicine)
tris-dcl
63%(v/v)
catalase
chlroide
3.5-4.0%
25-29.5%
2.7-3.2m
hexamine
"4.8
10%"
"8.0
20%"
"pet3350,"
(acrylic
"6.5/7.0,"
"1000,
8"
vcid6271
"sodium,,"
"peg3330,"
"6.5,
30"
"li2so4),"
covalent
increase
tris-hcl
degrees.
pressure
conc.=10
"ph4
400"
"peg2000,"
myristic
ch3coona
in-house
"micro-m,"
"ph=7.50,"
(0.47mm)
"5.7
20%"
reported
"7.5
22%"
l-lysine
"(s)-glu,"
acetate.
bridges.
12-14.5%
"7.4
150"
purified
(95%/5%)
5.5-6.15
protein:
resolved
dibasic/
"medi-um,"
33%(v/v)
0.6-1.1m
"(ph9.4),"
"pr(ac)3,"
"mme
0.1"
"4000
20"
28.0%w/v
"5.6
1.0"
2.8-3.8m
"5.6
10%"
"4.5
0.2"
"peg1,000"
"6.2-6.8,"
vcid7620
1:1(v/v)
ndsb-195
"10%dmso,"
direct).
"24mg/ml,"
2.2-2.6m
"5.5-6.5,"
"glycol;,"
mesylate
formate.
anatrace
"sulfite,"
tris-hc1
udp-gal;
blodgett
langmuir
"6.2-6.6,"
premixed
"of:
2.2"
31%(v/v)
"1500
5%"
"nacl
25"
mix/well
dibasic;
28.8%w/v
26.7-30%
peg-3350
acid/90%
"7.5
18%"
"8.0-8.2,"
oxamate;
"8.0,
3%"
"5.5
15%"
3350/peg
"cdcl2,10"
ethylene
naac/hac
easyxtal
dmso/0.5
pyruvate
"beta-me,"
sulfate:
"8.5
25%"
1.4-1.65
"(30min),"
aliquots
"nacl
10"
100.00mm
0.23-0.3
"tribase,"
"40mg/ml,"
oxamate:
"peg1500,"
previous
22.5-27%
"8000,100"
arginine
"7.5-7.9,"
200.00mm
"10mg/ml,"
puck/pin
carbonic
atrapbp1
"5.3-5.4,"
"3350
20"
(10mg/ml
"5.0
100"
"15mg/ml,"
"endovii,"
adjacent
seeding;
"mpeg550,"
"15%
w/v"
27.5-40%
20mg/ml;
"hepes-k,"
pmme5000
"3350
3%"
(150:150
"peg4000,"
"volumes,"
"4.8
200"
brd4_bd1
1.2-1.5m
microm3)
strategy
"soaking,"
"6.7-7.1,"
"ligand.,"
"nad(p)+,"
nad(p)+.
"26mg/ml,"
"(100mm),"
"277.16k,"
"11mg/ml,"
"
15-20%"
resevior
streaked
1.5-1.8m
"10-16%),"
"ndsb211,"
6.1-6.7;
"cymal-3,"
formate;
phospate
contrast
32%(w/v)
although
peg-5000
0.0108mm
benzoate
"mme5000,"
"k2(so4),"
0.5mg/ml
(ph7.5).
"
frozen"
"aulfate,"
"
emodin"
mixture:
"in
0.1m"
"(ph5.3),"
"bistris,"
"4.8-5.4,"
2.1-2.3m
"peg-800,"
residues
"4.9-5.0,"
tyrosine
"5.8-6.0,"
"camphor,"
ammomium
cofactor
"(ph9.0),"
"6.0-7.5,"
"6.5-6.8,"
"liquor),"
ed-2001;
buffered
1.6-1.8m
"6.2-6.7,"
"400,0.15"
mutation
original
"7.4-8.0,"
"peg-200,"
"details,"
"acatate,"
"ca(oac),"
"lactone,"
"thymine,"
2.0mg/ml
ethelene
"7.0-8.0,"
1.1-1.5m
0.9-1.2m
0.4-0.6m
"methods,"
"proline,"
0.6-0.8m
bis_tris
3.8-fold
1.2-1.3m
"choride,"
1.8-2.2m
80-120mm
nacitrat
"(ph7.4),"
"(ph8.0),"
"281.16k,"
"nadp(+),"
"297.16k,"
peg-2000
0.6-0.7m
lutetium
"4.3-4.5,"
"peg3340,"
"6.4-6.7,"
1.4-2.0m
1.0-1.4m
acetate;
"chlorid,"
"suflate,"
presumed
"5.5-7.0,"
[4fe-4s]
ph3:ph5)
exchange
"5000mme,"
"ph4.5-5,"
"chamber,"
nitrogen
protease
proline.
0.6-0.9m
"4.5-5.5,"
peg-1500
8.0-8.5;
"glycols,"
0.2mg/ml
9-methyl
(5.8-6.8
0.2-0.18
tryptone
"4000,100"
"polymer,"
seconds.
complex:
siroheme
dl-malic
floating
8.0-9.5%
60%(v/v)
21%(v/v)
26%(w/v)
50%(w/v)
80-100mm
"n-oxide,"
nh4h2po4
3.5-4.5m
formate)
1.0-2.0m
11%(w/v)
27%(w/v)
21%(w/v)
(diluted
"6.1-6.7,"
0.3-0.6%
n-acetyl
"oxamate,"
minutes.
0.8-1.0m
3.8-4.0m
holliday
junction
"(ph8.7),"
42microm
0.1-0.15
"(ph5.5),"
1.1-1.3m
1.0-1.2m
1.2-1.6m
42%(v/v)
13%(v/v)
inositol
0.3-0.4m
1.4-1.8m
0.0015ml
dioxane.
n-octyl-
17%(v/v)
1.5-2.5m
"phasing,"
udp-glc)
udp-galp
percent.
(24hrs).
tertiary
"6.5-7.4,"
"(ph4.6),"
"(ph6.5),"
dextrane
"butanol,"
allowing
strictly
"3350mme,"
"4.0-6.0,"
"(ph8.5),"
proteins
(protein
"glycero,"
contains
infected
incubate
40%(w/v)
tris/hcl
"(1:100),"
glucose.
"22mg/ml,"
8.5-9.0)
na/hepes
20%(v/v)
dioxygen
critrate
2-ethoxy
"27mg/ml,"
classics
complete
0.1-0.2m
hepes/na
exposure
"7.0-7.3,"
fragment
1.0-1.5m
"4.2-5.2,"
"56mg/ml,"
3.2-3.4%
trishcl.
0.9-1.0m
1.8-2.5m
7.5mg/ml
alkaline
"6.2-6.5,"
"5.0-5.5,"
trigonal
glycine)
60-190mm
"nh4hpo4,"
inhbitor
"agarose,"
"(ph5.6),"
6.0-7.5.
dilution
"furoate,"
"6.5-8.5,"
"nakhpo4,"
adjusted
"281.15k,"
peg-1000
181-506)
7.0mg/ml
"mes-hcl,"
22%(v/v)
6-7mg/ml
peg4000.
"33mg/ml,"
"(mopso),"
"
0.005m"
1.1-1.6m
7.4-8.2.
"5.7-5.9,"
l-serine
farnesyl
"screen),"
"5.9-6.3,"
crystal.
separate
9.0mg/ml
(ph8.7).
0.6-1.2m
zinc(ii)
"ed-2001,"
peroxide
dialysed
followed
"seconds,"
bis/tris
"(nadph),"
5000mme)
0.5-1.5m
0.25g/ml
"ethanol,"
"celsius,"
transfer
tris-oac
"7.8-8.5,"
"7.6-8.0,"
"50%dmso,"
0.1-0.25
"cadmium,"
complex.
diffused
"9.0-9.8,"
"trs-hcl,"
35%(v/v)
1.8-2.4m
2.4-2.6m
sucrose.
"
1.344m"
"tri-hcl,"
"buffer),"
"6.0-8.5,"
25%(v/v)
"7.7-8.0,"
"5.5-7.5,"
"peg3000,"
hepes-ph
15-17.5%
peg-6000
"seeding,"
magnetic
(genomic
platform
cryschem
"25%
peg"
gel-tube
"slufate,"
ammonimu
"(ph6.7),"
coenzyme
sandwich
tracking
"pek4000,"
seeding.
"mes/koh,"
"tris-hc,"
oxamate.
bicelles
cocktail
"udp-glc,"
25.5%w/v
0.3-0.9m
"a861146,"
relative
mops/koh
"method.,"
propanol
(ph7.0).
10-100mm
"peg3400,"
pyridine
0.65-0.9
"
screen"
9.3mg/ml
included
"7.5-8.2,"
12.5%w/v
"(ph7.0),"
"na/kpo4,"
0.2-0.3m
"5.6-6.6,"
nanopure
"6.1-6.6,"
"7.5-8.0,"
0.1-0.4m
employed
"5.4-5.8,"
"nh42so4,"
"35mg/ml,"
cysteine
20-22.5%
1.5-1.9m
1.3-1.5m
s-methyl
"
5-10mm"
naac-hac
ethilene
adenylyl
20mgs/ml
peg3350;
4.5mg/ml
40%(v/v)
bivalent
ca(no3)2
0.2-0.6m
"(ph7.5),"
29%(w/v)
"results,"
"sucrose,"
straight
0.6-0.75
"glycrol,"
degassed
"
mixing"
15mg/ml;
"(ph6.0),"
"ndsb195,"
settting
"tris.cl,"
0.1mol/l
"
30-45%"
23%(w/v)
"compnd
"
constant
"cymal-7,"
15%(w/v)
"oxalate,"
"cholate,"
45%(v/v)
"293.15k,"
peg8000;
1.2-1.35
0.3-0.5m
glc-6-p;
"6.0-8.0,"
"7.5-9.0,"
"sulhate,"
3-5mg/ml
30%(v/v)
"mm
n,n-"
17%(w/v)
vortexed
thiamine
22%(w/v)
"nacl,100"
diameter
chamber:
"
remark"
1.5-1.7m
occurred
"dibasic,"
"7.0-7.4,"
"cymal-6,"
peg3350.
50%(v/v)
peg3350)
2.6-3.0m
0.4-0.8%
20w/v(%)
"
cobalt"
"(ph6.6),"
24%(v/v)
2.5-5.0%
agmatine
"peg-600,"
"6.5-8.0,"
2.3-2.5m
(ph=4.2)
0.15-0.3
0.25-0.4
"
azide,"
"25mg/ml,"
tribasic
60-100mm
l-fucose
14%(w/v)
"4.6-5.2,"
mmsodium
5.5mg/ml
buffer);
containg
magesium
"na(oac),"
"formate,"
(london)
"betaine,"
"uridine,"
generate
"
0.0003"
"7.0-8.5,"
"glycine,"
0.6-1.0m
includes
monomers
"tricine,"
16%(v/v)
cymal-6.
interest
"alanine,"
ca(oac)2
enriched
(crystal
2.0-2.2m
grb2-sh2
lead(ii)
acetate)
ferritin
"(peg4k),"
"glycol.,"
tris-bis
vanadate
"(ph4.5),"
15%(v/v)
5.0-5.5.
aldolase
probably
"5.0-6.0,"
"hega-10,"
"k3(cit),"
analogue
"droplet,"
"ca(ac)2,"
13.5-15%
10-22.5%
peg2kmme
"peg-300,"
8.7mg/ml
distinct
"reagent,"
"hepes,ph"
"(1978).,"
nanodrop
aspartic
"4000,15%"
"bromide,"
"liquor.,"
10%(v/w)
12%(w/v)
quality.
"7.7-7.8,"
crushing
suitable
"oxidase,"
measured
(soaking
tris-so4
(nh4)so4
malonate
24%(w/v)
(c11dao)
kformate
9.5mg/ml
lowering
rod-like
(emerald
7.9mg/ml
1.2-1.4m
gylcerol
selected
tcep-hcl
a-641359
wizard-i
"tric-cl,"
nac2h3o2
(sitting
titrated
a-420983
ndsb-256
ascorbic
1.4-1.6m
his6-hod
a-770041
"4.5-5.0,"
"crystal,"
1-oxide.
na/k-po4
(6mg/ml)
0.05-0.1
(ph=7.3)
crystal)
35%(w/v)
7.4mg/ml
7.3mg/ml
prepared
"8000,0.1"
sulfate.
"burrows,"
0.5-1.0m
glycolic
actually
"mixture,"
1.0-1.3m
"3350,200"
"blewett,"
"udp-gal,"
7.8-8.2;
"8.5-9.2,"
magnisum
peg1000;
sulfate)
"7.0-7.5,"
tartaric
(malonic
citrate)
addition
10microm
10microl
13%(w/v)
"15%-25%,"
5.0-6.0.
hepes(ph
bestatin
"277.15k,"
"6.0-7.0,"
morpheus
protein-
peg10000
"4000,0.2"
"nacl,1mm"
shikimic
2-methyl
12%(v/v)
taurine.
dioxane)
2.6mg/ml
"peg3.4k,"
"sulfide,"
mixtures
"ph5.8-6,"
"nacl,and"
1.6-2.0m
n-oxide.
"7.5-7.7,"
"minutes,"
p2000mme
improved
"5.0-5.2,"
glycine.
setting:
"
liquid"
degreesc
glutamic
"months.,"
1.9mg/ml
trypsin.
"4.6-5.0,"
nah2po4/
0.5-0.7m
"tartate,"
"8.0-8.5,"
7.5%-10%
"
washed"
30%(w/v)
"hanging,"
"peptide,"
"(ph6.8),"
1.3-1.6m
bromide.
"4.0-4.5,"
"3,4-dcb,"
(ph=5.5)
silicone
19%(w/v)
"4.2-4.6,"
1.9-2.1m
ammpnium
0.15-0.2
pegmme5k
minimize
2.6-2.8m
"4k,100mm"
"5.6-6.3,"
"5.2-5.6,"
(ph=8.5)
1.7-1.9m
ethanol.
20microl
"mannose,"
"ala-pro,"
"citrite,"
symmetry
kcitrate
40-100mm
(18mg/ml
"suphate,"
crystool
"4.0-5.5,"
peg4000;
peg8000.
5-formyl
(ph=7.1)
(wt/vol)
pluronic
presence
"16mg/ml,"
"nacl,0.2"
"however,"
2micro-l
freundii
"peg1450,"
(25mg/ml
"glycol),"
stepwise
peg1500.
tris_hcl
reagents
resevoir
spermine
"hepes,10"
nah2po4.
"mes/kcl,"
(freshly
celcius.
"acteate,"
1micro-l
na-azide
zn(oac)2
"floride,"
platinum
"bennett,"
"121-125,"
soaking.
"nah2po4,"
"licl,100"
"50mg/ml,"
1.2-1.8m
6.0-6.5.
saturate
droplet.
32%(v/v)
actetate
2.7-3.0m
(ph=7.5)
293-295k
mannose;
peg-3000
soaking:
dissolve
affinity
"choline,"
hepes_na
alcohol.
11.5-13%
20mg/ml.
"gycerol,"
relation
langerin
"peg8000,"
18%(w/v)
peg-600.
"celcius,"
citrate/
"6.0-6.6,"
cytosine
"mme2000,"
"6,000).,"
"acetete,"
replaced
combined
analysis
paratone
"peg-mme,"
"5.2-5.4,"
50-200mm
protein)
"3350,0.1"
"5.3-5.6,"
mounting
"glyerol,"
peg-200.
28%(v/v)
"ndsb201,"
cracking
modified
peg5kmme
"
50-100"
hepes-na
18%(v/v)
(ph7.2).
required
two-fold
resulted
2.5mg/ml
internal
triethyl
biphenyl
repeated
(15mg/ml
"7.2-8.6,"
6.5mg/ml
rubidium
bcl6-btb
"amp-pcp,"
"tcep-cl,"
cis-caad
peg-4000
"
glycol"
70%(v/v)
"7.2-7.6,"
20%(w/v)
"peg3550,"
16%(w/v)
dilluted
albicans
celsius;
"(hepes),"
iron(ii)
xylitol.
"taurine,"
oxidase;
humidity
pel10acm
0.20000m
"6.6-7.6,"
4.5-4.6.
"mepeg2k,"
hanging-
"process,"
mtdhqase
0.3-1.0m
flouride
cleavage
cytidine
"k-hepes,"
sulphate
"6.5-7.0,"
2mg.ml-1
"methane,"
ligands:
"6.5-7.5,"
1.8-1.9m
10%(w/v)
2.0-2.5m
jeffamin
tric-hcl
0.1-0.3m
"sulafte,"
(peg3350
(na-salt;
",ammonium"
"(ph=6.5),"
describes
k2pt(cn)4
"mcsg1-h6,"
"6.5-7.5),"
97-101.]]
150-225mm
"6.5
0.2m"
"peg35000,"
"8000,0.2m"
"3350
200"
"pegmme5k,"
tartrate;
0.05-0.2m
3-8%(w/v)
"sri-7614,"
compound)
(crystals
"reagents,"
"caps/koh,"
indicated
delivered
2.3m-2.7m
phoshpate
mes/naoh;
sulphate;
l-alanine
"langerin,"
"318922c9,"
"(qiagen),"
described
dl-maleic
mtris-hcl
cobaltous
0.05-0.10
"phoshate,"
(18.1mg/l
n1-acetyl
"8.6-9.2),"
guanidine
d/uw-3/cx
1.45-1.65
"
1.9-2.4"
"nah2p2o7,"
"peg20000,"
"nach3coo,"
"5.5mg/ml,"
"ndsb-201,"
otherwise
23-cyclic
"tcep
18%"
ir(cl)5co
perfluoro
1.0mg/ml;
"mmpeg500,"
magensium
"
crystal"
"beta-udm,"
a12/biod4
"6.3-7.1.,"
of:sodium
paraton-n
"(ligand),"
"cd(no3)2,"
microbath
oxamate).
"
hanging"
complexes
tris-hcl)
4.7%(w/v)
jcsg(d2):
"(bistris,"
28777091)
"pegmme2k,"
3.5%(w/v)
"base/hcl,"
screening
"20%peg4k,"
recovered
"glycerol,"
0.06-0.12
"cytidine,"
"6000
0.1"
"peg2kmme,"
disulfide
colorless
"
0.2-0.4"
"na-azide,"
"kacetate,"
"w/v
0.1m"
chloride:
"1000
10%"
cytoplasm
naturally
trisodium
deuterium
"291-293k,"
"6000,tris"
100-140mm
2-butanol
megnesium
sulfamoyl
0.25-0.35
tmpep1050
"rhamnose,"
molecules
peg-smear
ampso/koh
(10mg/ml;
peg500dme
1.2-1.36m
"tris
20%"
"dioxiane,"
"peg-1000,"
"peg3,350,"
tartrate.
"naformat,"
0.05-0.1m
"sitting
"
hepes/koh
atpgammas
"
calcium"
22.5mg/ml
"peg1,000,"
0.1-0.25m
"5.0-5.75,"
"present.,"
"tric/hcl,"
"peg8,000,"
"2000-mme,"
exclusion
"nacl
10%"
magnesiun
citrate);
magnesium
2.5%(v/v)
monoethyl
imadazole
tak1-tab1
0.65-0.75
"(nh4)so4,"
sulphate.
"nacitrat,"
peg200/5%
"creatine,"
peg550mme
"295124f1,"
"peg6000.,"
"248209h3,"
"7.5-7.6),"
"peg10000,"
"7.5mg/ml,"
"peg4000),"
l-sorbose
nitrogen:
19.5mg/ml
"6.0-7.5),"
tribasic:
"mes-naoh,"
submitted
"tryptone,"
"hepes.na,"
co2+2-hai
"dialysis,"
sarcosine
"231_chol,"
"(cid4597,"
cryoloops
available
"oxidized,"
conducted
"(hr2-320,"
150-300mm
research)
"pressure,"
inorganic
"cit-phos,"
carba-nad
"nanodrop,"
"6.0-7.0),"
"
soaking"
"drops,1:1"
"cholride,"
cryosoak:
"betaine),"
synthesis
"gly-naoh,"
"dibasic),"
"solution,"
benzamide
dihydrate
"peg-3000,"
"belgium),"
exchanged
"accetate,"
l-proline
1.5-3.0ml
"bes-naoh,"
"peg3350),"
"tartarte,"
0.07-0.08
100-150mm
(morpheus
malonate;
na+-pipes
0.15-0.35
"30%peg8k,"
trehalose
"5.5
0.4m"
inhibitor
combining
d-xylose;
"rahmnose,"
detergent
(~380-750
1.46-1.60
bis:tris:
"9.7mg/ml,"
"amia
2.2"
tacsimate
acid/0.04
"underoil,"
"
c11dao,"
"peg5kmme,"
"
peg3350"
pde9q453e
"dtt,tris,"
"hepes,10%"
triggered
"6.0.
1ul"
nicotinic
"(ph=4.5),"
"
peg300,"
"dmso
16%"
"4000,0.2m"
"zm241385,"
"fragment,"
synthetic
"1,9mcscl,"
lipoamide
udpglcnac
exchanges
"naac-hac,"
l-leucine
schaeffer
"peg-1500,"
"ndsb-195,"
formation
k-acetate
cystamine
cartesian
"peg10,000"
140-200mm
"pantoate,"
"
absence"
undergoes
ck2alpha'
"tris.hcl,"
"3350
100"
ammmonium
chlorides
guaiacol.
condition
na-bicine
"with:
10"
immersion
ammonimum
expressed
"of
these"
"ada-naoh,"
"8000
20%"
"acrylate,"
"3350
5mm"
contains:
"citrarte,"
indirubin
crystals)
"udp-gal),"
"100mg/ml,"
"sulphate,"
ultrapure
peg20000.
"chloride,"
"kno3
18%"
0.95-1.5m
"sulfate),"
chorismic
"phophate,"
"di-basic,"
glycerol;
"mgcl2,
5"
"skf86002,"
glycerol]
0.1-0.5mm
chloride]
cocktail:
"dioxane),"
200-400mm
"(protein,"
"tirs-hcl,"
skf86002.
"ammonium,"
"(rs)-1,2-"
znacetate
1.16-1.36
"8.0
0.2m"
"l-malate,"
centricon
resevior;
"hepes
ph"
nanoliter
"caffeine,"
"1-oxide.,"
crystall.
"7.5
0.75"
thaumatin
"ada/naoh,"
expansion
"7.5,
25%"
"degrees.,"
"hepes/na,"
hodm-heme
ammonnium
cryo-soak
"fumarate,"
"cacl2
30"
0.5microl
7.5%(w/v)
"0.1mkscn,"
"kau(cn)2,"
"na+hepes,"
"4000
0.2"
"6.5
0.16"
"soaking.,"
[protein]
"mpeg5000,"
"
sulfate"
(nitrate)
tetra-hcl
elongated
"mg-salts,"
"arsenite,"
guanidium
"p-cresol,"
(peg2000)
"acetate),"
magnisium
(succinic
"peg8000),"
"peg12000,"
"glycine),"
monometyl
0.28-0.30
activator
"difusion,"
"6000
200"
acetate);
"tris-hci,"
"
n-oxide"
additive.
"5000-mme,"
"suplhate,"
"ndsb-211,"
acid-naoh
preformed
"6.0
0.2m"
16mmcdcl2
cryogenic
"phospate,"
caps:naoh
"1500
20%"
manganous
compound.
"vanadate,"
"lysozyme,"
triclinic
protocols
peg-3350.
tris-hcl.
cisplatin
"details),"
ammoinium
"nacl
.1m"
0.15-0.25
tris/hno3
bris-tris
occupancy
pyruvate.
0.15-0.20
chts-dhfr
690-760mm
"citrate.,"
homopipes
0.18-0.24
"bicelles,"
"fluoride,"
15-20%peg
d/l-malic
"ph4
0.4m"
"mgcl2,20%"
"propanol,"
"30%peg4k,"
nanolitre
1.85-1.90
0.75-0.95
0.05-0.15
mgformate
(mixtures
ches-naoh
underwent
homologue
(13mg/ml)
monomeric
0.57-0.90
"cacl2
5%"
"
culture"
"lithium
"
phosphine
pottasium
"8.5
0.2m"
"4000
200"
cysteine.
bis-tris.
quinonoid
"chlorite,"
"riboside,"
"pga-lm
5"
smyd2-sam
(40mg/ml)
"glycol,30"
6.7%(w/v)
additive;
"peg-8000,"
reference
peg3350).
"additive,"
"
sucrose"
"tris:hcl,"
0.1-0.15m
"ly466195,"
"7.5-8.0),"
150=225mm
detectors
"sucrose.,"
"propane),"
forensics
molecule:
"peg20,000"
harvested
tris/hcl;
"methonal,"
"zn(oac)2,"
"mgcl2
30"
syringol.
dissolved
necessary
"na/k-po4,"
"hanging
"
accuscope
"ethanol.,"
"formate.,"
[morpheus
ph5.5-6.5
h155n-cdo
"%
sodium"
stablized
crystals.
wild-type
binocular
"7.1mg/ml,"
methanol.
deionised
peg-10000
chloride)
"peg3000),"
(adjusted
additive)
12.8mg/ml
fragments
glycoside
lanthanum
gamma-pga
"dmso
15%"
sulfoxide
including
mg(hco2)2
"mpeg2000,"
apo-hire1
"5000,0.2m"
ammoniumu
tartrate)
%(w/v)peg
0.1-0.275
truncated
"nh4(so4),"
20.8mg/ml
fluoride;
(547-977)
ethelyene
"tris-dcl,"
c164s-cdo
(24%(w/v)
"
screen:"
"proponal,"
(10mg/ml)
"(ph7.25),"
geometry:
"/nah2po4,"
"25%(w/v),"
phosphate
citations
"30%(w/v),"
decribing
isoniazid
"chroride,"
100mm-mes
(27mg/ml)
vortexing
solution:
according
published
"li2(so4),"
sulfonate
"etghly,ph"
"chrolide,"
"(na2hpo4,"
extensive
glycerine
glycerol:
"formiate,"
equimolar
"aha
drop"
"is
named"
optimised
"tyrosine,"
five-fold
nacitrate
low-light
"buffer,ph"
dehydrate
"na/k3po4,"
"hepes,peg"
0.16-0.24
adenosine
prepared)
"4000
0.1"
"c-di-gmp,"
"nh4h2po4,"
anhydrous
exception
compound;
"acarbose,"
"peg3350],"
"mes/naoh,"
"drops
of"
construct
"264489b1,"
potassium
"bis_tris,"
peg500mme
appeared.
zk200775.
hepes-hcl
protocol:
20.7mg/ml
"
sample:"
"cbz-glcn,"
succinate
"klpdc/ml,"
6-hydrate
"mgcl2,0.1"
"6.5-6.75,"
"7.4
0.25"
acetate).
anaerobic
undiluted
canavalin
amcitrate
"scpdc/ml,"
"3350
0.3"
vitrified
"citation,"
difficult
treatment
"alpha-kg,"
"an
equal"
essential
strontium
jeffamine
"tris-bis,"
"(k2hpo4),"
"
mixture"
"nacl,0.1m"
"
trypsin"
hepes-mes
"glycerin,"
brd4(bd1)
"8000
100"
"7.5
1.26"
buffer:20
"peg1000),"
rpmi-1640
h155q-cdo
"8.5,
0.2"
sacharose
"7.5
0.2m"
deionized
polyvinyl
optimized
kanamycin
0.2microl
"soaking),"
micoliter
collected
"mg(oac)2,"
"5100
0.1"
"3.8-5.6),"
picolinic
generated
"peg6,000,"
"7.4
0.8m"
inhibited
anhydrase
"5.5,
25%"
600-800mm
"catechol,"
"nacl,50mm"
15.5mg/ml
gd-hpdo3a
"19%
nacl"
direction
(vol/vol)
"7.0,
200"
"c

drop"
dipeptide
400/27.7%
"ch3coona,"
apramycin
hydrazide
oil-micro
"salphate,"
"nacl
20%"
"4.5
20mm"
"tcep-hcl,"
resorufin
0.26-0.32
(hewl)-pt
procedure
following
tungstate
"ph4.6
2m"
"nacl
18%"
"(ph=4.6),"
"4000
100"
"8.5)
200"
38.00%w/v
4.5-16.5%
nitrogen.
"gsh/gssg,"
"8.5,
30%"
"4000
15%"
divalents
tartarate
tribasic;
mentioned
(qiagen).
"301633a1,"
"peg_8000,"
0.42-0.58
"8000
200"
"acid
30%"
mgamp-pnp
0.25-0.15
"fridborg,"
solution;
"ndsb-221,"
diffusion
"5100
30%"
capillary
0.5%(v/v)
protected
"6h2o
5mm"
chloride;
mgacetate
(easyxtal
"(gly-gly,"
"mes/tris,"
arabinose
(protein)
"400
0.1m"
subjected
(additive
0.35-0.50
bacterial
"against
"
(16mg/ml)
intervals
present).
formamide
"(ph=7.0),"
0.10-0.09
1.43-1.48
"buffer
,"
"ca(oac)2,"
holo-nrde
"ndsb-256,"
"mg/ml
25"
"4000
10%"
"udp-glca,"
sulphate:
"6.0-6.2),"
"5.5
0.2m"
(swissci)
bis-tris)
"7.9-8.4),"
(r)-mvapp
1-9%(v/v)
(jbscreen
"alcohols,"
"actetate,"
analysis.
"
200-400"
pre-grown
nucleated
molecular
"6.5,
0.2"
"peg-4000,"
"amp,
3.3"
ascorbate
compounds
"naac,0.1m"
syringes.
comprised
imidizole
chloride.
utilizing
paratone.
tris(hcl)
monooctyl
plas-labs
clusters.
"6.2-6.5),"
hepes-na+
hepes-koh
300294b8.
200-350mm
"
against"
"(ph=8.5),"
"(13-14%),"
"pyruvate,"
cofactor.
"mm
hepes"
(nh4)2so3
"sorbitol,"
symmetry=
jbcscreen
manganese
microseed
"tartrate,"
"10k)
0.2"
"agmatine,"
"malonate,"
"8000
0.1"
(protein:
hydroxide
120-160mm
beryllium
"hepes-na,"
0.22-0.25
"acid
0.1"
"protease,"
18.4mg/ml
"
peg400,"
"(ph=7.5),"
"7.5,
20%"
n-dodecyl
"nl

ret"
"paratone,"
nh4h2po4.
n-butanol
na-malate
(chloride
"flouride,"
"(pegsii),"
"imidazol,"
crystals:
nh4ch3coo
substrate
hexagonal
2.56-3.20
"d-xylose,"
"(10mg/ml,"
(titrated
"(ph-7.5),"
"pyridine,"
(hampton)
"bestatin,"
caps/naoh
t-butanol
suspended
"mg(no3)2,"
ytterbium
"4000
0.3"
dialaysis
fluoride.
"7.6mg/ml,"
dn_eg_002
monoolein
premiertm
(mol/mol)
sulfate).
"oxamate),"
incubated
"nacl
25%"
4000/6000
maltoside
avibactam
f-barx-wt
"bis/tris,"
employing
resevoir:
1.5%(w/v)
hexaamine
(schricks
eliminate
"3350
0.2"
tribasic/
"tris/hcl,"
"nacl
1.5"
"nh4h2po3,"
"6.2-6.3),"
(15mg/ml)
"tris_hcl,"
additions
"dcadomet,"
"3350
0.1"
malonate.
glycerol.
0.1-0.175
"benzoate,"
agitation
iodomuron
231_chol.
trihyrate
"6000
100"
"kcitrate,"
alternate
"gradient,"
"tris-hcl,"
(solution
0.18-0.22
"reduced),"
"nicotine,"
"peg-6000,"
"citrate),"
0.1-0.18m
wizard3/4
citrate).
trihydate
"crystals,"
dl-malate
(residues
micolytic
"seed
100"
"research,"
0.075-0.2
assembled
(relative
"peg-3400,"
solution-
1-butanol
"details.,"
dimension
prismatic
5-7%(w/v)
96x2-well
0.15-0.55
seed-bead
"
domain."
"ches-hcl,"
"4000,0.1m"
"acetate.,"
"7.5-8.5),"
"d,l-malic"
d-mannose
"mes:naoh,"
actinonin
"peg400
1"
hepes/hcl
"400
0.2m"
his313gln
(buffered
"6.4-6.6),"
"07292021,"
auranofin
peg-4000.
"1526003a,"
typically
suggested
"bis-tris,"
"peg-5000,"
0.125-0.3
threefold
spermine.
"mops,50mm"
carlsberg
four-fold
"mpd,
0.2"
"(vxd5-6),"
peg3350);
solution)
"25%peg4k,"
propylene
pegmme550
"
trishcl"
"peg_6000,"
"acetone.,"
(270-614)
"anaeroby,"
"sulphite,"
"peg33500,"
guanosine
beamline:
"
(soaked"
"6.1)
15%"
12.5mg/ml
"aps21idf,"
12.1mg/ml
"compound,"
xylobiose
0.14-0.20
peg3000);
ches:naoh
"l-lysine,"
augmented
resulting
"naborate,"
d-camphor
genistein
saturated
(nh4)so4.
"protein.,"
gd2(so4)3
carbamoyl
conjugate
transfers
mn2+2-hai
glycerol)
performed
"was
bace"
peg4000);
hexammine
"(li)2so4,"
solutions
reservoir
22.5%-30%
differing
palmitoyl
dilutions
patterns.
"and
0.1m"
(356-525)
(137-322)
"crystal
"
solution.
iron(iii)
(dibasic)
"arginine,"
"(14-16%),"
"mgcl2,100"
tribasic]
di-sodium
"6.8-7.5),"
"5.8-6.2),"
"ck2alpha,"
"5.5,
45%"
"elastase,"
17-20%peg
(tertiary
"butanol),"
buffer-ph
"nacl
0.1"
interface
"amp-pnp),"
"nh4(oac),"
"8)
mixed"
"acid/koh,"
co-enzyme
"(li2so4),"
"m7gpppg.,"
imidanzol
glutamate
dl-serine
dl-lysine
"rifampin,"
phenethyl
"6.5-7.25,"
"cy-digmp,"
acid/naoh
"(nh)2so4,"
propanol;
"peg1500),"
distilled
(ammonium
libraries
geometry.
"7.4mg/ml,"
[barcode:
"284871d9,"
dissolve.
"cysteine,"
carnitine
trimethyl
increased
"peg4k
10"
dot1l-sam
tris-base
crystalls
(2.5mcl):
phospahte
0.95-1.10
"6k

the"
"suramine,"
"nitrogen,"
sollution
tris/hoac
eppendorf
"tris-8.0,"
"7.5,
0.2"
complexed
"
citrate"
additives
1.4-1.55m
reductive
bis-tris:
"3350,0.2m"
aammonium
1.7%(v/v)
"minutes.,"
5.0%(v/v)
"anthrone,"
(sts-78).
180-220mm
stabilize
identical
suramine)
"nacl
22%"
dispensed
"peg8000.,"
deposited
"glyercol,"
"melbourn,"
ph=5.82).
8-10mg/ml
"
acetate"
"
propane"
d-glucose
"nadp,10mm"
glucoside
(117-601)
"ches
200"
surrogate
carefully
(nh4)2so4
"gdcl3,10%"
cacodylic
mg(cooh)2
routinely
"
protein"
purchased
resultant
myristoyl
mw=3350).
(nh4)2po4
"
covered"
na+-hepes
microbach
coverslip
cathepsin
oxidized)
0.00025mm
"(ph-6.5),"
"freezing,"
caps-naoh
5.0%(w/v)
catalytic
0.08-0.14
"8.5,
15%"
egg-white
"protein),"
different
"nacl,0.2m"
initially
"ferritin,"
"kformate,"
5.5%(w/v)
ch3coonh4
"l-fucose,"
generally
"mes(6.5),"
1.25-1.5m
200/100mm
"nor-noha,"
"
peg4000"
"7.4
2.56"
extracted
bosutinib
levulinic
ornithine
structure
"hepes_na,"
naformate
"(excess),"
tdp-qui3n
enoyl-acp
100-200mm
"fructose,"
peg4000).
"sulfate.,"
reservour
caacetate
"(ph=8.0),"
7-8%(w/v)
"peg-3350,"
0.1%(w/v)
"w/v.
1mm"
infection
fluoride:
"the
well"
arginine.
reductase
"celsius.,"
"(buffer),"
"3350,0.1m"
annealing
"5.0)
10%"
"(nh4)2ac,"
"nitrate.,"
"4.0-5.0),"
reservior
quercetin
1.85-1.9m
"1605003a,"
zaragozic
carbonate
"4000
140"
overnight
(ethylene
2.92-3.0m
monobasic
sisomicin
"6.1-6.6),"
150-200mm
"l-valine,"
"tris/dcl,"
shuttle's
"1500
0.1"
therefore
component
"2%peg400,"
4-dioxane
measuring
"265717h6,"
"
150-300"
"methanol,"
"mounting,"
"glcn-6-p,"
8.45mg/ml
gradually
molybdate
"5.3-6.8),"
"0.1mtris,"
1.9m-2.0m
aliquots.
tascimate
overlayed
0.5%(w/v)
permeable
(rs)-mpd.
"3350,0.3m"
"mes.naoh,"
"
complex"
0.16-0.2m
8.9-9.9).
2.58-2.73
na-borate
freezing.
0.15-0.30
1.5microl
reduction
4-7%(w/v)
consisted
"na2moo4.,"
"peg4,000,"
"4000
20%"
additive:
galactose
"nach3co2,"
cocktails
isopropyl
"
2.5-15%"
"
lithium"
compound:
pyridinol
"(c11dao),"
(~1mg/ml)
l-peptide
0.2%(w/v)
20mgs/ml.
"tribasic,"
"1.9mcscl,"
"l-serine,"
14.5mg/ml
l-fucose;
"nacl
100"
histidine
"acetate,,"
"spermine,"
(1.5mcl):
methylene
(dl-malic
(spermine
"halogens,"
peg-3350;
1.6m-1.7m
under-oil
technique
sulfate);
"mng-3-c8,"
300~500mm
"beta-ddm,"
"tris
1.6"
(ph=7.5)]
protocol.
"seeding.,"
mcilvaine
"0.2mg/ml,"
contained
"peg3350.,"
protease.
buffer(ph
cytotoxin
ammnonium
propionic
imidazole
nter=gfqt
ethylene.
"addition,"
addtional
naacetate
"glicerol,"
pde9-ibmx
7.98mg/ml
0.95-1.0m
continued
"na-hepes,"
"
li2so4,"
ammounium
250-500mm
(nh3)2so4
"arsenate,"
activated
"
several"
"tris-so4,"
0.2-0.25m
"peg_3350,"
imidozale
hmmp-9-wt
tris-hcl;
tacismate
"exchange,"
trachaeal
0.15-0.5m
unligated
"1000
240"
"acid,
ph"
"peroxide,"
anomalous
"311079g8,"
"3350
1:1"
"7.0)
20%"
"m
sodium"
bis-tris;
"mgcl2,5mm"
"
yttrium"
pyridoxal
bis-tris-
"tric-hcl,"
protamine
(6.8-13.5
myoglobin
100-300mm
"kcl,
200"
"8.25
55%"
"hepes7.5,"
estradiol
critically
"tris-hcl.,"
"mgcl2,0.1m"
"(10mg/ml),"
equivolume
"
27.5-40%"
reservoir:
neuraminic
(20mgml-1)
"5.6
340mm"
structure.
wavelength
"nacl
1.5m"
"cofactor.,"
strychnine
protein:20
"adenosine,"
"3350,
0.1"
"6.28,
0.2"
co-crystal
"ph6.5
0.2"
"detergent,"
"mgcl2
25%"
"imidazole,"
"2000mme
2"
adenosine.
cryostream
0.04%(w/v)
"5.0-5.75),"
maleoneate
"ph7.0-7.5,"
"maleonate,"
"peg-10000,"
identified
condition)
magenesium
protection
"homopipes,"
"
crystals"
parameters
(anatrace)
"reference,"
"nh4ch3coo,"
cryobuffer
"naacetate,"
his-tagged
880-1440mm
tryhydrate
mycrolytic
mg-acetate
n-paratone
"ammonium
"
17%peg8000
(nh4)h2po4
hepes:naoh
surrounded
mgcl2.6h2o
"2-butanol,"
resolution
"acid/naoh,"
"atpgammas,"
"k-formate,"
additives.
naoac/acoh
"co-factor,"
t-butanol.
"d-glucose,"
completely
"gtpgammas,"
"nicl2
0.1"
copper(ii)
"tetra-hcl,"
"magnesium,"
"l-lactate,"
"
morpheus"
detergent.
nh4acetate
"4000,100mm"
0.02%(w/v)
"tyrosinol,"
stabilized
na-formate
dl-serine)
"7)
12-15%"
20%peg3350
"6k

jm12"
harvesting
"nacl
0.1m"
l-tartrate
"5000
0.1m"
"c3h5(oh)3,"
"peg500mme,"
co-complex
"substrate,"
42.5%(v/v)
chemicals)
homoserine
"shikimate,"
cerevisiae
"6000,
0.1"
positioned
tris(hoac)
"(tilander,"
monobasic/
ch3coonh4.
"monobasic,"
"3350
0.2m"
phosphate/
"was
used,"
d-tartrate
0.03-0.05m
contained:
jcsg+(b8):
consisting
udp-glcnac
znacetate.
"nacl
20mm"
"analogue),"
dehydrated
"anapoe-35,"
"sulfate;
"
0.02-0.20m
"
ammonium"
mgcl2x6h2o
0.25-0.35m
ca-acetate
l89s-febmb
methane/40
"(hampton),"
na-acetate
pre-loaded
"phosphine,"
"faropenum,"
nanoliters
(hampton's
monoclinic
"peg4k
16%"
"(w/v)
300"
"2,4-methyl"
(reference
telaprevir
saturating
transition
"gamma-pga,"
"under-oil,"
"solution.,"
moenomycin
12.2mg/ml:
(molecular
industrial
"buffer,0.1"
"8000
0.1m"
500mme/peg
pegmme5000
overnight.
"mgcl2
10%"
ampicillin
production
1-butanol.
"tert-buoh,"
setting-up
"3350
0.1m"
propolyene
"t-butanol,"
li2so4;2.2
hexokinase
"23.4mg/ml,"
suspension
"18.5mg/ml,"
microlites
postassium
"medium
5%"
androstene
"peg550mme,"
0.14-0.20m
"hepes
25%"
"salt,
200"
pegmme2000
"jeffamine,"
26.5%(w/v)
13.5%(v/v)
0.05%(w/v)
2-propanol
submersion
equivalent
"peg-2kmme,"
"ul

well"
experiment
"technique,"
n-terminal
phenylurea
"nach2cooh,"
pha-848125
hepes-naoh
"research),"
hepes/mops
optimized:
225985d11.
"chlroride,"
"solution:,"
15.9%(w/v)
"oil-batch,"
"anaerobic,"
(ebsi4333)
"pipes-na+,"
represents
"dasatinib,"
atmosphere
reoxidised
procedures
"550,
0.03"
"nascn
100"
neoformans
"dyhydrate,"
glucuronic
"14.5mg/ml,"
hepes/naoh
"li2so4,0.1"
synthetase
containing
"acetate,
"
"glutamate,"
"mgcl2
100"
"cocl2
0.1"
"na-borate,"
tetragonal
"4000
0.2m"
dl-serine;
"7.25-8.25,"
15%peg3350
"peg400,0.1"
a(122-403)
"4,000
0.2"
"harvested,"
"mpd
100mm"
tri-sodium
"pegf-4000,"
",(nh4)2so4"
"8000
0.2m"
afterwards
naringenin
"(drop),20%"
"mg/ml
0.4"
(dissolved
"(racemic),"
"20%
(w/v)"
mono-ethyl
(additive)
"glycerol),"
"
dioxane,"
"3350
0.3m"
"(nh4)2so4,"
diammomium
"sarcosine,"
udp-galnac
"rs-malate,"
"mm
mopso,"
wellbuffer
"400
0.325"
"peg5k-mme,"
polyamines
"leupeptin,"
clavulanic
"l-leucine,"
c-centered
"cacl2
100"
sulphate).
"sulfate,5%"
immidazole
laevulinic
"naoac
0.1"
"200
150mm"
inhibitors
diclofenac
zn-acetate
phosphate-
cocodylate
"10%peg400,"
research).
isomaltose
"20.0mg/ml,"
"liso4
0.1"
"(nh4)2so3,"
(compounds
pire1alpha
"overnight,"
"5.5
11.6%"
"hepes
10%"
"additive.,"
pi3kg-his6
gsk2850163
magnessium
"macroseed,"
triangular
"acid:tris,"
"screening,"
"estradiol,"
"tris-base,"
ph8.6;1.2m
5-15%(w/v)
piperidine
restrained
"ph6.5-7.5,"
cacodilate
thiopental
"mepeg2000,"
5%glycerol
"
acetate,"
micro-g/ml
8-12%(w/v)
"dtt,10%mpd"
hydroxide;
methionine
"(0.0012ml,"
"(peg2000),"
30%peg4000
benzamidin
"were
then"
"(peg4000),"
l-glutamic
0.12-0.14m
"succinate,"
solutions.
(300x40x40
"
sulfate,"
subsequent
ligand-ttr
"3350,
1.7"
nucleation
namalonate
"peg
3350,"
"29.3mg/ml,"
additional
thereafter
"bromoform,"
"sunnyside,"
22.5-27.5%
"hepes-koh,"
trihydrate
sinefungin
covalently
"tcep
drop"
9%(wt/vol)
"7.5

the"
keto-babim
dl-lysine;
1%glycerol
hexaammine
"pepstatin,"
"ches-naoh,"
commercial
(350-400um
0.01-0.025
mes-buffer
"7.5
100mm"
research's
alkylation
cacodylaic
homo-pipes
imidazole.
"solutions,"
backsoaked
frugiperda
"nascn
15%"
fractional
reservoir.
"sacrosine,"
"c-hega-10,"
10-12mg/ml
"maltoside,"
cocadylate
"mg/ml
2.0"
spodoptera
"
suitable"
"sulphate),"
95%n2/5%h2
"crystals
"
(condition
(nh4)2so4.
trilithium
"8.5),
30%"
"k3citrate,"
"acetate,ph"
0.25%(w/v)
"ph6.1-6.2,"
(typically
condition.
hsp90a-ntd
(base)/hcl
"20%
hepes"
"choloride,"
"ph7.0
0.1"
compounds:
edta/dtt);
"mgac
0.1m"
"
compound"
gadolinium
"(0.0006ml,"
"0.1m
dmso"
operations
(vcid3088)
hepes.naoh
cultivated
expression
lanthanide
fos-mea-10
"ph8.3-8.5,"
"mopso-na+,"
"peg10,000,"
(bis-tris)
"ph5.2-5.6,"
mgacetate.
cubic-like
"imidazone,"
bipyramids
formation.
drop/vapor
neurospora
32.5%(v/v)
"condition,"
conditions
index(g5):
naacetate;
"ph3.0-4.5,"
"peg-20,000"
12.52mg/ml
"galactose,"
"20.5mg/ml,"
18.4%(w/v)
peg5000mme
"peg4000,50"
phosphate.
"
freezing"
"kirbac3.1,"
"melatonin,"
"(peg-300),"
three-fold
"chloride),"
18-crown-6
dehydrate.
mcsg1(b8):
na(ch3coo)
"tris-hno3,"
sulfoxide)
"(malonate,"
"40.2mg/ml,"
"mgcl2
26%"
tsernoglou
l-allo-thr
"l-tartrat,"
"3,350
0.1"
n-octanoyl
serum-free
"kh2po4,0.1"
"benzidine,"
condition:
"mgcl2
0.1"
/inhibitor
"d-camphor,"
"performed,"
(nh4)2so4)
33.6-45.9%
(construct
jannaschii
"tascimate,"
"sulfate,
"
reservior:
ascormbate
microscope
desialated
"d-mannose,"
tribenuron
"amicyanin,"
peg-3350).
eth-glycol
"threonine,"
15.75mg/ml
monobasic;
solution).
25.5%(w/v)
0.001mg/ml
di-hydrate
"pegme2000,"
derivative
coordinate
"threalose,"
solution:(
increments
dihydrate)
"
degrees."
na-citrate
photassium
"peg-20000,"
radiation.
"nh4(so4)2,"
"formation,"
magunesium
(mes)-naoh
techniques
"glycerol,,"
pramociane
monomethly
bicine-hcl
beta-octyl
mg-formate
macrobatch
"tris_base,"
throughout
cys336ser)
"peg750mme,"
"buffer
20"
anandamide
22.5%(w/v)
27.5w/w(%)
17.5%(w/v)
"
obtained"
"ph7.0-8.5,"
"0.1mhepes,"
0.06-0.12m
na-tricine
"7.5mgr/ml,"
"(nh4)2po4,"
"ph5.5
200"
"thymidine,"
"tris.base,"
"22.9mg/ml,"
penoxsulam
"7.5,
0.2m"
mcsg1(e3):
"ch3co2nh4,"
"x-linking,"
plate-like
microbatch
dihydrate;
benzamide.
copurified
"na-citrat,"
"fluoride),"
vortexing.
mcsg1(f5):
reductase=
0.05-0.15m
"carbonate,"
mes-sodium
chloride).
emeraldbio
reservoir;
"
22.5-35%"
sequential
"1000
12.5"
"imidizole,"
additives:
"potassium,"
suspending
9-11%(w/v)
(racemic);
"cacl2
0.1"
(3.5mg/ml)
determined
protein/ml
fosfomycin
"1,6-hexane"
"cisplatin,"
li-acetate
cohexamine
microlytic
mcsg1(d3):
hexanediol
"na3c6h5o7,"
monosodium
introduced
"2000
.02m"
butanediol
concerning
"glabridin,"
"polyether,"
micromoles
mmtris-hcl
de-ionized
"hepes/koh,"
reservoirs
dl-alanine
"
(mangel,"
"dl-lysine,"
apoprotein
c-terminal
2.36-2.58m
"sulfphate,"
"8.6
22.6%"
8-14%(v/v)
"6.25-7.25,"
"inhibitor,"
"guanidine,"
starbursts
"8000,100mm"
"nacitrate,"
phosphate)
"tartrate),"
following:
imidazole:
0.12-0.24m
cytochrome
methylated
"phthalate,"
"4000/6000,"
jcsg+(d5):
"activator,"
"k-citrate,"
mes/sodium
7.5%-17.5%
0.1&#181;l
nacitrate.
1.5&#181;l
pyridozxal
diffusion.
"293949g10,"
pipes-naoh
0.28-0.38m
"bsi108214,"
cobalt(ii)
"
solution"
monomethyl
"hepes-hcl,"
"30%peg400,"
tobramycin
trehalose.
tacsimate;
gabaculine
"w/v
hepes"
reservoir)
alprenolol
"hydroxide,"
"solution),"
ttr:ligand
"21.5mg/ml,"
1051-1348)
"naformate,"
"diffusion,"
"caodylate,"
"peg-4,000,"
easyxtal).
l-malate);
"20%peg400,"
12.5-13.5%
cocrystals
"35%peg400,"
dithionite
"myoglobin,"
acetate-na
inhibitor)
transfered
microliter
pre-formed
(reservoir
reference.
10.37mg/ml
volasertib
17.5-22.5%
"sunitinib,"
"(nh4)3po4,"
"mesophase,"
artificial
oxypurinol
"pegmme550,"
"variation,"
l-cysteine
"3350,200mm"
"dl-serine,"
9.75%(w/v)
(0.15-0.25
dihydrogen
"afterward,"
isopropano
1.25-1.35m
"5.6
0.015"
centrifuge
12.5%(v/v)
"
hexylene"
jcsg+(a5):
(nh4)2so4]
jeffamine]
"8-10mg/ml,"
dehydrate)
thoroughly
"sulfate
4"
f33y-cubmb
imidazole/
hemi-babim
"mpd;
tris"
"
resevoir"
"divalents,"
incubating
"ph5.9,60mm"
"aspartame,"
"micromesh,"
"mgso4
20%"
(imidazole
1.54-1.62m
successive
"trisodium,"
mcsg1(a1):
"glycerol.,"
"mepeg5000,"
protectant
cyclohexyl
1049-1052]
phosphinic
"sulfate
1"
100mmhepes
"nh4ch3co2,"
"formamide,"
"micobatch,"
32.5%(w/v)
(nh4)so4).
24%peg2000
"
sulphate"
filtration
"deaza-plp,"
"1.25%
peg"
cacodilato
"
tris-hcl"
diffusion;
biosystems
"freezing.,"
previously
"(morpheus,"
"acetate,50"
"tris/hoac,"
"ph=7
1.5m"
ethoxylate
reductase)
"sulphate.,"
(~20mg/ml)
16%peg8000
diethylene
saturation
"8000,
100"
pottassium
p-coumaric
"
(hampton"
incubation
"phospahte,"
"chloride.,"
"kcl,20-30%"
(anaerobic
apo-enzyme
luciferase
collection
"ph7.0-7.2,"
"ch3coonh4,"
"5-no2dump,"
"ascorbate,"
discussion
"acid-naoh,"
unliganded
"(25%-29%),"
"dihydrate,"
[imidazole
t790m/c797
"hepes
30%"
"8351-8357,"
12.3%(w/v)
"
presence"
"4000/3350,"
dissolving
indicating
unbuffered
"4,000
0.1"
monobasic.
"7.5
200mm"
"
propane,"
"lisulfate,"
"1990)
the"
technique.
dl-serine.
substrate.
"protein).,"
0.18-0.205
trinitrate
cacodylate
dl-malate;
"l-alanine,"
jcsg+(c1):
"znso4,0.2m"
"5.8
0.125"
mikroliter
"bis-tris.,"
(nh4)2so4;
"vitrified,"
"na/kh2po4,"
"3350,100mm"
ketoprofen
13-17mg/ml
boceprevir
1-propanol
"
peg6000,"
vitrified.
"6000/8000,"
"gd2(so4)3,"
"l-cystein,"
cryocooled
"8.0,vapour"
"19.3mg/ml,"
na3citrate
continuous
microlitre
[compound]
"(nh4)2s04,"
"wild-type,"
centigrade
"amsulfate,"
14.4%(w/v)
"
soaking:"
l-arginine
dimensions
hexahedron
"
0.7-1.0m"
"kanamycin,"
"
oxamate,"
hydroxide.
"(easyxtal,"
"22.5mg/ml,"
mikrolitre
tryptophan
toxoflavin
"(nh3)2so4,"
8-10%(w/v)
"hexandiol,"
"l-fuctose,"
"ph6.0,0.2m"
"nanodrop',"
piperazine
galactose.
"caacetate,"
"6.5
0.02m"
"mgacetate,"
compound);
morphology
"oxidized),"
"reductase,"
imidazole;
n-propanol
dl-serine:
holoenzyme
"30%ppg400,"
phosphate;
"naac(5.0),"
"3350(w/v),"
(nh4)(ac);
"znacetate,"
"
protein,"
decreasing
"mgso4
0.1"
n-decanoyl
"dehydrate,"
methoxypeg
"l-proline,"
subtilisin
(~60mg/ml)
chloride);
adenosine;
natartrate
(magnesium
nickel(ii)
"glutamine,"
"aromatase,"
"ches:naoh,"
10.0%(w/v)
glucoside.
"tdp-qui4n,"
lysine-hcl
"tacsimate,"
25-30mg/ml
"k-acetate,"
15.5-16.5%
(screening
disulfiram
"(peg)3350,"
procomplex
15-25mg/ml
(described
"6,000
100"
(v/v)0.003
crizotinib
d-mannose;
"(bsi1606),"
"8.5
0.02m"
depression
d-fructose
18%peg8000
"disulfide,"
"
20%(w/v)"
"(w/v)
peg"
gentamicin
25%peg3350
"phosphase,"
(vol/vol);
"acid
65mm"
"
glycerol"
"d-lactate,"
proteinase
d-ribose);
"ph5.3-5.6,"
"3350,
1:1"
"avibactam,"
"hepes
and"
glycerol).
14.37mg/ml
hydroxamic
literature
converting
dihydrate.
comprising
"amformate,"
"buffer
ph"
"sulfonate,"
"acetate
5"
triethanol
diffusion:
"4000,
0.2"
solutions:
hydrolyzed
"acid:naoh,"
mops/hepes
"(nh2)2so4,"
"tungstate,"
peg2k-mme;
naoac/hoac
"2,3-cyclic"
"1000
0.2m"
"ph6.5,0.2m"
penicillin
l-aspartic
"dm,
100mm"
rod-shaped
"peg2k-mme,"
"1-butanol,"
"
sucrose,"
"crystals.,"
liquor-20%
acetyl-coa
milliliter
"nacl,100mm"
cop'gen-i.
"peg400
10"
"nitrogen.,"
"10mg.ml-1,"
"analysis.,"
(981-1108)
gramicidin
22.5-23.5%
"20%peg500,"
inhibitor.
"ches/naoh,"
increasing
"hadacidin,"
li-sulfate
"trehalose,"
ammmounium
"contained,"
solutions)
mgsulphate
udp-xylose
hygromycin
glycol/peg
10.0%(v/v)
0.05m-0.1m
tazobactam
"3,350
200"
originally
(nh4)2hpo4
12.5%(w/v)
spermidine
1.95-2.10m
(including
"(swissci),"
"sulfoxide,"
microseeds
"structure,"
"dicloride,"
"(peg3350),"
dichloride
"reservoir,"
mcsg1(f1):
"peg20,000,"
tris-borat
"c4h4knao6,"
"tartarate,"
daptomycin
"tris
drop"
bistrishcl
"6000
0.1m"
manuscript
cacadylate
three-days
"monoolein,"
paratone-n
"adenylate,"
"ar-r17477,"
micromolar
33mg.ml-1.
novobiocin
formulated
"mgformate,"
"28.5mg/ml,"
brzozowski
thiocynate
"glucoside,"
"molybdate,"
"mg(hco2)2,"
spermadine
"pegmme500,"
"citrate,
"
"edta
well"
asymmetric
"diffusing,"
s-adenosyl
o-vanillin
facilitate
citrate(ph
(hr2-211).
1-butanol;
"peg500dme,"
p-vanillin
"(dibasic),"
"(0.001ml),"
"dihrdrate,"
"pa200
0.1"
10-15mg/ml
glycerol);
(propionic
acid(naoh)
proplex-96
0.12-0.58m
"additives,"
"deiminase,"
2-proponal
tris-h2so4
"phosphate,"
peg2000mme
asparagine
instrument
"pyridoxal,"
"mm
sodium"
"k/nah2po4,"
"
protein:"
"mgcl2
30%"
"acetylcoa,"
"
ethylene"
"chloride,,"
"microbach,"
"
spermine"
"
ca(oac)2"
"carnitine,"
"3,350
0.2"
millimolar
tacsimate.
"dl-malate,"
d-sorbitol
"n-butanol,"
0.1msodium
"anhydrous,"
13.5%(w/v)
mono-olein
comparison
"8.5
0.03m"
"21.8mg/ml,"
solution);
(swissci).
hepes-mops
vitrified:
individual
succinate/
metal-free
components
carboxylic
imideazole
diammonium
pentandiol
acetate(ph
amphiphile
"bis-tris,,"
suplemented
"glycol
20%"
pyrrolidone
"(500-8000),"
"ethanediol,"
hexahydrate
cycloserine
"mg/ml
drop"
"n-butyrate,"
3-phosphate
"1-propanol,"
"monoclinic,"
"tungstate.,"
"mono-olein,"
"ph=8.6-8.8,"
8/3-hydrate
his6-tagged
nogalamycin
containing:
"nucleotide,"
pentanediol
"propionate,"
zn(ch3coo)2
"tobramycin,"
"naoh-hepes,"
"peg4000
2%"
12.53mg/ml:
essentially
"(32%),
mes"
"formate
20"
glycine-hcl
gdp-mannose
keto-babim.
l-arginine)
amm.sulfate
"(ph=6.8).
"
dl-glutamic
anti-fungal
"saturated),"
"8000
100mm"
lyophilized
"mes-buffer,"
"peg4000
.1"
"mgcl2
0.2m"
"tris
200mm"
"
inhibitor"
"hepes,
25%"
"nano3
0.03"
"structures,"
triammonium
suspension.
(nh4)2so4).
exonuclease
(monobasic)
"hepesph7.5,"
"10%peg1000,"
"mgcl2,nacl,"
olomoucine.
sulfate/10%
triethylene
"20%peg6000,"
"40.69mg/ml,"
"mopso-naoh,"
"(100mg/ml),"
bis-tris-cl
mes/acetate
"d,l-lysine,"
"ethoxylate,"
"any1
100mm"
protein:sah
(udm/fa231)
propane/hcl
"mes(ph6.5),"
"microlytic,"
"peg3350,10%"
stabilizing
"harvesting,"
"hepes:naoh,"
"nascn
1.5%"
"propane
ph"
"mgcl2.6h20,"
polyacrylic
acetate-hcl
pha-680626)
monohydrate
"sulfate
2%"
"
phosphate"
"mm
na2so3,"
"(tribasic),"
0.250-0.275
temperature
"cadodalyte,"
composition
"mgcl2.6h2o,"
"pulverized,"
p110(delta)
"cadaverine,"
"atmosphere,"
phosphoenol
sulfate(the
"2-proponal,"
hepes\/naoh
"8.0)
mixed"
"5,000,
1.0"
"li3citrate,"
"
harvested"
centigrade.
25-28%(w/v)
18%(w/v)peg
"mes/sodium,"
polystyrene
"
magnesium"
immediately
sodium-tart
cacodylate;
"peg4k
0.01"
"ca-acetate,"
"cacl2.2h2o,"
centrifuged
"mono-basic,"
"sulfate
5%"
"8.5
23-30%"
"1,4-dioxane"
"m
ammonium"
"cocadylate,"
"(nh4)4p2o7,"
"7
tryptone"
"glycol
0.1"
"procedures,"
"298.0
cryo"
"nacl
after"
"20%peg3350,"
"
tris-hcl,"
nucleotides
mono-methyl
"citrate
20"
"triglycine,"
"techniques,"
appropriate
"nucleation,"
isofagomine
"added
from"
"kh(2)po(4),"
"cacodalyte,"
"50mm
stock"
conditions.
"mg-formate,"
"3350
200mm"
"ph8.5
0.2m"
20%ethylene
"glycol,293k"
"millimolar,"
"tryptamine,"
"acrylamide,"
"4000
200mm"
"sulfate
50"
"propyl-amp,"
griffithsin
"propane
20"
"peg-550mme,"
1-phosphate
sulfobetain
"mgso4,
0.1"
"tris/h2so4,"
"mgcl2,
0.1"
combiclover
"
condition"
"methionine,"
incorporate
"nh4formate,"
"peg4000
50"
"tris-hcl,ph"
"l-tartrate,"
buffer(10mm
"phosphate.,"
inhibitors.
microseeded
"chorismate,"
"mg/ml
well"
nasuccinate
"citrate
10"
mono-sodium
"soaked
for"
protection:
"1-naphthol,"
bicine-naoh
"
contained"
dehydration
"m
glycerol"
"10%peg6000,"
recombinant
saracatinib
deoxycholic
"
saturated"
"ph7.5
0.2m"
"4.0.
20-25"
precipitant
"peg-20,000,"
propanediol
caps/bicine
trihydrate.
dl-alanine;
crystallize
"sulfate,10%"
apoferritin
publication
acetate/hcl
"dichloride,"
introduced.
"n-valerate,"
tris-acetic
"bromide,30%"
oxaloacetic
"mgcl2
well"
"20%peg4000,"
micromole).
"30%peg4000,"
"glycerol
2"
"dmso
well:"
unassembled
"sulfate
8%"
2-propanole
solubilized
"mg-acetate,"
"ph4
12-15%"
"3350
10.0%"
"peg4000
25"
bicarbonate
"(nh4)2hpo4,"
"8000,soaked"
cryo-cooled
"paratone-n,"
nh4-acetate
cholesterol
"peg-350mme,"
"compound;
"
tropisetron
chlorimuron
"acetate
ph"
tentatively
"glycol2000,"
glucosidase
21.43mg/ml;
citrate-hcl
"pegmme2000,"
infiltrated
"micromole),"
tert-butano
"na-oxalate,"
(+)-sucrose
"7.0;
cryo:"
"glycol
200"
pde9a2-ibmx
microseeds.
"hexanediol,"
"li2so4
0.1"
"spermidine,"
"
chloride,"
50-100-fold
"peg-mme550,"
healthcare)
30-43%(v/v)
"iodide
20%"
"glycerol
7"
"citrate,0.1"
delipidated
combination
20%(wt/vol)
(269601c8):
diphosphate
(5/4/po/oh)
peg2000/0.1
crystalline
solution:50
bicine/tris
hexanediol.
rectangular
rescreened.
mcsg1_a2-c2
guanidinium
macroseeded
illuminated
micro-litre
"
reservoir"
25~29%(w/v)
di-hydrogen
ngrrnle227a
"phenylurea,"
ngrrnlr149a
ngrrnlk326a
"olomoucine,"
milliliters
(nlysx-cmp7
"asparagine,"
2-propanol;
"(1r,4s,5r)-"
"hepes/naoh,"
(originally
dc26/adohcy
0.2ul:0.2ul
"
100-140mm"
"mg/ml,
and"
monododecyl
"chloride,
"
33.15mg/ml.
isopropanol
"(nh4)2)so4,"
"(nh4)h2po4,"
"
140-200mm"
12.25%(w/v)
tryptophan;
"collection,"
5-phosphate
tris/bicine
"peg5000mme,"
"isoleucine,"
8.3;screen:
"xylitol
5%"
"acetate,5mm"
d-galactose
percipitant
dideuterium
bis-tris(ph
glycol(peg)
l-arabinose
"
glycerol,"
tacsimate);
ligand-dmso
"cacadylate,"
tetramethyl
"tris-h2so4,"
"10%peg4000,"
nh4-sulfate
"namalonate,"
phosphate);
pu-11-trans
na-tartrate
60~100mg/ml
propane:hcl
apo-22(ctc)
"transition,"
"acetate
10"
transferred
10-16%(v/v)
peg5000-mme
bistris/hcl
"diffusion.,"
pressurized
"n-propanol,"
co-crystal.
cacodylate/
tacsimatetm
oxaliplatin
nah2po4/1.0
"keto-babim,"
ches/sodium
"k-tartrate,"
"peg-10,000,"
"d-fructose,"
"(bis-tris),"
na+-citrate
"l-gutamate,"
formulation
"reservoir.,"
"chloride,50"
precipitate
"cacodelate,"
co-crystals
"4000,0.150m"
na3-citrate
"(monoolein,"
"
imidazole"
l-glutamate
(nh4)2so4);
"salicylate,"
"diffusion
"
"cacodylate,"
"suspension,"
glucosamine
"malate/hcl,"
"5.6
20.00%"
(carboxylic
"8.5,
0.03m"
coverslips.
preparation
na-fluoride
"peg20k
20%"
full-length
"acetate,0.1"
fos-choline
transfering
"acetyl-coa,"
"na-acetate,"
"dihydrate),"
well-formed
d-trehalose
synthesized
"dl-alanine,"
"cellobiose,"
"glycol3350,"
cryocooling
"protein,
2"
0.025-0.125
"udp-glcnac,"
"trimannose,"
"
potassium"
imidazolium
"adp-ribose,"
concentrate
"d-sorbitol,"
"protein
14"
(14.5mg/ml)
experiments
"sulfate,100"
"imidazole
"
"structure),"
"20,000
0.3"
"tris-hcl,
"
"15%peg4000,"
"isoprpanol,"
inhibitor).
"(additive),"
"7.5;
prior"
"by
soaking"
glygly/ampd
"nitrate
10"
octahydrate
"sulfate,0.1"
capillaries
ca(151-231)
24.33mg/ml:
"mm
li2so4,"
"20%peg8000,"
mops/sodium
"were
grown"
small-scale
dehydrating
"sinefungin,"
"4000;

10"
"ispropanol,"
"mops/hepes,"
"cacl2,
15%"
"dehydrate),"
"14-dioxane,"
dimensions)
"sulfate
);"
ehubiquitin
"trizma/hcl,"
"isocitrate,"
oikonomakos
proteolysis
bis-oxalate
crystalized
"mgcl2,6h2o,"
(rs)-(+/-)-
10-12%(w/v)
dl-arginine
refinement:
"nh4sulfate,"
beta-keggin
"peg2000mme,"
microlytics
"conditions,"
"peg400
100"
polythermal
diffracting
"subtilisin,"
equilibrate
na-oxamate;
"25%peg3350,"
mecillinam)
"phosphate),"
20-25%(w/v)
protein/dna
"cacodilate,"
"dihydrogen,"
"6.5
sodium"
citrate/hcl
tri-hydrate
"pegmme5000,"
thermolysin
di-ethylene
sulfate/peg
sulfoxide);
precipating
protectant:
"immidazole,"
decahydrate
t790m/v948r
d-ala-d-ala
6-phosphate
tri-citrate
co-purified
"30%peg3350,"
"inhibitor.,"
"(30min-1h),"
25-32%(w/v)
tris-maleic
"
diffusion"
0.18-0.22mm
"hepes-naoh,"
naphosphate
dimyristoyl
bistris-hcl
cobalt(iii)
30-35mg/ml.
"butanediol,"
acetate:hcl
25-30%(v/v)
"derivative,"
"peg550-mme,"
micro-molar
"appearance,"
"amp-pnp
20"
"nh4(h2)po4,"
nah2po4/0.8
"reservoir),"
lithocholyl
israelensis
3-oxo-delta
"propane,1.8"
"bis-tris,ph"
precipatant
"ph6.8-7.5),"
bromophenol
"medium
0.1"
"phosphate
"
carboplatin
"monobasic.,"
"5%glycerol,"
(diethylene
micromolar)
cryobuffer:
c773a/c999a
phosphinate
naformate);
"tris/ph8.0,"
undisclosed
"16%peg8000,"
"dithionite,"
"diffuction,"
30%(wt/vol)
mercury(ii)
"nh4acetate,"
"asbeta-gly,"
"incubation,"
"li2so4.h2o,"
"ampicillin,"
"di-hydrate,"
succinate);
"stharaf62a,"
"glutathion,"
hhmb(sigma)
"na3citrate,"
"proflavine,"
propoxylate
evaporation
"peg8k
0.1m"
"sulfate
12"
"
manganese"
"30%peg8000,"
"d-peptide),"
polyethlene
"li(ch3coo),"
"creatinine,"
"l-arginine,"
18-21%(w/v)
collection.
equilibrium
"yl1-038-31,"
glecaprevir
piperidine;
20-24%(w/v)
"li-sulfate,"
gly-gly-gly
microliters
"isoflurane,"
"10%peg3350,"
"na-oxamate,"
hewl/nami-a
replacement
"piperidine,"
"cadodylate,"
"22%peg3350,"
fluconazole
reductively
nah2po4/0.1
zwittergent
nah2po4/0.4
"na-lactate,"
30-35%(w/v)
12-14(w/v)%
"phosphates,"
methane-hcl
instrument.
derivative.
apo-crystal
"naoac.3h2o,"
citrate:hcl
j.mol.biol.
"acetate
30"
"bistrishcl,"
dihydrate);
tris-bicine
thiosulfate
"microseeds,"
collection:
"perrhenate,"
28-32%(w/v)
"5.5,
vapor"
"tryptophan,"
"na-acetete,"
polythylene
"mgcl2x6h2o,"
"dl-serine),"
"24%peg4000,"
"tris,ph8.0,"
coordinates
equilvalent
ligand-free
"2000
0.02m"
"7.3.
ratio"
inactivated
tris-hcl(ph
chapso:dmpc
(reservoir)
nah2po4/1.6
"na-formate,"
"hepes/mops,"
"nacl;
drop"
udp-glucose
"expression,"
millipore).
preliminary
baculovirus
escherichia
"sulfate
10"
incremental
"10%peg3000,"
"2191-2193.,"
tris-sodium
"acetate
50"
reservoir\:
metsulfuron
(containing
30-60%(v/v)
atmospheric
dmpc/chapso
"nh4no3
20%"
"potassium
"
micrometers
conditions:
20-30%(w/v)
diffraction
naktartrate
30-100mg/ml
"acetate,0.5"
"formate,20%"
20%(w/v)peg
"amsu,
0.1m"
"25%peg4000,"
1-propanol.
"glyoxylate,"
"mm
trishcl"
"12%peg3350,"
"na-nitrate,"
"sulfoxide),"
"(imidazole,"
"cacl2
0.1m"
cryostream.
"isomaltose,"
18-20%(w/v)
atp-gamma-s
environment
"mes
28-32%"
(imidazole;
30-42%(v/v)
equlibrated
jcsg+(e11):
"propandiol,"
equilbrated
"buffer:
20"
15-17%(w/v)
transformed
containing;
dimensions]
"peg400
0.1"
(dihydrate)
maintaining
glycol/5.7%
(w/v)peg750
"15%peg3350,"
"microliter,"
supernatant
spontaneous
(nh4)2so4))
experiment.
tri-lithium
dhfr/folate
phytochrome
"glycerol,20"
d207l-y263f
"mgcl2
0.1m"
"afterwards,"
stabilising
10%glycerol
(pre-filled
20-22%(w/v)
"2-propanol,"
"experiment,"
valpromide)
"acetate_na,"
mg(ch3coo)2
"
0.08-0.14"
resveratrol
synchrotron
0.085-0.125
dicyanamide
acid/sodium
pre-reacted
iteratively
15-20%(w/v)
"fosfomycin,"
"peg4000,10%"
"(d-glucose,"
2-propanol.
"microbatch,"
"hydroxide),"
reservoirs.
micro-batch
"pipes-naoh,"
nah2po4/1.2
siliconized
(12.2mg/ml)
"cpr=8mg/ml,"
dithionite.
"citrate
5%"
equivalents
"
sulphate,"
na-formate;
techniques.
"(0.5-1.0m),"
"(h412n)
in"
neutralized
"3350
cryo:"
"imidiazole,"
micro-liter
"liso4
0.1m"
"peg3350
4%"
"peg3350
2%"
methylation
0.005%(v/v)
10-15%(w/v)
"tartronate,"
propan-2-ol
"glycol
0.6"
dl-tartrate
caps/sodium
"glycogenin,"
"

protein"
"na(ch3coo),"
milli-molar
resuspended
presqualene
microliter.
benzylamine
"natartrate,"
"na-citrate,"
angiotensin
[imidazole;
k-succinate
polyethylen
"20%peg1000,"
"(nh4)2so4),"
"increments,"
micro-sized
"na/citrate,"
"d-tagatose,"
"na/acetate,"
k-phosphate
"thiocynate,"
propane-hcl
antibiotics
20%peg33500
"i-propanol,"
benzamidine
homogenized
"m
tris-hcl"
"(racemic)],"
bipyramidal
"imidazole),"
hexanetriol
"protectant,"
"cacodyrate,"
"dimensions,"
superdex-75
"acetate-d3,"
"containing,"
oxide(ddao)
"peg4000
8%"
(ethylated)
"mg-sulfate,"
"l-tyrosine,"
(millipore)
tris-buffer
"1500

180"
"isopopanol,"
"li-acetate,"
exahydrate;
"inhibitors,"
mikroliters
glutathione
phosphonate
"hexabediol,"
"lisulphate,"
20%glycerol
isomorphous
dipotassium
0.001-0.003
"3350

the"
1microlitre
urchin-like
"ph5.8-6,10%"
microlitres
"zn-acetate,"
25%peg3350.
approximate
microfludic
"tripeptide,"
morphology.
"k(2)hpo(4),"
"nicl2.6h2o,"
harvesting.
nacl/sodium
"unbuffered,"
10~20%(v/v)
"diffusioni,"
"na.acetate,"
"peg600
0.1"
"trihydrate,"
methylether
na-malonate
needle-like
cacodylate.
centrifugal
thiocyanate
di-ammonium
polycarpine
peg-5000mme
crystallant
"l-cysteine,"
"7,5
sodium"
(comprising
"glycol
10%"
cephalothin
"(reservoir,"
19-20%(w/v)
dimensions.
octyl-beta-
"gentamicin,"
"

sitting"
"2-methyl-2,"
"buffer
20%"
"15%peg1000,"
"solutions.,"
protection.
"choline-cl,"
"18-crown-6,"
acid-sodium
d-galactose;
m7-gtp-bound
"genz-669178,"
protein:well
macroseeding
nah2po4/1.2m
"2m(nh4)2so4,"
2-microliter
(innovadyne)
"(30min-1hr),"
agglomerates
plate-shaped
di-potassium
"imp-0001088,"
"nitrate
20%"
"citrate_na3,"
aminocaproic
"dmpc/chapso,"
"sulfate.
it"
cryo-buffer:
"citrate:hcl,"
transferring
hydrochloric
precipitate.
biochemistry
monohydrogen
"tris-buffer,"
"l-carnitine,"
"mncl2
2.5mm"
hyoscyamine.
nah2po4/0.8m
l-methionine
"
cacodylate"
bicarbonate.
protein/well
microliters)
"isobutyrate,"
additionally
"l-aspartate,"
sddc-0001914
"sittingdrop,"
thiocyanate.
"5.60)
salt:"
"
reservoir:"
dinucleotide
dimensions).
"
tri-sodium"
"tri-citrate,"
5'-phosphate
"ca-chloride,"
"measurement,"
"mg/ml,mixing"
isopropanol;
"nh4sulphate,"
micro-bactch
"dtdp-phenol,"
2-propanol);
"sulfate,50mm"
"pentanediol,"
"bistris/hcl,"
"zncl2
well:"
anapoe-x-405
"amso4
drop:"
equilibrate.
"udp-glcnaca,"
solid-liquid
"maleate/hcl,"
expt:sitting
"nh4-formate,"
capillarity.
diffraction.
"temperature,"
tetrahydrate
"tris-bicine,"
imidazole-cl
crystallyzed
"peg-2000mme,"
"l-ornithine,"
experiments.
(296175h10):
"bistris-hcl,"
"acetate:hcl,"
"glycerol,10%"
"7.5.

used"
beta-d-octyl
"kendrew,j.c."
"thermolysin,"
acetyl-coa).
equilbriated
"k-phosphate,"
equlibrating
"hydrate
0.1"
crystallized
"diphosphate,"
"mgno3(h2o)6,"
"isopropanol,"
microliters.
"nacl.
mixed"
"(ph5.0-6.0),"
#NAZWA?
"ph5
calcium"
rhombohedral
"mg/ml;
drop"
crosslinking
propanediol;
terephthalic
hanging-drop
rbv-infected
"d-trehalose,"
replacements
"mg.ml-1
1:1"
"6-phosphate,"
"peg8000
0,2"
"peg400
0.1m"
"8.3;
screen"
multiplicity
"sulfate,0.1m"
"acetate
100"
mg(ch3cooh)2
sequentially
"mes/acetate,"
"days
ligand"
"phosphate
,"
"propane/hcl,"
"1,4-lactone;"
0.0025%(v/v)
"microliter.,"
"peg8000
0.1"
"butyryl-coa,"
reproducible
mycophenolic
cryo-cooling
nah2po4/1.6m
"glucuronate,"
"mg/ml
ratio"
yttrium(iii)
nakphosphate
"bicarbonate,"
benzamidine.
morphologies
"galectin-3c,"
"mg(ch3co2)2,"
pentanediol.
tuberculosis
"li2so4
0.1m"
concentrated
"dimensions),"
"
[and]
26%"
orthorhombic
"propane
20%"
"acetate
17%"
"propane-hcl,"
"propane:hcl,"
"(nh4)2so4
5"
nacacodylate
fosmidomycin
solution:100
[collection:
"d-maltoside,"
"maltotriose,"
p500mme_p20k
monohydrate)
"7.0);
cryo:"
"mg/ml
well:"
"calcodylate,"
temperature.
"8.8
protein"
micro-seeded
"sulphate,0.1"
"fluorinated,"
acid/na2hpo4
sulfobetaine
solution:0.8
"glutathione,"
hexaethylene
"0.1m
sodium"
"fluoride,20%"
"sulfonamide,"
"benzoyl-coa,"
pentahydrate
"glycerol,12%"
microgravity
lb-nanofilms
trichloride;
l-tryptophan
tripotassium
"instruments,"
"sulfate,
20"
18%-30%(w/v)
"acetate
18%"
"li-sulphate,"
"centigrade.,"
"l-glutamate,"
na-malonate;
8.3);screen:
"ca(ch3coo)2,"
thiocyanate;
polyehtlyene
polyglutamic
"risedronate,"
"1,4-dioxane,"
iso-propanol
"(nh4)2(so4),"
"phosphonate,"
(empirically
"mes/peg6000,"
"isoproponol,"
"l-histidine,"
"precipitant,"
"publication,"
"tritonx-100,"
"thiocyanate,"
"chloride
5%"
"peg-mme-550,"
"l-norvaline,"
"imidazole
8"
ribonuclease
"isovalerate,"
microfluidic
dl-ornithine
sulfometuron
"naphosphate,"
"peg-mme2000,"
"sulfate
16%"
"bace
mut46b"
respectively
"tri-hydrate,"
microliter):
"(reservoir),"
"9.0

soak:"
"po/oh)
0.2m"
tris/acetate
"gly-gly-gly,"
deoxycholate
solution:0.1
tmk-s.aureus
tris-acetate
"thiacloprid,"
"peg4000,
50"
precipitant.
quasi-labile
nfeg12a-n18y
oxaloacetate
"6
magnesium"
"ph=7.6
0.1m"
"resveratrol,"
glycerol/peg
cholesterol.
nak-tartrate
"(inhibitor),"
acid-na2hpo4
supplemented
"isoproponal,"
"mg(ch3coo)2,"
"the
hanging"
"solution
of"
"protein
0.2"
crystallant:
"l-arabinose,"
"0.2m
sodium"
"amp-pnp
24%"
ethylacetate
"tris/bicine,"
bis-tris:hcl
bis-tris/hcl
"
cisplatin,"
"peg4000
0.2"
acid/peg3350
cryocooling.
glutathione)
"sulfate,	0.1"
"peg8000
0.2"
"mgcl2/cacl2,"
"nasuccinate,"
"
0.25%(w/v)"
supernatant.
"li(ch3coo)2,"
"hexahydrate,"
"sulfate
32%"
hexanoyl-coa
ethanolamine
#NAZWA?
cryofreezing
"3%
glycerol"
non-standard
myo-inositol
"8.5
protein"
"nh4-acetate,"
"
stabilized"
condensation
l-sorbitol);
"nh4-citrate,"
"glycol-3350,"
inositol-6-p
"phosphate).,"
"
monomethyl"
"propanediol,"
subsequently
"sulfate
20%"
na-cacodylic
na-phosphate
acetaldehyde
"citrate-hcl,"
"citrate/hcl,"
"ul
protein:"
"peg3350
0.2"
"acetate
0.1"
flash-cooled
defluorinase
microlitres)
"ter-butanol,"
"acetate
20%"
2.400000000m
concertation
isopropanol.
"naktartrate,"
"formate
0.1"
1.5-year-old
"thrihydrate,"
"sulfate
0.2"
"na-malonate,"
"sulfate
0.1"
"acetate
2.0"
microseeding
"citrate
0.1"
endonuclease
inositol-5-p
"diffusion,
"
reservoir:9%
triphosphate
"water
well:"
"trichloride,"
"peg4000,0.1m"
cryptococcus
benzaldehyde
precipitants
"peg-5000mme,"
sitting-drop
"tacsimatetm,"
"bromide
20%"
erythrocytic
testosterone
"peg500,
and"
"na2so4
0.1m"
tert-butanol
manipulation
"
phosphate,"
"acetate/hcl,"
"acetate
15%"
monoammonium
"naglutamate,"
optimization
sodium-hepes
"tris
23-26%"
substituting
"mgcl2,
0.1m"
flash-frozen
commercially
"formate
20%"
antibiotics.
"propane
0.2"
"micro-batch,"
methyl-ether
polyethelene
ferricyanate
"l-glutamine,"
"benzamidine,"
"nitrate
0.1"
glucose-free
brevianamide
crystallizes
"peg600
0.1m"
mes/imidazol
"aad-1
cryo:"
imidazol/mes
imidazol/hcl
"mg/ml,buffer"
"liso4,
0.1m"
motherliquor
capillaries.
"fibrillarin,"
microgram/ml
"5.5
protein"
"citrate
100"
"ph=8.5
1.5m"
"acetate
10%"
intermediate
"peg3350
100"
monohydrate;
"peg3350
0.1"
"n-dodecyl-n,"
ceftobiprole
cross-linked
"glycols
0.1"
constituents
"acetate
30%"
"acetate
32%"
"l-arg-l-lys,"
na(ch3)2aso2
acetonitrile
"
nickel(ii)"
purification
precipitant;
"cholesterol,"
nah2po4/0.4m
"4-pentadiol,"
l-asparagine
"li3-citrate,"
complemented
nicotinamide
"d(+)sucrose,"
"1-phosphate,"
"mg-chloride,"
bromosporine
"citrate
(ph"
trimethoprim
"peg4000
0.1"
temperature)
preincubated
"citrate
15%"
"amm.sulfate,"
"na(ch3)2aso,"
bis-tris-hcl
"10%glycerol,"
"peg3350,0.2m"
"monohydrate,"
poly(acrylic
dehydration)
tris-maleate
precipitated
n-morpholino
thiocyanate)
polyethylene
acetate-naoh
bioscience).
"peg2000-mme,"
"glycol
0.1m"
seed-crystal
"peg3350
10%"
"tcep
mother"
nahepes/mops
"dithionite),"
"ph=5.5,
25%"
"3350,
1.7mm"
p550mme_p20k
"ph=7.5,
25%"
tartrate/bis
"

crystals"
"iospropanol,"
"udp-glucose,"
chymotrypsin
"proteolysis,"
equilibrated
methotrexate
"microbathch,"
"glycerol
5%"
glycine-naoh
"na-tartrate,"
formaldehyde
"bicine-naoh,"
"sulfate
100"
mg/mlprotein
"sulfate
15%"
"tdp-benzene,"
levoglucosan
"crystallant,"
"citrate
20%"
nh4-sulphate
"sulfate
25%"
"collection.,"
hexahydrate.
well:protein
citrate/0.5m
"d-ala-d-ala,"
hexahydrate;
promirolysin
hydroxyethyl
"nucleotides,"
"1-monoolein,"
"acetate
peg"
"chloride,peg"
conventional
"monolaurate,"
"d-ornithine,"
"cacodylate,,"
"buffer
cryo"
"cladosporin,"
polyacrylate
propane:naoh
precipiation
"perchlorate,"
"gdp-mannose,"
na-succinate
"na-sulphate,"
"citrate
30%"
"bis-tris-cl,"
monohydrate.
naoac-acetic
"aps21-id-g),"
"chloride
6%"
"isoporpanol,"
experimental
"sulfate
30%"
"20%peg-8000,"
(untitrated)
"isopropanal,"
isethionate.
20%-25%(w/v)
"sulfate
.1m"
"10%glicerol,"
"propoxylate,"
praseodymium
(precipitant
"glycol-4000,"
"
containing"
propan-2-ol.
"
afterwards"
hexahydrate:
"base/bicine,"
precipitant:
"l-threonine,"
"dmso
double"
"nah2/k2hpo4,"
alpha-keggin
"1000,
12.5%"
"na3-citrate,"
dl-histidine
"m
magnesium"
"5.5-7.0
22%"
l-aspartate)
"fluoride
20"
ethylmercury
prostacyclin
hepes/sodium
"peg-8000,10%"
"2-propanol.,"
"bis-trishcl,"
"water
mixed"
"d-galactose,"
"glycol
0.2m"
"
diffusion,"
"and
15mg/ml"
composition:
crotonyl-coa
"glycol-8000,"
"5-phosphate,"
"20%glycerol,"
"25%glycerol,"
photoreduced
"gadoteridol,"
"liquor:
30%"
l-gulonate);
"arg-hcl,20mm"
8-azaxanthin
"were
soaked"
"cacodylate.,"
"d-captopril,"
"peg5000mme),"
"were
placed"
"0.1tris.hcl,"
na(malonate)
"evaporation,"
"%
peg-3350,"
"bicine-tris,"
heptahydrate
geldanamycin
"as
follows:"
"methylether,"
"peg-550-mme,"
"chloride,0.1"
glycyglycine
"ethoxylate),"
15-reservoir
knatartrate;
cryosolution
"prinomastat,"
unverified);
"thiocyanite,"
cop'gen-iii.
"benzylamine,"
"knatartrate,"
"atp-gamma-s,"
cng-etpp(k+)
"thiosulfate,"
"(v/v)
0.003"
"citrate
peg"
"ph6.5
0.02m"
temperature:
(nh4)2(so4).
polyehtylene
(bsi111353):
"2-methyl-2,4"
pentapeptide
0.200000000m
nh4-acetate;
"cacl2
well:"
"glycerol
30"
"propane
25%"
concanavalin
na3-citrate;
0.1mbis-tris
chlorambucil
modification
"dibasic
20%"
tri-ammonium
precipitant)
"ca(ch3co2)2,"
"techniques.,"
"1,8-cineole,"
crystallised
"(c-hega-10),"
"formate
1mm"
"(monobasic),"
"1,4-dioxane)"
"ca(c2h3o2)2,"
"propan-2-ol,"
di-ammoinium
"formate
15%"
"decahydrate,"
temperaturek
isopropanol)
d-glucuronic
"mes-acetate,"
"(w/v)
cacl2"
monocrystals
2.000000000m
"alanine/hcl,"
"glycerol
20"
"acetate,0.1m"
"chloride
20%"
microdialysis
sulphobetaine
non-detergent
"tris-hcl
(ph"
macro-seeding
acetylacetone
"peg8000,
0.1"
"peg3350,
0.1"
"(thimerosal),"
phosphate/1.6
"(sample:well,"
(dmpc):chapso
trihydrate(ph
"crystallized,"
stoichiometry
"hanging-drop,"
equilabration
precipitating
"ono-ae3-240),"
"w/v
anaeroby"
"anapoe-x-405,"
microseeding:
bis-tris:hcl;
butyrolactone
"peg1000
0.1m"
"8.5
2.5-2.65"
"bis/tris/hcl,"
27.5-35%(v/v)
"buffer,
0.2m"
4mu-6s-glcnac
"dibasic
0.2m"
"naoac
27-29%"
thuringiensis
phosphorylase
200microlitre
synaptotagmin
(protein:well
myristoyl-coa
aminohexanoic
physiological
respectively)
"phosphate
2%"
"polyacrylate,"
na-cacodylate
"peg8000
0.13"
eqillabration
tris-chloride
"tris-hcl
1.6"
"4.5

soaked"
"glycol,
30um"
"tris-acetate,"
"r,r-bislysine"
plp_snyder496
streptomycin;
monomethylpeg
"glycine-naoh,"
"parrish,r.g.,"
poly(ethylene
cryosolution:
"peg3350,100mm"
"
temperature"
"monohydorate,"
"l-proline
50"
"mpd
compound"
equilibrating
vitrification
"peg3350
2.1%"
"oxamate
0.1m"
"dl-threonine,"
"ph6.5,
0.02m"
"mixture,
0.1"
micro-seeding
"glycol
0.03m"
"pyridoxamine,"
plp_snyder530
"arginine
0.1"
"sulfonate
ph"
"hexanoyl-coa,"
"nah2po4
0.91"
"triton-x-100,"
"acetate-naoh,"
switzerland).
"labolatories,"
benzamidinium
4-nitrophenyl
"pegsmear
0.1"
"peg3350
0.7%"
"peg8000
0.2m"
"citrate
50mm"
"uro'gen-i
to"
"8.3,
screen:"
"formate
0.1m"
"ddt;
screen:"
pyrophosphate
rs-thiomalate
decarboxylase
"3350
buffer:"
"fluoride,
20"
kp04/nap04-ph
"nacl,
20-22%"
tcglck(f337l)
acetonitrile.
samarium(iii)
"cryo-xylitol,"
"5.8,saturated"
spectinomycin
"phosphate
30"
"8000,ammonium"
"sitting-drop,"
"citrate
0.05"
"tcep
hanging"
microseeding.
[co(nh3)6]cl3
"glycerol
5mm"
"malonate
12%"
"stabilizing
"
"peg3350
35mm"
"peg3350,
0.2"
"6-10%peg6000,"
"tuberculosis,"
"(mmt)-buffer,"
"microseeding,"
sodiumformate
0.75:1.0:0.25
hydrocinnamic
crystallized:
"5'-phosphate,"
"rrraddsddddd,"
"(w/v)
bicine"
microseeding;
"20%
glycerol"
gelfiltration
"5.0,
crystal"
ck2alpha'/4b0
beta-mercapto
"ethanolamine,"
pegmonomethyl
spontaneously
macroseeding.
"(nh4)2so4
1m"
trace-amounts
"peg4000
0.10"
"ethanol,
36%"
"inositol
400"
"acetate,
0.1"
"citrate-naoh,"
microcrystals
"nakphosphate,"
bicine/sodium
"tew.
protein"
"8.3.
screen:"
"glycol
hepes"
"phosphate
10"
"3%
glycerol."
flash-cooling
"sulfate
20mm"
"naformate,10%"
"citrate
0.11"
"citrate
0.06"
"sulfate,
45%"
"peg400,
0.1m"
"chloride
10%"
"4-butanediol,"
"nicotinamide,"
"hydrochloric,"
respectively.
"sulphate,0.1m"
glycylglycine
tetrahydrate.
poly-ethylene
"precipitants,"
equilibration
"sulphate
30%"
corresponding
tri-potassium
"chloride
100"
"acetate
0.05"
"formate,
0.1"
"4000
crystal"
"acetate
0.1m"
pre-incubated
"sulfate
0.2m"
pluronic-f-68
acetazolamide
"microgravity,"
"iso-propanol,"
"peg3350
0.1m"
"sulphate
100"
"thiocyanate),"
"pentaglycine,"
crystallizing
ratio.seeding
"(ph8.5),100mm"
"protein
0.02"
"mes,
5%(w/w)"
"na-phosphate,"
udp-galactose
meso-tartrate
sodiumcitrate
"mes/imidazol,"
"peg4000
0.1m"
"purification,"
(base)/bicine
"reservoir,20%"
4-pentanediol
"sulphate,60mm"
"na-succinate,"
"acetate,
25%"
"isopropanole,"
"temperature
"
"m
cacodylate"
"fad;
screen:"
imidazole/mes
hanging-drop:
"p550mme_p20k,"
sulfo-betaine
dimethylallyl
stabilisation
"imidacloprid,"
d-glycerate);
d-mannonate);
"sodium-hepes,"
imidazole/hcl
"monodisperse,"
"sulfate
0.1m"
"clothianidin,"
sitting-drops
d-arabinose);
methylpentane
d-galactose);
thiordidazine
"glycerol
0.1"
mes-imidazole
"glycerol,0.1m"
international
"peg3350(w/v),"
(tris/bicine)
perdeuterated
"chloride,
25"
"1,6-hexandiol"
mes/imidazole
bicine/trizma
"sulfate
80mm"
monohydrate).
"malonate
0.1"
"2-propanol,20"
"peg-5000-mme,"
"8.3;
screen:"
"1:1
protein:"
"tartrate
10%"
"of
imidazole"
na/k-tartrate
"chloride
28%"
"fluoride
0.1"
"citrate,
25%"
"acetonitrile,"
"acetate,
20%"
"bis-tris-hcl,"
na-k-tartrate
approximately
"
precipitant"
guanidine-hcl
"co-saturated,"
"peg-5000-ome,"
configuration
"chloride
peg"
"
isopropanol"
"sulfate,
100"
hydrochloride
p2(1)2(1)2(1)
precipitation
dithiotheitol
"chloride
25%"
"tartrate
20%"
"spermine_hcl,"
"li2so4,
0.1m"
"6-hexanediol,"
tris-carbonyl
"peg-mme-2000,"
2'-br-dappnhp
"7.5
protein:"
"

reservoir"
"dtt

ligand"
"nad;
screen:"
"
cacodylate,"
"additionally,"
liquid-liquid
optimization:
purification.
"l-citrulline,"
tris-buffered
"chloride
0.1"
protein:lipid
trisaccharide
(perchlorate)
k-thiocyanate
tetrahydrate;
arsenocholine
"sulfate
tris"
melting-point
"heptahydrate,"
crystaldirect
(2.8571428571
pentaethylene
mes-imadazole
"acetoacetate,"
streak-seeded
mops/na-hepes
"hepes-sodium,"
dl-glutamatic
(concentrated
"5.8.
crystal"
top96(a5):0.1
"5.0.
mixing:"
"mgcl2,
0.08m"
"citrate
0.1m"
"ribostamycin,"
"sulphate
0.1"
monochromator
"mes-bis-tris,"
anaerobically
mops/hepes-na
k/na-tartrate
trizma/bicine
"5-6.5.
vapor"
cryo-solution
"ferricyanide,"
"peg-mme-5000,"
monopotassium
"tris/acetate,"
methylmercury
braba.00113.a
dehydrogenase
enhia.00579.a
solution:0.2m
non-chelating
dehydroquinic
cryoprotector
bobua.01478.a
"respectively,"
(polyethylene
"l-methionine,"
nak-phosphate
reconstituted
cryprotecion:
"
reservoir.,"
intracellular
equilibriated
crystallizion
"heptanetriol,"
anpha.00817.a
"2-methyl-2,4-"
"bis-tris/hcl,"
iminodiacetic
braba.10050.a
hosaa.18070.a
"kna-tartrate,"
d-(+)-glucose
sulfate/100mm
"microfluidic,"
(v/v)ethylene
monophosphate
hydroxylamine
imidazole-hcl
"arginine-hcl,"
10-20%peg4000
"mg-atpgammas,"
acetat-puffer
cross-linking
solution:0.1m
"(w/v)peg4000,"
"nacl,10%(w/v)"
"nacacodylate,"
"propane:naoh,"
imidazole:hcl
"d(+)-sucrose,"
"[[brzozowski,"
"
crystallant"
"thioridazine,"
"tris-sulfate,"
"formate,100mm"
"tetrahydrate,"
ch3coona.3h2o
stabilization
l-glutathione
"precipitant.,"
manganese(ii)
k7a/r10a/k66a
"2-methyl-2,4,"
l-cycloserine
"sulfate-free,"
precipitant1.
saccharomyces
"subsequently,"
tetraethylene
"tricine-naoh,"
"(innovadyne),"
"kh2phosphate,"
"saccharopine,"
"myo-inositol,"
"glutathione),"
(precipitant)
"p550mme/p20k,"
"naf,nabr,nai,"
"mes-imadzole,"
"anapoe-c12e8,"
glutathione);
"micro-seeded,"
"(unbuffered),"
"na/k-tartate,"
"halofuginone,"
"pantothenate,"
"nak-tartrate,"
"benzaldehyde,"
mono-ammonium
morpheus(b2):
"
microliters"
"tris-glycine,"
equillibrated
propionyl-coa
"l-tryptophan,"
"chymotrypsin,"
"progesterone,"
"gamma-lactam,"
polypropylene
well-solution
"dinucleotide,"
"1,4-dioxane),"
"bis-tris,0.2m"
braba.00005.a
"homocysteine,"
"bis:tris:hcl,"
"tert-butanol,"
cacodylate(ph
"glutaryl-coa,"
supplementing
"preparation),"
reservoir:10%
mpd_p1k_p3350
triethylamine
tert-butanol.
imidazole-mes
"tris-propane,"
"tlck-treated,"
"consisted
of"
"oxaloacetate,"
"isopropanol.,"
cryoprotected
"butyrlactone,"
"triphosphate,"
"bis-tris:hcl,"
k2hpo4/kh2po4
"hepes(ph7.5),"
compound-soak
"na(malonate),"
"nh4so4,0.225m"
kh2po4/k2hpo4
cryo-amenable
plunge-cooled
"succinyl-coa,"
"measurements,"
dodecanedioic
crystallising
mother-liquor
"3350
crystal"
"fluoride
20%"
"kthiocyanate,"
staurosporine
"chloride,0.1m"
"malonate
20%"
"peg8000
0.1m"
ethylenglycol
"peg3350
0.2m"
"protein:well,"
"sulfate,
0.1"
"specifically,"
(composition:
"dibasic,
20%"
"1,6-hexanedio"
"8000
buffer:"
"spermine-hcl,"
"tartrate
0.1"
"4.6
ammonium"
"cholesterol),"
8-azaxanthine
ethoxyethanol
mycobacterium
"

inhibitor"
"temperature.,"
ck2alpha1-335
"threehydrate,"
"5.1
soaking:"
"this
mixture"
cryopreserved
"400

soaked"
"3350
protein"
"carboxylates,"
equlibration:
"jeffamine600,"
"monohydrate),"
"
solubility."
"macroseeding,"
"imidazole
ph"
"sulfate
0.01"
na-dithionate
"sulfate,
10%"
"acetate,
100"
"peg4000
0.2m"
na-ascorbate.
p-nitrophenyl
concentration
"azithromycin,"
chloride-free
"mother
liquor"
protein/emodin
"12%2-propanol,"
"the
reservoir"
"s)-dobutamine,"
"5000mme
soak:"
ethyleneglycol
condition:0.2m
(approximately
sulfate/sodium
"10
mikroliter"
"1,3-butanediol"
"galactosamine,"
"mops/na-hepes,"
concentration.
"glycerol
0.02"
methylmercuric
"propionyl-coa,"
2-oxoglutarate
"(nh4)2hpo4,0.1"
dibasic/citric
microcrystals;
(concentration
glutaraldehyde
endoproteinase
benzoylformate
acetate-acetic
co-substituted
dithiotheritol
aminopeptidase
"n5-formyl-thf,"
isothiocyanate
"phenylacetate,"
"4000,magnesium"
"chloride,
100"
ethylenglycol.
peg-monomethyl
"(nh4)2so4
33%"
"peg400
sodium"
"(nh4)2so4
22%"
"halorhodopsin,"
"
polyethylene"
"2000,
100-300"
"flash-cooling,"
rigakureagents
"sulphat25-50%,"
protoporphyrin
"(s)-glutamate,"
cocrystallised
6-aminocaproic
"7.5

protein"
dibasic/sodium
deoxythymidine
"hepes/mops-na,"
"mope/hepes-na,"
"staurosporine,"
"l(+)-tartrate,"
spiroadamantyl
"citrate
14-20"
"bis-tris/naoh,"
"[co(nh3)6]cl3,"
19-20%(w/v)peg
"natetraborate,"
dihydroorotate
"2,3-butanediol"
nadh/l-malate;
"peg3350,
54.6"
beta-secretase
"dehydrate
1.0"
(citrate/mes).
hydrochloride;
"only.
protein"
"respectively),"
"na-propionate,"
"trihydrate,0.1"
"n172k,r196e_i,"
8-azaxthantine
"dtt
cryo:
25"
"cryoprotector,"
"dehydrogenase,"
"1,2-ethanediol"
"guanidine-hcl,"
citrate-citric
"microseeding.,"
"(p:r)
protein"
"udp-galactose,"
"mg/ml
protein"
peg4000/sodium
"sodiumacetate,"
"mncl2,
0.002m"
wire-inhibitor
trimethylamine
"5.6-6.2
20-30"
"tetrachloride,"
3-n-morpholino
flash-freezing
pharmaceutica.
bistrispropane
"2-iminobiotin,"
"3350.
protein"
"hanging
drop,"
"2m(nh4)2so4,5%"
"sulfate,sodium"
"(70mm
na2hpo4"
stock-solution
"(nh4)2so4
34%"
equilibration:
"sulfate,
0.1m"
microcapillary
"
precipitant:"
equivolumetric
"0.1m
ammonium"
polyvinylidene
mononucleotide
crystallizaion
"20%(w/v)peg1k,"
"3000
glycerol"
"na-k-tartrate,"
deoxyguanosine
2-hydroxyethyl
"na-dithionite,"
"mgoac
protein"
microseeding.;
"bicine/trizma,"
"(nh4)2so4
0.1"
"dihydrate,
20"
"sulphate
0.1m"
systematically
0.15m(nh4)2so4
"chloride,
20%"
"chloride
0.1m"
"3-o-sulfamate,"
"solution:
0.1"
cryo-protected
sodiumformiate
"(nh4)2so4,0.1m"
nah2po4/k2hpo4
na-thiocyanate
"dithithreitol,"
equilibration)
"citrate,
ches"
dithiothreitol
micro-seeding.
"4-pentanediol,"
"sulfanilamide,"
"malonate,
0.1"
"phosphate,0.2m"
"acetate,sodium"
"acetate,
0.1m"
"4000
crystals"
"deoxycytidine,"
"k-thiocyanate,"
poly(ethylene)
micro-crystals
"sodium
azide,"
"tetrahydrated,"
"sulfate
hepes"
"sodiumcitrate,"
"na,k-phosphate"
cocrystallized
"homogentisate,"
acetate-sodium
nitromethylene
"6000

formed"
&#1084;&#1052;
"k,na-tartrate,"
morpheus(h12):
oil-microbatch
"pep

sitting"
"d-(+)-sucrose,"
"tacsimate,0.1m"
"equilibration,"
"acetate.
drop"
phosphate(na/k
"na/k-tartrate,"
"vitrification,"
"tris-chloride,"
octylglucoside
"fluoroacetate,"
"tcep;
protein"
hydrochloride.
"k/na-tartrate,"
"respectively.,"
"sodiumformate,"
approximately:
dl-isocitrate.
"micro-seeding,"
"pyrophosphate,"
"na-cacodylate,"
k/na-phosphate
penta-ethylene
"1,4-butanediol"
"(nh4)2so4
.1m"
per-deuterated
monosaccharide
"mes/imidazole,"
pentaerythitol
"chlorsulfuron,"
cacodylate:hcl
"streak-seeded,"
"tartrate,
20%"
hexaminecobalt
"chloride,
0.1"
"6.5.
morpheus"
"(v/v)glycerol,"
3-deazathiamin
citrate/sodium
solution(15-20
na/k-phosphate
"dmso
crystals"
"mops/hepes-na,"
pde9q453e-ibmx
phosphate/1.6m
free-interface
mono-potassium
udp-glucuronic
acetate-buffer
8-azaxanthine;
"li2so4
10-15%"
"
(oikonomakos"
"fos-choline-9,"
2-ethylestrone
tri-na-citrate
"tetra-hydrate,"
"mes,0.14-0.20m"
concentrators.
"hydrochloride,"
cryoprotective
"with
crystals"
2-hyrdoxyethyl
"orthovanadate,"
pre-incubation
acetate/acetic
alpha-glucosyl
phosphate-free
protein:ligand
acetate:acetic
na2hpo4:citric
"azide,
0.0003"
nah2po4/kh2po4
glyceraldehyde
cryoprotection
"mpd_p1k_p3350,"
"succinate
0.1"
protein-ligand
"glycylglycine,"
"dl-isocitrate,"
"nathiocyanate,"
"concentration,"
"protein:well),"
"kh2po4-k2hpo4,"
acetylcoenzyme
"(2-methyl-2,4-"
xtalcontroller
"microcrystals,"
solution:100mm
"inhibitor
0.2"
kh2po4/na2hpo4
"dihydrate
20%"
"solution:
2.2"
cacodylate/hcl
"ch3coona.3h2o,"
propane/citric
kh2po4/citrate
"imidazole-hcl,"
"phosphoserine,"
"peg3350
200mm"
(reservoir+20%
streak-seeding
acetate(ph4.6)
"anaerobically,"
carbenicillin)
"drop,nanodrop,"
stoichiometric
"na-cacadylate,"
35-40%ammonium
citrate/citric
ethanesulfonic
"8-azaxanthine,"
"polyethylene
"
"(nh4)2so4
12%"
protein:mother
"phenylalanine,"
"chloride
50mm"
"nitrate
28-43"
"1,6-hexandiol,"
"~15mg/ml
drop"
"sulphate
mpeg"
5-fluoroindole
phosphorylated
enmetazobactam
anaerobically.
"dihydrate
0.1"
anderson-evans
[poly(ethylene
"acetylcholine,"
4-aminobenzoic
(l-glutathione
"cyclohexanone,"
"monophosphate,"
protein-biotin
"1,2-hexanediol"
equilibration.
crystalization
"(nh4)2so4
200"
b-nicotinamide
protein/ligand
"(nh4)2so4
0.5"
5-chloroindole
"
temperature:"
"diaminouracil,"
"
dinucleotide"
"kh2po4/k2hpo4,"
"precipitation,"
naa50:4b:accoa
(precipitant).
"imidazole/hcl,"
cryoprotecting
"deoxy-bigchap,"
"mm.
reservoir"
"(precipitant),"
sodium-citrate
na2hpo4/kh2po4
"imidazole/mes,"
"9.
inhibitor:"
"protein,
0.05"
citrate:citric
cacodylate-hcl
"1,4-butandiol,"
sodium-acetate
"tartrate
0.1m"
"imidazole:hcl,"
concentration)
"glycerol
0.1m"
concentration:
centrifugation
"ketoglutarate,"
"ethylenglycol,"
"(nh4)2so4
17%"
glycylglycine)
"(nh4)2so4
32%"
glycyl-glycine
pentaerythriol
"tris-phoshate,"
bis-acrylamide
"8.0
1.5m-1.6m"
"volume(500ul),"
concentrations
"mes-imidazole,"
"phosphate
0.1"
"2,5-hexanediol"
chromopyrrolic
diamond-shaped
"8.00)
organic"
"4000
ammonium"
"7.5);
screen:"
"(35mm
na2hpo4"
"glutamate
25%"
trialscrystals
"cacodylate-na,"
mopso/bis-tris
"l-glutathione,"
"5.6-6.3
20-30"
"tris-hcl/naoh,"
"k-na-tartrate,"
dehydroquinate
chromatography
nonylglucoside
k2hpo4/nah2po4
"hexahydrate,
"
"dithiotreitol,"
"8.3);
screen:"
"microdialysis,"
morpheus(f12):
"mg/ml
buffer:"
"bis-tris,
25%"
na3citrate-hcl
"1,4-butyldiol,"
[ca=carboxylic
"dmso,saturated"
"
macroseeding"
"solution.
15%"
na2hpo4/citric
"phosphate
100"
"na/cacodylate,"
methanol/water
"butyrolactone,"
"aminoacidsmix,"
"8.3),
screen:"
"bromide
0.03m"
"phosphate
20%"
pre-incubating
cryoprotectant
tris-phosphate
"imidazole-mes,"
l-(+)-ammonium
2-ketohexanoic
"1,2-butanediol"
"sulfate
100mm"
"peg3350
hepes"
"1,6-hexanediol"
"tcep;
screen:"
25-30%mpeg2000
"chloride.
sah"
"spermidine-hcl,"
"protein,
0.005"
"dithiothrietol,"
"na-thiocyanate,"
"trihydrate
20%"
glutaraldehyde.
"(nh4)2so4
0.1m"
supersaturation
"bistrispropane,"
orthophosphoric
"

precipitant"
"benzamidinehcl,"
"phosphocholine,"
"propanol,sodium"
polyoxometalate
crystallisation
above-mentioned
"crystalsupport,"
"citrate(ph5.6),"
(hydroxymethyl)
"lithiumsulfate,"
"25%peg3350,0.2m"
"gdp-perosamine,"
"hepes/naohph=8,"
"ribonucleotide,"
hexadecanedioic
"peg5000mme
0.1"
precipitant:27%
"trimethylamine,"
"cacodylate/hcl,"
"1,2-ethanediol;"
2-oxoglutarate.
"glutaraldehyde,"
"cryoprotection,"
monopalmitolein
"8000

buffer:"
sodium/potasium
"l-homocysteine,"
"ammoniumsulfat,"
"citrate
sodium"
"orthophosphate,"
vapor-diffusion
respectively---
"8.5;
inhibitor"
"na,k-phosphate,"
"(nh4)2tartrate,"
"5.0-6.5.
vapor"
"sodium
acetate"
"np_isopropanol,"
"kh2po4/na2hpo4,"
"6.0-7.5
24-30%"
dithiothreitol.
concentration:7
"(nh4)2hcitrate,"
"1,3-propanediol"
"nacl
reservoir"
"2,3-butanediol,"
cryoprotection:
"1,2-propandiol,"
(v/v)ethanediol
cyclohexylamine
"acetate,10mg/ml"
"na-citrate
20%"
concentration).
"
iminodiacetic"
pentaerythrytol
"tris-phosphate,"
malate/mes/tris
cryoprotectant.
"sulfate
sodium"
"(saturated),peg"
"ammoniumiodide,"
"(nh4)2so4,
0.1"
6-aminohexanoic
concentrations.
dithiothreitol)
pi3kg:inhibitor
"
cryoprotected"
crystallization
oligonucleotide
"n-5-formyl-thf,"
anhydrofructose
"2,4-pentanediol"
"peg-1000
100mm"
"cacodylate
30%"
n-(2-acetamido)
"0.88mm
an12855"
cryoprotection.
"1,2-propanediol"
"cacodylate
20%"
"sulfate
20-25%"
nadh/l-lactate;
"na/mes/acetate,"
nadh/l-oxamate;
"7.7

oxidized"
"trypsin:hdac10,"
"1,6-hexanediol,"
"(buffer)
20-30"
"20-25%pegmme2k,"
imidazole/malic
monomethylethyl
acetohydroxamic
"chloride,
0.05"
"cacodylate-hcl,"
"nonylglucoside,"
"2,5-hexanediol,"
co-crystallized
tribasic/citric
"1.6-hexanediol,"
mercaptoethanol
"12%(w/v)20,000,"
4-nitrocatechol
"phosphate,
100"
"acetate,
100mm"
"delta-12-lmarg,"
"lithiumacetate,"
protein-to-well
"adenosine-5'-
"
triethanolamine
propylphosphate
"20%isopropanol,"
"monoethylether,"
cryo-protected.
"4000/6000/8000,"
"monosaccharide,"
monomethylether
tetrahydrofuran
gadolinium(iii)
(non-volatile):
cryo-protecting
d-erythronate);
"mm)
compound1:"
"8.6-9.2)
0-20%"
saccharolactone
"1,4-butanediol,"
uch-1/proctitis
"tri-li-citrate,"
"isothiocyanate,"
"monohydrate
ph"
geranylgeraniol
protein-ligand:
cryoprotectant-
"na2hpo4/kh2po4,"
"acetic-acetate,"
"acetate
25-30%"
high-throughput
pre-powerstroke
ammoniumcitrate
crystallography
"dithiothreitol,"
d-glucuronate);
"fluoride
0.03m"
cacodylate-naoh
"sulfate,
0.100"
"nah2po4/k2hpo4,"
phospho-citrate
"na/k-phosphate,"
"18-crown-ether,"
nvp-afj144-nx-2
"methanol,hepes,"
"pb(oac)2(oh2)2,"
"dithiotreithol,"
"stock
solution"
"1,2-butanediol,"
"concentration),"
hexamminecobalt
iron-containing
sodiumphosphate
phosphoramidate
ammoniumacetate
"calciumacetate,"
"1,2-hexanediol,"
"100
millimolar"
"2-oxoglutarate,"
sodium-tartrate
"pegmme2000
1.0"
"sigma-aldrich),"
"acetate
buffer"
"1,6-hexanediol;"
"1,4-butanediol;"
"20%peg8000,0.1m"
ethoxylate(15/4
preequilibrated
benzylhydrazine
glucopyranoside
"l-na-glutamate,"
"citrate(ph4.4),"
supplementation
"8.0

protein:"
"sulfate
15-23%"
acetate:15mg/ml
4-hydroxybenzyl
acetyl-coenzyme
parafin:silicon
lithiumsulfate;
dithiothreitol]
centrifugation.
bis-trispropane
cryo-protectant
co-crystallised
methenyl-h4mpt+
"1,6-bisphophate"
"sulfate;
cryo:"
"9-deazaguanine,"
"sodium-acetate,"
"8
precipitant:"
tri-methylamine
"nacitrate
50mm"
polyethylglycol
"k2hpo4/nah2po4,"
"l-argininamide,"
8-aminooctanoic
parallelepipeds
cryoprotectant:
chloramphenicol
"ammoniumacetat,"
"(ac-3,5-dii-yg)"
l-na-glutamate;
ammoniumsulfate
"streak-seeding,"
1d-myo-inositol
"glycerol
0.005"
"cacl2.
complex"
monosaccharides
"1,2-ethanediol,"
polymer-induced
"sulphate,20-25%"
"octylglucoside,"
microl.cryo:30%
3-butylthiolane
"phosphate
0.1m"
"1,5-pentanediol"
"tri-na-citrate,"
"mes
0.14-0.20m"
alpha-d-glucose
"tris-hcl,20-25%"
"hexanediol-1,6,"
"n172k,r196e_iii"
"ethyleneglycol,"
pentaerythrivol
"26%peg1500,0.2m"
trifluoroacetic
"
nacacodylate,"
"-butyrolactone,"
(mes/imidazole)
(sigma-aldrich)
"1,3-butanediol,"
"protein,
0.050"
"n172k,r196e_ii,"
"fos-choline-14,"
cryo-protection
decarboxylation
"2000

protein"
"trihydrate
0.1"
"acetate
12-20%"
"methylmalonate,"
2-oxoglutarate)
dihydrochloride
"bromide
20-25%"
pegmme5000/0.2m
"mononucleotide,"
3-aminopyridine
citrate/citrate
"dihydroorotate,"
"acetate-buffer,"
cacodylate/tris
"cryoprotectant,"
propanesulfonic
d-phenylalanine
propoxylate(5/4
"dihydrate
2.5%"
"l-tartrate
21%"
"na2-dithionite,"
fluorophosphate
monomethylester
dichloromethane
"8.15

protein"
dimethyl-lysine
"sodium-citrate,"
"formate

drop"
"cacodylate:hcl,"
"glycyl-glycine,"
"concentrations,"
"5.6-6.2,
20-30"
"
concentration"
"edta
reservoir"
n-oxalylglycine
pentaerythritol
"mg/ml).
mother"
(weight/volume)
bistris-propane
malate-mes-tris
"dichloromethane,"
"trihydrate
0.1m"
[crystallization
alpha-me-glcnac.
5'-monophosphate
cryo-protectant.
malate/imidazole
trcra.00019.a.b1
myava.01530.a.a1
l-allo-threonine
"
cryo-protected"
ammonium-sulfate
tetrahydrofolate
"d-(+)-galactose,"
"shelf.
crystals"
peg20k-peg550mme
"crystallization,"
acetohydroxamate
"meso-erythritol,"
mg/ml)containing
crystallizations
lysophosphatidic
"sodiumphosphate,"
"trihydrate,
2.4"
tertiary-butanol
"bis-tris(ph5.5),"
"1,3-propanediol."
bis-tris-methane
"iso-propanol,20%"
trbra.00438.a.b1
"8.00)
additive:"
crystallisation.
anatrace/calibre
"crystallisation,"
mg/ml.afterwards
nitrilotriacetic
butha.17973.a.a1
sodium/potassium
citrate/ammonium
co-crystallized.
sodium-potassium
"hydoxycobalamin,"
d-(+)-melezitose
"acetate.
remark"
"glucopyranoside,"
monomethyl-ether
elana.00983.a.b1
mysma.00247.b.a1
"10%(v/v)peg4000,"
chloride/calcium
"monosaccharides,"
"cryoprotection),"
"lithium-sulfate,"
coima.00584.a.a1
trifluoroethanol
"octyl-glucoside,"
ammonium-citrate
"bis-tris

drop"
"isopropanol,0.1m"
4-hydroxybenzoyl
"sulphate
15-34%"
"bistris-propane,"
cryo-protectant:
phosphate/citric
"phospho-citrate,"
(n-(2-acetamido)
"vapor-diffusion,"
molecular-weight
selenomethionine
"5.0-5.5
300-500"
(poly-l-glutamic
na-cacodylate(ph
sulfate.crystals
"25%(w/v)peg3350,"
oxidized/reduced
"6000
reservoir:"
"bis-trispropane,"
ritya.18390.a.b2
(crystallization
"ammoniumacetate,"
"ammoniumsulfate,"
buvia.00139.a.b1
pentaerythritiol
"1,6-hexanediol
"
2-ethylestradiol
enhia.01296.a.a1
"(1,6-hexanediol;"
cryo-protectant;
crystallisations
hexakisphosphate
"cacodylate
drop"
ultrafiltration.
"hemicholinium-3,"
(cryoprotectant)
"hepes-na(ph7.5),"
"na2hpo4/nah2po4,"
"hexahydrate
30%"
"calciumchloride,"
bupha.00054.a.a1
mono-methylether
hexaminecobaltic
5-aminoimidazole
protein/compound
"mercaptoethanol,"
"mpd,cacl2,sodium"
"trypsin:zhdac10,"
sodiumcacodylate
citrate/bis-tris
"1.2-propanediol,"
potassium-sodium
phosphate:citric
"triethanolamine,"
"1,3-propanediol)"
crystallisation:
"isopropanol
0.1"
"thiocyanate
40%"
"drop,temperature"
"chloride/amppnp,"
sodium:potassium
"monohydrate
20%"
"sulfate
buffer:"
"glycol,magnesium"
sodium-phosphate
(pentaerythritol
imidazole/malate
egfr-t790m/v948r
"cryoprotectant.,"
hydrochloride(ph
crystallization:
"7.5.
reservoir:"
bis_tris_propane
"
ethanesulfonic"
peg550mme/peg20k
monobasic/1200mm
"ethylene-glycol,"
"%(v/v)
glycerol"
"1,5-pentanediol,"
characterization
"1,3-propanediol:"
methanol/ethanol
enzyme-inhibitor
"
cryoprotection"
"merceptoethanol,"
"20%(w/v)peg6000,"
medium-molecular
"(sigma-aldrich),"
"acetate
buffer:"
di-ethylammonium
ethanolamine-hcl
monomethylethyer
"monomethylether,"
monobasic/sodium
potassium/sodium
compound:protein
cryo-protectant)
"1,6-bisphosphate"
counterdiffusion
"chloride,
0.003"
solution:protein
"1,3-propanediol;"
trisodiumcitrate
butha.00944.a.a1
"1,3-propanediol,"
cryopreservation
bis-tris-propane
dihydroneopterin
braba.17620.a.a1
"peg400
1.2-1.5m"
"n-oxalylglycine,"
sodium/phosphate
penta-erythritol
"chloramphenicol,"
"lithiumsulphate,"
(2-carboxyethyl)
"cryo-protection,"
3-aminobenzamide
"sodium-malonate,"
"hepes:naoh,
10%"
"
cryoprotectant"
2-(n-morpholino)
"(1,6-hexanediol,"
crystallization.
"mes
monohydrate"
n-dodecyl-beta-d
l-lysylsulfamoyl
"murine
delta114"
imidazole-malate
[fe]-hydrogenase
monoacylglycerol
"mgformate,
0.1m"
"gly-gly-gly-gly,"
enzyme/inhibitor
myaba.00725.a.a1
"peg3350
protein"
"methanol,calcium"
"hexane-1,6-diol,"
butha.00438.a.a1
"hexahydrate
0.1"
hepes/naohph=7.4
"cryoprotectant),"
well-diffracting
"1,2-propanediol;"
"na2hpo4-citrate,"
"(nh4)2so4,
0.1m"
"2,4-pentanediol,"
"data
collection"
"20%(w/v)peg3000,"
"cryo-protectant,"
pentaerythritole
"1,5-pentanediol)"
sulfate(12-20mm)
"d-desthiobiotin,"
5-sulfosalicylic
crystallographic
bupse.01471.a.a1
"(1.5microliter),"
"nacl
reservoir:"
"tris-hcl(ph8.5),"
hexaamminecobalt
"2-iodomelatonin,"
cryo-protection:
ammoniumsulphate
butha.01294.a.a1
"1,2-propanediol,"
"decylubiquinone,"
"methenyl-h4mpt+,"
(vapor-diffusion
vapour-diffusion
pre-equilibrated
"tetrahydrofuran,"
"contradiffusion,"
polyoxotungstate
phosphonolactyl-
"dihydrochloride,"
nacitrate/citric
"trihydrate.
0.1"
(2-hydroxyethyl)
"2-ethoxyethanol,"
acetylphosphate.
"trifluroethanol,"
"butane-1,4-diol,"
bupsa.00102.a.a1
"concentrated
at"
"benzamidine-hcl,"
"sulphate,
100mm"
co-crystallizing
"acetate,
peg4000"
"me-man
reservoir"
"monohydrate
0.1m"
"oxaloacetate
1.0"
citrate/phosphate
hydrogenphosphate
"peg8000,trimethyl"
"(+/-)-2-methyl-2,"
cocrystallisation
"tetraoxyethylene,"
(w/v)polyethylene
"temperature
100k"
protein-inhibitor
"benzylphophonate,"
room-temperature.
(malate-mes-tris)
reservoir:protein
trifluoropyruvate
"diethylphosphate,"
"ammonium-sulfate,"
"diffusion,sitting"
n-acetylglutamate
"imidazole-malate,"
dodecyl-maltoside
"10%
isopropanol,"
"1,3-propanediol),"
"isopropanol
0.1m"
cocrystallization
"-mercaptoethanol,"
"acetate
bis-tris"
man-alpha1-6-man;
bupsa.00130.a.d21
polietilenoglicol
tris(base)/bicine
"cryo-protectant.,"
beta-nicotinamide
trimethylammonium
"b-octylglucoside,"
imidazole/maleate
1-hydroxyfarnesyl
"chymotrypsin:alk,"
"ammonium-acetate,"
photo-degradation
"crnec.00830.a.b1,"
tetrakisphosphate
pentakisphosphate
enhia.01648.a.d18
propionate/sodium
"imidazole(ph6.5),"
"heteronucleation,"
"microliter
drops"
"imidazole/malate,"
"l-dihydroorotate,"
"bis-tris-propane,"
2-mercaptoethanol
"(dithiotreithol),"
11miligram/millil
well-diffracting.
"hydroxycobalamin,"
"triflouroethanol,"
"hepes/naohph=7.4,"
inhibitor:protein
magnesium/calcium
"sodium
chloride,"
"propane-1,2-diol,"
"7.5;
precipitant"
"tcep.
reservoir:"
(2-(n-morpholino)
"(cryoprotectant),"
"counterdiffusion,"
inhibitor/protein
diffusion/hanging
"peg4k).
soaking:"
"0.1m
d-threonine"
"100mm
cacodylate"
"10%(v/v)glycerol,"
"dihydrophosphate,"
"nh4so4

protein"
"phosphate;
cryo:"
4-phenylimidazole
"
1,6-hexanediol,"
enhia.01033.a.mb1
peg550-monomethyl
2'-deoxyadenosine
"1,2-propanediol),"
"glycol
additive:"
2-phosphoglycolic
"monomethyl-ether,"
citrate-phosphate
"imidazole.malate,"
"bis-tris,0.2-0.3m"
dibasic/monobasic
diffusion/sitting
"vapor
diffusion,"
"sulfobetaine-195,"
counter-diffusion
"ammoniumsulphate,"
phosphate-citrate
"hepes.

protein"
protein:inhibitor
"
crystallisation"
"1,6-diaminohexane"
"5.5
precipitant:"
"25%(v/v)glycerol,"
"25.9%peg1500,0.2m"
"dithioerythritol,"
"isopropanol
0.5%"
"mgcl2
reservoir:"
"1,4-diaminobutane"
"sodiumcitrate
20"
sodium-cacodylate
fucose-containing
base/hydrochloric
"
cryoprotectant:"
"diffusion,hanging"
"polyacrylate
0.1"
"trifluoroethanol,"
d-galacturonate);
d-glucopyranoside
potassiumcloride.
"trihydrochloride,"
"
cryoprotectant;"
"isopropanol,200mm"
"(v/v)isopropanol,"
"undecylmaltoside,"
dimethylsulfoxide
b-mercaptoethanol
"morpheus_edo_p8k,"
sodium/postassium
monohydrochloride
(cryo-protectant)
bis-tris-propane)
polyethylenglycol
protein:reservoir
"ammonium_sulfate,"
protein/reservoir
"hexahydrate,
0.1"
"diethyleneglycol,"
co-cystallization
"nacacodylate
30%"
praseodymium(iii)
"peg2000/peg6000),"
"beta-d-maltoside,"
"5-diaminopentane,"
"na-formiate
0.10"
"imidodiphosphate,"
"na3c6h5o7-c6h8o7,"
"
crystallization"
"2-mecaptoethanol,"
"citrate
tribasic"
4-hydroxyphenacyl
protein-to-mother
"5'-monophosphate,"
phosphate/citrate
dhfr-folate-nadp+
"1,8-diaminooctane"
protein/inhibitor
"25%w/v

crystal"
"hepes/naohph=7.2,"
"overnight

cryo"
semet-substituted
"data
collection."
"1,6-bisphosphate,"
methylpentanediol
"1,2,6-hexanetriol"
cryo-preservative
"crystallization.,"
n-trans-cinnamoyl
counterdiffusion:
na-cacodylate/hcl
n-octanoylsucrose
"6.1-6.5)
150-300"
"li3(c3h5o(coo)3),"
"citrate-phophate,"
"tetrahydrofolate,"
praseodimium(iii)
"asparate.
mother"
crystal-containing
beta-lactoglobulin
"o6-methyl-2'-dgtp,"
"acetate
harvested"
"(nh4)2so4
300-400"
counter-diffusion:
dl-malate-mes-tris
protein/nucleotide
solution:reservoir
2-mercaptoethanol.
cryo-stabilisation
tetrabutylammonium
"drop,
temperature"
tartrate-4-hydrate
"5.5.
precipitant:"
"methylpentanediol,"
"triethyleneglycol,"
steady-temperature
"di-ethyleneglycol,"
tetraethylammonium
"(diethyleneglycol,"
"bis-tris
0.2-0.3m"
"1,5-diaminopentene"
"cacl2.
reservoir:"
"nonyl-d-glucoside,"
"glycerol;
protein"
"1,2,6-hexanetriol)"
"p-hydroxybenzoate,"
"glycerol
soaking:"
"beta-cyclodextrin,"
"1,6-diaminohexane,"
"1,4-diaminobutane,"
"1,5-diaminopentane"
"1,8-diaminooctane,"
cyclohexylammonium
"b-mercaptoethanol,"
gamma-butrylactone
"dimethylsulfoxide,"
tetrahydrochloride
"tetrahydrate,
20%"
"citrate-phosphate,"
glycerol-phosphate
"
crystallization:"
d-glucopyranoside.
"phosphate-citrate,"
polyethyleneglycol
tris-hydrochloride
"acetate.
crystals"
ribose-5-phosphate
"cocrystallization,"
o-phospho-l-serine
"peg1000,
20%(v/v)"
"tetrahydrate
0,1m"
alpha-chymotrypsin
"
mercaptoethanol,"
"citrate/phosphate,"
"recrystallization,"
ck2alpha/inhibitor
"hydrogenphosphate,"
"dmso)
precipitant"
"(well:prot:inhib),"
dimensions/calibre
protease-inhibitor
s-hexylglutathione
cocrystallization.
methanocaldococcus
alpha-ketoglutaric
cobalt(ii)chloride
"peg3350

protein"
"b-octyl-glucodise,"
b-mercaptoethanol.
2-methoxyestradiol
"(precipitant)
0.2"
"1.6-diaminohexane,"
"temperature
20.0k"
microgravity/vapor
"3-nitropropionate,"
"8000
precipitant:"
"sodium-cacodylate,"
"adenosylcobalamin,"
"8.5).
preparation"
co-crystallization
polyacrylate/hepes
20-30%polyethylene
"n-octanoylsucrose,"
"gly-
gly-gly-gly,"
"protein:reservoir,"
perfluoropolyether
tri-sodium-citrate
citrate-phoshphate
"polyethyleneimine,"
"thiopyrophosphate,"
"phosphate/citrate,"
"acetate

protein"
"magnesiumchloride,"
co-crystallisation
"methylphosphonate,"
"reservoir
protein"
"concentration.
in"
"4-methylimidazole,"
"peg3350:reservoir,"
"cacodylate(ph6.4),"
"sodiumcitrate
20%"
"glycerol.
crystal"
"imidazole/maleate,"
"phosphate-dibasic,"
"solution
crystals"
chloride:magnesium
"dmso
precipitant:"
polypropylenglycol
monohydrochloride;
"monohydrochloride,"
"ammonium
acetate,"
"tris(base):bicine,"
"counter-diffusion,"
2-mercaptoethanol)
"4-phenylimidazole,"
"2-mercaptoethanol,"
"sulfate:reservoir,"
methylmalonyl-coa.
"1,2,3-heptanetriol"
dl-5-hydroxylysine
"tetrahydrate;
0.2m"
"ck2alpha'cys336ser,"
"isopropanol,agarose"
phosphatidylcholine
phosphate/potassium
glycol-polyethylene
"methyl-pentanediol,"
protein:crystallant
"2-oxoglutarate,0.1m"
glucose-6-phosphate
"na-citrate,ph5.0,2m"
co-crystallization.
triethanolamine-hcl
"1,6-hexanediol
150"
"co-crystallization,"
"7.50)
precipitant:"
idh2/r140q:agi-6780
"sulfate,2-propanol,"
"ph5.6
precipitant:"
"peg3350

ligands:"
trans-4oh-l-proline
phosphate-monobasic
"1-deoxynojirimycin,"
"tris-hydrochloride,"
beta-octylglcoside.
3-fluoro-l-tyrosine
disodium/monosodium
2-phosphoglycerate.
"2-phosphoglycolate,"
"dimethylsulphoxide,"
"isopropanol
20.00%"
cacodylate/bis-tris
beta-octylglucoside
"anaerobic
chamber."
"1,2,3-heptanetriol."
"mo:water:phosphate,"
"1,6-bisphosphatase,"
pentaethyleneglycol
"alpha-chymotrypsin,"
"sulfamoyladenosine,"
"2-mercapto-ethanol,"
diffraction-quality
screening/reservoir
triethanolamine/hcl
gdp-alpha-d-mannose
alpha-methylmannose
"bistrispropane/hcl,"
"phosphate-citrate.,"
"trimethylamine-hcl,"
"polyethyleneglycol,"
"diffusion,
hanging"
phosphate/monobasic
precipitant/protein
"mq
crystallization"
"batch/microseeding,"
"concentration.
15%"
tetramethylammonium
tris/glycylglycine)
n-perfluorohexanoyl
s-thiolodiphosphate
"citrate
dihydrate,"
"nah2po4/1.0mkh2po4,"
gamma-butyrolactone
"dmso.
precipitant:"
n-octyl-d-glucoside
"triethylene-glycol,"
dehydration-induced
"(v/v)
polyethylene"
tetraethyleneglycol
protein/precipitant
n-acetylglucosamine
dihydrogenphosphate
"(+/-)-2-methyl-2,4-"
protein-precipitant
di-ammoniumhydrogen
alpha-ketoglutarate
monobasic/potassium
"tetrahydrochloride,"
glucose-1-phosphate
"1,2,3-heptanetriol,"
protein:precipitant
"tri-sodium-citrate,"
"magnesium-chloride,"
microlytic/anatrace
"hemi(pentahydrate),"
"solution:
6.0mg/ml"
"octylthioglucoside,"
"n-methylmorpholine,"
"9.5
cryoprotectant"
bsi5663/propyl-amp;
3-mercaptopicolinic
"reservoir
solution"
"bupsa.00130.a.d214,"
"tetrahydrate,sodium"
pa-iil/glycomimetic
polypropyleneglycol
"methanol
30%-42.5%"
"methanol,
30-42.5%"
"ribose-5-phosphate,"
acid/imidazol/boric
"3-phosphoglycerate,"
poly-gamma-glutamic
"2,2'-anhydrouridine"
"crystallisation.
1"
"tri-ethyleneglycol,"
"dihydroresveratrol,"
"6-phosphogluconate,"
co-crystallisation.
trypsin-benzamidine
mpd/peg1000/peg3350
"magnesium
complexed"
polyvinylpyrrolidone
"2-methyl-2-propanol,"
"methyl-propane-diol,"
"alpha-ketoglutarate,"
phosphoethanolamine.
"reservoir,17-20mg/ml"
"solution
containing"
"d-3-hydroxybutyrate,"
"potassium
phosphate"
"enzyme/4p
mixture.,"
pentaethyleneglycol;
"heptane-1,2,3-triol,"
"polypropyleneglycol,"
tris(2-carboxyethyl)
"mes-bis-tris-buffer,"
"pyridoxal-phosphate,"
beta-mercaptoethanol
bis-tris-methane-hcl
"(r,r)-2,3-butanediol"
"epsilon-caprolactam,"
hexamminecobalt(iii)
(poly-gamma-glutamic
beta-octylglucoside.
"tetraethyleneglycol,"
glucose-6-phosphate.
"mpd_peg1000_peg3350,"
"ck2alpha-'cys336ser,"
na-phosphate-citrate
beta-octyl-glucoside
"(0.44m)-precipitant,"
di-ammonium-hydrogen
2-aminothiazole-type
"glucose-6-phosphate,"
low-molecular-weight
"(rs)-1,2propanediol,"
cys336ser)/inhibitor
"s-thiolodiphosphate,"
polyethyleneglycerol
pentaethyleneglycol.
2-aminobenzimidazole
phenylmethylsulfonyl
post-crystallization
"beta-octylglucoside,"
gamma-butyrolactone.
"dtt(dithiothreitol),"
"gamma-butyrolactone,"
"2-methyl-2,4-pentane"
phospho(enol)pyruvic
"mercaptoethanol
.1m"
"trypsin-benzamidine,"
methoxy-polyethylene
"betamercaptoethanol,"
"methyl-pentane-diol,"
"1,10-phenanthroline,"
chymotrypsin:protein
"7.5
crystallization"
28%(w/v)polyethylene
"cobalt(iii)chloride,"
acetate/hydrochloric
"n-acetylglucosamine,"
"2,2'-anhydrouridine,"
"glycylglycylglycine,"
"n8-acetylspermidine,"
s-adenosylmethionine
"mg/ml

microseeded"
"dihydrotestosterone,"
"n,n-dimethylglycine,"
(protein+reservoir};
pentaethyleneglycol:
"sulphate,
0.05-0.1m"
alpha-glucopyranosyl
microcrystallization
"k2hpo4/kh2po4/h3po4,"
"phosphate

remarks"
vibration-isolation.
pentaethyleneglycol)
"(10mg/ml)
reservoir"
"dtt
crystallization"
bis-tris-propane-hcl
protein-ch3-h4folate
4-methylumbelliferyl
poly(ethyleneglycol)
"phosphoenolpyruvate,"
"triethanolamine-hcl,"
"phosphate-monobasic,"
fe-guanylylpyridinol
"citrate

condition"
"pentaethyleneglycol,"
"n-octyl-d-glucoside,"
"dihydrogenphosphate,"
"the
crystallization"
tris[2-carboxyethyl]
"nh4h2po4/(nh4)2hpo4,"
"aminoethanesulfonate,"
hexaamminecobalt(iii)
"sulphate
30%glycerol"
pyridoxal-5-phosphate
"beta-mercaptoehtanol,"
beta-mercaptoethanol.
"6000
soaking-buffer:"
"4-hydroxybenzoyl-coa,"
"beta-mercaptoethanol,"
beta-mercapto-ethanol
"octyl-beta-glucoside,"
"7.5.
cryoprotectant:"
"tetra-ethyleneglycol,"
"beta-octyl-glucoside,"
monohydrate-potassium
"(s)-2-methylbutyrate,"
"8.5.
cryoprotectant:"
"polyvinylpyrrolidone,"
"drop
crystallization"
"fructose-6-phosphate,"
"microbatch-under-oil,"
"diffusion,temperature"
braba.11339.a.pw27637
"glycerol-3-phosphate,"
"
protein/precipitant"
"penta-ethyleneglycol,"
"against
optimization"
"methylether-peg-5000,"
reservoir/precipitant
"pentaethyleneglycol),"
tetrabutylphosphonium
4-cyclohexyl-1-butyl-
penta-ethyleneglycol;
"formate
precipitant:"
"gamma-butyrolacetone,"
"(rs)-1,2-propanediol,"
(protein:precipitant)
"l-2,4-diaminobutyrate"
"bis-tris-propane
10%"
"peg3350
0.1mbis-tris"
"20%(v/v)peg3000
0.2m"
n-octyl-b-d-glucoside
monoolein:cholesterol
monohydrate/potassium
"sulfate
precipitant:"
dimethylethylammonium
1-oleoyl-rac-glycerol
methyl]-2-aminoethane
"protein:chymotrypsin,"
"6.6.
crystallization"
"s-adenosylmethionine,"
"glutathione(reduced),"
"concentration.
ratio"
"acetate(0.1m)-buffer,"
buffer=mops/hepes-na]
"omp
cryo-protection:"
"mercaptoethanol
0.1m"
beta-mercaptoethanol)
glycyl-glycyl-glycine
glycol-550-monomethyl
beta-glycerophosphate
"na-phosphate/citrate,"
temperature-regulated
"pala
crystallization"
"3350
cryoprotectant:"
"glycerol

reservoir"
"precipitant.
protein"
manganese(ii)chloride
"dithioerythritol(dte),"
"
(dl-dithiothreitol),"
"1-oleoyl-rac-glycerol,"
dimethylbenzylammonium
"s.schultz,a.f.v.wagner"
p-chloromercuribenzoic
(delta)abd-p110(delta)
"n-omega-propyl-l-arg.,"
"arabinose-5-phosphate,"
"hydrochloride

plate"
"k2hpo4/kh2po4
protein"
s-adenosylhomocysteine
"2,4-diaminopyrimidine,"
pyridoxal-5'-phosphate
(protein:precipitant).
imidazole/hydrochloric
beta-d-glucopyranoside
"glycyl-glycyl-glycine,"
"ingredients:
polymer:"
"desnitro-imidacloprid,"
beta-mercaptoethanole)
p-chloromercurybenzene
"2-methyl-2,4-pentadiol"
"acetate.
soaking/cryo"
"di-ammonium-phosphate,"
"beta-mercaptoethanol.,"
"7.4

crystallisation"
"hoc(coona)(ch2coona)2,"
(2-(n-cyclohexylamino)
"solution
supplemented"
n-acetyl-d-glucosamine
"diammonium-l-tartrate,"
temperature-controlled
"solution;

reservoir"
"2,4-methylpentanediol,"
"2,2,2-trifluoroethanol"
"1,3-butanediol,amppnp,"
cetyltrimethylammonium
benzyltriethylammonium
tacrine(10)-hupyridone
"penta-ethyleneglycol),"
"dtdp-3-aminoquinovose,"
"acetate
concentration"
"chloride
citrate/tris"
protein-to-precipitant
"concentration(4mg/ml),"
tetrahydrodeoxyuridine
"peg400
cryoprotectant"
"n-octyl-b-d-glucoside,"
"methyl-2,4-pentanediol"
broad-molecular-weight
"1,6-hexanediol,
vapor"
dodecylmaltopyranoside
p-chloromercurybenzoic
8-10%(v/v)isopropanol.
"theophylline
compound"
"7.5)
temperature(13),"
"pyridoxal-5-phosphate,"
"5.5).
cryoprotectant:"
n-[tris(hydroxymethyl)
cyclopentanecarboxylic
beta-phosphoglucomutase
s-adenosyl-l-methionine
"peg-5000-o-methylether,"
"crystallisation.
drops"
(1-oleoyl-rac-glycerol)
medium-molecular-weight
"1,3-dimethylimidazolium"
"1,4-dithio-dl-threitol,"
cacodylate/hydrochloric
2-(n-morpholino)-ethane
"s-adenosylhomocysteine,"
"k2hpo4/nah2po4
protein"
udp-n-acetylglucosamine
sulfonato-calix[8]arene
protein/reservoir-ratio
35%(w/v)pentaerythritol
"3,4,5-trimethylthiazole"
"tri-sodium-citrate
15%"
n-butyryl-dl-homoserine
undecylresorcinol-bound
"lithium-meta-tantalate,"
bis-tris/hepes/tris-hcl
"nacl

crystallisation"
"2-methyl-2,4-pentadiol,"
pyrrole-2-carboxylate);
"n-octylglucopyranoside,"
n-abietoyl-l-tryptophan
"pyridoxal-5'-phosphate,"
"beta-d-glucopyranoside,"
"nah2po4)
cryoprotected"
"trimethylamine-n-oxide,"
sn-glycerol-1-phosphate
"pyrrole-2-carboxylate),"
n-hexanoyl-l-homoserine
"methyl-2,4-pentanediol,"
"&#946;-mercaptoethanol,"
"2-methyl-2,4-pentandiol"
n-acetyl-d-glucosamine:
trimethyl-amino-n-oxide
n-dodecyl-b-d-maltoside
"trihydrate,polyethylene"
"(precipitant)
0.1-0.25"
alpha-d-mannopyranoside
"2,2,2-trifluoroethanol."
"octyl-beta-d-glucoside,"
"n-beta-octyl-glucoside,"
"n-acetyl-d-glucosamine,"
"converting
uro'gen-iii"
n-decylpentaoxyethylene
"2,2,2-trifluoroethanol,"
"nh4-dihydrogenphosphate,"
lpboa.19561.b.b1.ps38498
bupsa.00122.a.a1.pw28612
negoa.00743.a.b1.ps37949
"crystals
cryo-protected"
brmeb.01563.a.b1.ps01874
2-methyl-2-4-pentanediol
brova.17352.a.b1.ps02313
"3-methyl-1,5-pentanediol"
"inhibitor.
precipitant:"
"9.50
tri-sodium-citrate"
protein/carboplatin/dmso
3-(1-pyridino)-1-propane
negoa.00040.a.b1.pw37902
crpaa.00612.a.a3.pw37710
bobua.18943.a.b2.ps02467
bupsa.00122.a.a1.pw28261
"2-methyl-1,4-pentanediol"
selenomethionine-labeled
klpnc.00252.a.b1.pw38989
"2s,4r-4-methylglutamate,"
acr_pegish_amac_dmso_ada
"microbatch,
temperature"
acbac.00002.a.b1.ps02398
p-hydroxymercuribenzoate
lemaa.01212.a.a1.p001468
morpholineethanesulfonic
lepna.00809.a.b1.ps38414
nafoa.18681.a.b2.pw37988
butha.00168.a.a1.pw33338
"5-phospho-d-arabinonate,"
"d-arabinose-5-phosphate,"
1(protein):1(buffer):0.4
stmaa.01463.a.b1.pw38755
bupha.01664.a.a1.pw32082
5-bromovinyldeoxyuridine
n-decyl-beta-d-maltoside
"2-hydroxybutyryl-coa,
5"
acbac.17885.a.b1.pw38925
buama.00118.a.b1.ps37963
mytud.17389.a.a1.pw30616
nafoa.18272.a.b1.ps38284
nafoa.01523.a.b1.pw37976
chtra.00612.a.b1.pw38393
crnec.19313.a.b1.ps38377
acbac.00867.a.b1.pw37632
"udp-n-acetylglucosamine,"
negoa.00097.a.b1.ps37929
"alpha,beta-methylene-atp"
"d-arabonate-1,4-lactone,"
"dmso;
protein/inhibitor"
buama.00078.a.b1.ps02512
mytha.00809.a.b1.pw37508
n-octyl-beta-d-glucoside
lpboa.19557.c.b1.ps38542
lepna.00944.a.b1.ps38423
"tcep
reservoir:
14-18%"
"n-acetyl-d-glucosamine),"
bucea.00010.v.b2.ps01749
"2-methyl-2,4-pentanediol"
elana.17127.a.b1.ps38341
lepna.01206.a.b1.ps38438
"d-arabonate-1,4-lactone;"
n-citryl-ethylenediamine
"n,n-dimethyldodecylamine"
"6.5
protein/buffer:
38"
morpholinoethanesulfonic
heptyl-b-glucopyranoside
mytud.18400.a.a1.ps01434
nafoa.00085.a.b1.ps38274
"n-dodecyl-b-d-maltoside,"
4-hydroxymercurybenzoate
"thiocyanate
benzamidine"
klpnc.18288.a.b1.pw39049
"2,5-pyridinedicarboxylic"
acbac.00054.a.b1.pw38905
klpnc.17456.a.b1.pw39057
lpina.18975.a.b2.pw38653
braba.17352.a.a1.ps01094
"soaking
crystallization"
"2-methyl-2,4-pentandiol,"
"1,6-didemethyltoxoflavin"
buvia.00118.c.b1.ps02537
psaea.00025.a.b1.pw37555
"2-hydroxyethyldisulfide,"
lepna.00888.a.b1.pw38319
malonate-imidazole-boric
"octyl-b-glucopyranoside,"
braba.10201.a.a1.pw37326
"sulfonato-calix[8]arene,"
crpaa.18681.a.b3.pw37711
adenosine-5-triphosphate
anpha.17905.a.b1.pw37686
lepna.00906.a.b1.ps38320
brova.17370.a.b2.ps02137
myula.00612.a.b1.pw37993
mykaa.20209.a.b11.pb00104
"n-octyl-tetraoxyethylene,"
adenosine-5'-triphosphate
"betaine.
crystallization"
myula.01062.a.b12.ps38539
"2-methyl-2,4-pentanediol;"
"2-methane-2,4-pentanediol"
"5a,6-anhydrotetracycline,"
"2-methyl-1,3-propanediol,"
"1,5-naphthalenedisulfonic"
pentaerythritolethoxylate
plvib.18219.a.fr2.ps38192
"2-methyl-2,4-pentanediol,"
"beta-mercaptoethanol,0.02"
myula.01062.a.b13.ps38558
"na-isothiocyanate
12-15%"
crnec.01141.a.b12.pw38396
"hexatungstotellurate(vi),"
trans-4-hydroxy-l-proline
malonate-imidazole-borate
"n-octyl-beta-d-glucoside,"
n-octyl-b-d-thioglucoside
bupsa.00020.b.ae1.ps38619
"adenosine-5'-diphosphate,"
para-chloromercuribenzoic
"3-methyl-1,5-pentanediol,"
"5-undecylbenzene-1,3-diol"
"5,6-dimethylbenzimidazole"
"mytud.00149.b.b1.pw38903,"
"n-acetyl-d-galactosamine,"
"reservoir:protein
ligand"
"4-hydroxymercurybenzoate,"
methenyl-tetrahydrofolate
"sulfat
peg8000
ethylene"
"2,6-naphthalenedisulfonic"
mysma.00937.a.ae1.pw38670
morpholino-ethanesulfonic
morpholino)ethanesulfonic
"2-methylpentane-2,4-diol,"
"2-methyl-2,4-pentanediol."
fac-[et4n]2[re(co)3(br)3]
s-adenosyl-l-homocysteine
"fructose-1,6-bisphosphate"
heptyl-thiol-b-d-glucoside
n-dodecyl-beta-d-maltoside
4-morphilineerhanesulfonic
"hydroxylamine.
reservoir;"
"n-hexadecyl-b-d-maltoside,"
plvib.18219.a.fr21.ps38348
"sodium-acetate-trihydrate,"
psaea.00166.a.dg15.pd00442
"beta-octylglucopyranoside,"
hexadecyltrimethylammonium
4-morpholineethanesulfonic
ethylenediaminetetraacetic
4-(hydroxymercury)benzoate
"beta-mercaptoethanol(bme),"
2-morpholinoethanesulfonic
"2-methyl-2,4-pentane-diol,"
"dmso;

protein/inhibitor"
coima.00629.a.fs11.pd00401
"morpholinoethanesulfonate,"
"fructose-1,6-bisphosphate,"
"n-octyl-r-glucopyranoside,"
5-bromothienyldeoxyuridine
"s-adenosyl-l-homocysteine,"
4-morphilineethanesulfonic
"4-methylbenzylphosphonate,"
protein/coenzyme/inhibitor
"glycerol
cryo-protection:"
streptavidin-2-iminobiotin
beta-octylglucopyranoside.
psaea.00166.a.dg15.pd00471
"trans-4-hydroxy-l-proline,"
crnec.00629.a.fs11.pd00460
"5,6-dimethylbenzimidazole,"
4-(hydroxymercurybenzoate)
"peg3350

crystallization"
"(rs)-1,2-propanediol,
0.2"
"(2-methyl-2,4-pentanediol)"
1-butyl-3-methylimidazolium
n-octyl-b-d-glucopyranoside
"4-(hydroxymercury)benzoate,"
"(2-methyl-2,4-pentanediol),"
benzo(b)thiophene-2-boronic
"sodium-potassium-tartarate,"
"n-dodecyl-beta-d-maltoside,"
2-morpholinopropanesulfonic
4-morpholinepropanesulfonic
c(nc1cccc1)c1=cc=c2ococ2=c1
morpholine-ethane-sulphonic
"trimethylamine-n-oxide
16%"
"4-(hydroxymercuri)benzoate,"
succinate-phosphate-glycine
"trans-4-hydroxy-l-proline),"
"polyethyleneglycol(peg)400,"
"beta-octyl-glucopyranoside,"
"
biochem.biophys.res.comm."
"citrate,
25%(v/v)glycerol,"
"2,3,4,5,6-pentafluorobenzyl"
1-ethyl-3-methylimidazolium
"[2-methyl-2,4-pentanediol],"
"4-(hydroxymercurybenzoate),"
p-chloromercurybenzoicacid)
"tranylcypromine-derivative,"
dimethylundecylamin-n-oxide
3-(1-aminoethyl)-nonanedioic
"n-octyl-b-d-glucopyranoside,"
selenomethionine-substituted
"anthraquinone-2,6-disulfonic"
"pentaerythritol-propoxylate,"
"(2-methyl-pentane-2,4-diole,"
"pentaerythritol
propoxylate"
"5'-adenylylimidodiphosphate,"
"pentaerythritolethyloxylate,"
cc(c)(c)oc(=o)n1cccc[c@h]1cn
"4-(hydroxymercurybenzoate).,"
"1,3-dithiolane-2-carboxylate"
tri(2-carboxyethyl)phosphine
hexamminecobalt(iii)chloride
"ammoniumdihydrogenphosphate,"
selenomethionine-derivatized
n-(2-acetamido)iminodiacetic
"n-dodecyl-n,n-dimethylamine-"
"millimolar
tfa-lys-pro-iso,"
(crnec.00629.a.fs11.pd00402)
"2-deoxy-2,3-dehydro-n-acetyl"
octyl-beta-d-glucopyranoside
"adenosine-5'-phosphosulfate,"
"naphthalene-1,3,6-trisulfonic"
octyl-beta-d-glucopyranoside.
"4-(benzo[1,3]dioxol-5-yloxy)-"
tris(2-carboxyethyl)phosphine
"dl-lysine
monohydrochloride;"
"(octanoyl-n-methylglucamide),"
"(4s)-2-methyl-2,4-pentanediol"
"octyl-beta-d-glucopyranoside,"
"n-dodecyl-(beta)-d-maltoside,"
"3350

cryoprotection:
0.2m"
"n-heptyl-b-d-glucopyranoside,"
"2-methyl-2,4-pentanediol
0.1"
(n-(2-acetamido)iminodiacetic
dihydro-nicotinamide-adenine-
(succinate-phosphate-glycine)
"n-dodecyl-n,n-dimethylglycine"
"hexamminecobalt(iii)chloride,"
tris(2-caboxyethyl)phosphine.
"(n-(2-oxo-5-(pyridin-4-yl)-1,"
"n-tetradecyl-beta-d-maltoside,"
n-[-acetamido]-2-iminodiacetic
2-(n-morpholino)ethansulfonate
"n,n-dimethyldecylamine-n-oxide"
tris(2-carboxyethyl)-phosphine
n-octyl-beta-r-glucopyranoside
"(+/-)-2-methyl-2,4-pentanediol"
(propionate-cacodylate-bistris
2-[n-morpholino]ethanesulfonic
"2-methyl-2,4-pentanediol(mpd),"
"tris(2-carboxyethyl)phosphine,"
tris-(2-carboxyethyl)phosphine
"3""-deamino-3""-hydroxykanamycin"
(n-[2-acetamido]-2-aminoethane
3-morpholinopropane-1-sulfonic
2-(n-morpholino)ethanesulfonic
"n,n-dimethylundecylamin-n-oxide"
3-(n-morpholino)propanesulfonic
"1-butyl-2,3-dimethylimidazolium"
(2-(n-morpholino)ethanesulfonic
"mg.ml-1
cocrystallisation
1:1"
"1-s-nonyl-beta-d-thioglucoside,"
tris(hydroxymethyl)aminomethan;
p-chloromercuriphenylsulphonate
"(+/-)-2-methyl-2,4-pentanediol,"
n-[2-acetamido]-2-iminodiacetic
tris(hydroxymethyl)aminomethane
n-[tris(hydroxymethyl)methyl]-2
2-[n-morpholino]ethane-sulfonic
"5-methyl-tetrahydrofolate-glu3,"
"2-methyl-2,4-pentanediol,
0.1m"
n-(2-acetamido)-2-iminodiacetic
n-octyl-beta-r-glucopyrandoside
"(+/-)-2-methyl-2,4-pentanediol."
"n-octyl-beta-d-glucopyranoside,"
"n-decyl-beta-d-maltopyranoside,"
2-(n-morpholino)-ethanesulfonic
"5-amino-2,4,6-triiodoisophthalic"
"n-heptyl-beta-d-glucopyranoside,"
"toluenesulfonylmethylisocyanide,"
tris(hydroxymethyl)aminomethane;
"tris(hydroxymethyl)aminomethane,"
dimethyl(2-hydroxyethyl)ammonium
[fe]-hydrogenase-methenyl-h4mpt+
methenyl-tetrahydromethanopterin
2(cyclohexylamino)ethanosulfonic
"n-acetylglucosamine-1-phosphate,"
n-(carbamoylmethyl)iminodiacetic
1-n-beta-octyl-d-glucopyranoside
"beta-d-maltoside.
cryoprotectant"
"1,1,1,3,3,3-hexafluoro-2-propanol"
tetrahydrothiophene-2-carboxylate
"n,n-dimethyldodecylamine-n-oxide,"
2-(cyclohexylamino)ethanesulfonic
"n-acetyl-glucosamine-6-phosphate,"
"5'-(beta,gamma-imido)triphosphate,"
n-cyclohexyl-2-aminoethanesulfonic
"1,1,1,3,3,3-hexafluoro-2-propanol,"
"alcohol,
10%peg20k,
20%peg550mme"
octyl-beta-s-1-thioglucopyanoside.
2-(bis(2-hydroxyethyl)amino)acetic
n-benzoyl-n'-beta-d-glucopyranosyl
"
sulfanyl]-2,4-quinazolinediamine"
5'-o-(n-(l-seryl)-sulfamoyl)uridine
"dtdp-4-amino-4,6-dideoxy-d-glucose,"
"n-dodecyl-n,n-dimethylamine-n-oxide"
"polyetheleneglycolemonomethylether,"
nc1=nc(=cs1)[c@@h]1cc(=o)oc11ccccc1
3-chloromercuri-2-methoxypropylurea
"cyclohexyl-methyl-beta-d-maltoside,"
n-cyclohexyl-3-aminopropanesulfonic
"2-mercaptoethanol.
crystallization"
"dtdp-3-amino-3,6-dideoxy-d-glucose,"
"tris(hydroxymethyl)aminomethane-hcl,"
"n-enanthyl-l-prolyl-l-phenylalanine,"
2-(4-(2-hydroxyethyl)-1-piperazinyl)
(n-cyclohexyl-3-aminopropanesulfonic
"dtdp-3-amino-3,6-dideoxy-d-galactose,"
5'-o-[n-(dehydroluciferyl)-sulfamoyl]
"4000
mgcl2
tris
glycerol
methanol"
n-(2-acetamido)-2-aminoethanesulfonic
"n,n-dimethyldecylamine-n-oxide(ddao),"
3-(cyclohexylamino)-1-propanesulfonic
5-bromo-2-(piperidin-3-ylamino)benzoic
"2-deoxy-2,3-dehydro-n-acetylneuraminic"
"2.5%
2-hydroxypropyl-beta-cyclodextrin"
"dimethylethyl-(3-sulfopropyl)-ammonium,"
"n-carboxybenzyl-l-prolyl-l-phenylalanine,"
dihydro-nicotinamide-adenine-dinucleotide
"d.groche,a.becker,i.schlichting,w.kabsch,"
"2-amino-2-(hydroxymethyl)propane-1,3-diol"
3-(n-morpholino)-2-hydroxypropanesulfonic
"n-(5-cyclohexyl)valeroyl-l-phenylalanine,"
cyclohexylbutanoyl-n-hydroxyethylglucamide
7-tetrahydrobenzo[b]thiophene-4-carboxylic
n-[tris(hydroxylmethyl)methyl]2-aminoethane
n-[tris(hydroxymethyl)methyl]-2-aminoethane
"1,2-diheptanoyl-sn-glycero-3-phosphocholine"
"cyclohexylbutanoyl-n-hydroxyethylglucamide,"
"tris(2-carboxyethyl)
phosphine.
reservoir"
"2,6-dimethyl-4-heptyl-beta-d-maltopyranoside"
5'-o-(n-(l-seryl)-sulfamoyl)n3-methyluridine
4-(2-hydroxyethyl)-1-piperazineethanesulfonic
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic
"n,n-bis(2-hydroxyethyl)-2-aminoethanesulfonic"
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic
4-(2-hydroxyethyl)-piperazine-1-ethanesulfonic
4-(2-hydroxyethyl)-1-piperazineethanesulfonate
"1,3-bis(tris(hydroxymethyl)methylamino)propane"
4-(2-hydroxyethyl)-1-piperazinepropanesulfonic
n-2-hydroxyethylpiperazine-n'-2-ethanesulfonate
"udp-2-acetamido-4-amino-2,4,3-trideoxy-d-glucose"
"1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine"
(n-(2-hydroxyethyl)piperazine-n-(2-ethanesulfonic
2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic
2-dihydropyridin-3-yl)-4-piperidin-1-yl)benzamide.
"6,6,6-trifluoro-5-hydroxy-3-oxo-5-phenyl-hexanoate"
bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane
3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic
2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate
n-[tris(hydroxymethyl)methyl)]-2-aminoethanesulfonate
(bis(2-hydroxyethyl)-amino-tris(hydroxymethyl)-methane)
"mes-bis-tris
mega8-solution
dtt
edta
licl
methanol"
2-fluoro-4-[4-(4-fluorophenyl)-1h-pyrazol-3-yl]pyridine
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
n-dodecyl-(beta)-d-maltoside-ligand-(delta)abd-p110(delta)
"n-{2-[4-(trifluoromethoxy)phenoxy]}acetoyl-l-phenylalanine,"
"ru(ii)(cymene)(1,3-dimethylbenzimidazol-2-ylidene)(chlorido)2"
"5-(5-bromo-2-propoxyphenyl)-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-7(6h)-one,"
"(6-amino-2,3-dihydro-4-phenyl-1h-pyrido[4,3-b][1,4]diazepin-8-yl)-carbamate,"
"(6as,9s,10as)-6,6,9-trimethyl-9-vinyl-6a,7,8,10a-tetrahydro-5h-indeno[2,1-b]indol-10-one"
"n-{2-[4-(thiophen-2-yl)-1h-imidazol-2-yl]ethyl}-2,3-dihydro-1,4-benzodioxine-2-carboxamide"
"(s)-4-(8-amino-3-(1-(4-(dimethylamino)butanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(thiazol-2-yl)benzamide"
"(s)-4-(8-amino-3-(1-(4-(dimethylamino)butanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(thiazol-2-yl)benzamide,"
"trdyeiqrerielgrcigegqfgdvhqgiymspenpalavaiktcknctsdsvrekflqealtmrqfdhphivkligvi
tenpvwiimelctlgelrsflqvrkysldlaslilyayqlstalayleskrfvhrdiaarnvlvssndcvklgdfglsry
medstyykaskgklpikwmapesinfrrftsasdvwmfgvcmweilmhgvkpfqgvknndvigriengerlpmppncppt
lyslmtkcwaydpsrrprftelkaqlstileeeklq"
